{"meta":{"query_hash":"4cfbdd9d7299","filters":{"venue":"American Journal of Clinical Dermatology"},"cohort_total":137,"direct_labels_cover":1,"predictions_cover":137,"exported":137,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4cfbdd9d7299","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Clinical+Dermatology"},"results":[{"id":"W119503694","doi":"10.2165/11593240-000000000-00000","title":"Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario HIV Treatment Network; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ontario HIV Treatment Network; Canadian Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Medicine; Cohort; Incidence (geometry); Erythema multiforme; Population; Retrospective cohort study; Pediatrics; Cohort study; Internal medicine; Dermatology; Environmental health","score_opus":0.05387720911183005,"score_gpt":0.3742420569830588,"score_spread":0.32036484787122876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W119503694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714166,0.000092828544,0.00017556298,0.0013542164,0.0001796294,0.00012003041,0.0000028637603,0.000009426196,0.00092380034],"genre_scores_gemma":[0.9951281,0.0003943897,0.0038140146,0.00058676815,0.00004207874,0.0000024385317,0.0000014140018,0.000017576369,0.000013244917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967144,0.00054846465,0.0019810481,0.00023385331,0.00024418277,0.00027806757],"domain_scores_gemma":[0.9968176,0.00086977537,0.0013445173,0.0003121379,0.00022304512,0.00043291086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090591045,0.00015211913,0.0016863905,0.00038007132,0.000022927617,0.0000034699892,0.00017709156,0.00013436993,0.000027797536],"category_scores_gemma":[0.0011705004,0.00012898466,0.00022801771,0.0003692864,0.0009183734,0.00026877085,0.00005215416,0.0007355734,0.0000121013645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018266626,0.0005199792,0.94856817,0.000020162774,0.00018422813,0.0028579575,0.00019907809,0.0000031619134,0.00030270108,0.000083384264,0.000019276104,0.047059234],"study_design_scores_gemma":[0.0012951447,0.000713236,0.9651332,0.00011978205,0.0002660896,0.030890446,0.0006875443,0.00013105643,0.00023073216,0.000116072166,0.0003125511,0.00010414572],"about_ca_topic_score_codex":0.00012395174,"about_ca_topic_score_gemma":0.00003997074,"teacher_disagreement_score":0.04695509,"about_ca_system_score_codex":0.000030203371,"about_ca_system_score_gemma":0.0002898704,"threshold_uncertainty_score":0.52598417},"labels":[],"label_agreement":null},{"id":"W1243598765","doi":"10.2165/11631880-000000000-00000","title":"Pharmacologic Interventions for Hidradenitis Suppurativa","year":2012,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"European Society for Dermatological Research","keywords":"Medicine; Hidradenitis suppurativa; Infliximab; Adalimumab; Randomized controlled trial; Adverse effect; MEDLINE; Psychological intervention; Discontinuation; Disease; Systematic review; Internal medicine; Physical therapy; Intensive care medicine","score_opus":0.36745854606808154,"score_gpt":0.5828050171403425,"score_spread":0.21534647107226096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1243598765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057823498,0.98920584,0.0006748897,0.006668576,0.0019047869,0.0010225188,0.0001080447,0.000025720552,0.00033180582],"genre_scores_gemma":[0.027116671,0.96682227,0.004209378,0.00005283518,0.0011994258,0.000098553144,0.00012115744,0.00007657884,0.0003031392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929796,0.0013271422,0.0045652045,0.000317013,0.00025840753,0.0005526659],"domain_scores_gemma":[0.9904312,0.003944592,0.0042738854,0.00030294075,0.00035833885,0.000689035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006646004,0.00049902586,0.007753934,0.00043741535,0.00008519863,0.000019053377,0.00036114382,0.0004024837,0.0005056698],"category_scores_gemma":[0.0009439738,0.00033159112,0.005618102,0.00034579993,0.0008539221,0.0001695452,0.00007082909,0.0012817018,0.00017338741],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016732163,0.0010537875,0.00048528166,0.0049062525,0.0025327848,0.020094177,0.00002791663,2.5856468e-9,9.1086235e-8,0.00010088509,0.0021260877,0.9685054],"study_design_scores_gemma":[0.0013778731,0.001882111,0.000027310518,0.004306839,0.009156105,0.39445463,0.000039163635,5.7651476e-7,6.7699585e-7,0.000034654844,0.58855987,0.00016019992],"about_ca_topic_score_codex":0.0000024553324,"about_ca_topic_score_gemma":0.0000010905168,"teacher_disagreement_score":0.9683452,"about_ca_system_score_codex":0.000091220594,"about_ca_system_score_gemma":0.0008471527,"threshold_uncertainty_score":0.99991363},"labels":[],"label_agreement":null},{"id":"W160731419","doi":"10.2165/00128071-200910040-00002","title":"Dapsone 5% Gel","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Dapsone; Medicine; Acne; Dermatology; Adverse effect; Isotretinoin; Pharmacology","score_opus":0.10312371780429515,"score_gpt":0.5060478937611652,"score_spread":0.4029241759568701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W160731419","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003762886,0.9962713,0.000062137005,0.0012892706,0.00060637237,0.00022462512,0.0000041335693,0.000013606215,0.0011522494],"genre_scores_gemma":[0.00045928397,0.9953243,0.0013889015,0.0016640711,0.0008862773,0.0000026970572,0.000016566282,0.000035451045,0.00022243716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957162,0.000655592,0.0027922515,0.00025250937,0.00024643008,0.00033699776],"domain_scores_gemma":[0.9948736,0.0012611453,0.002865818,0.00034703672,0.00015274576,0.0004996718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047820495,0.00036394113,0.007916817,0.00023102699,0.00004198395,0.000009796058,0.00022677513,0.00037472072,0.000059205897],"category_scores_gemma":[0.0005296011,0.00020294831,0.0022588633,0.00028537982,0.00046151032,0.000044682532,0.000037830345,0.0012854385,0.00014032582],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010929264,0.00043000252,0.0002730051,0.0008662359,0.0010432029,0.0044745402,0.000009054804,3.0498477e-8,1.3347555e-8,0.000027116734,0.009105167,0.98366237],"study_design_scores_gemma":[0.001116181,0.0031926902,0.00021860508,0.0051239873,0.0042582764,0.039749824,0.0000168156,0.0000010533557,1.2640396e-7,0.000025093836,0.9461387,0.0001586621],"about_ca_topic_score_codex":0.0000036917286,"about_ca_topic_score_gemma":3.3022957e-7,"teacher_disagreement_score":0.9835037,"about_ca_system_score_codex":0.00003410551,"about_ca_system_score_gemma":0.00086720183,"threshold_uncertainty_score":0.8275992},"labels":[],"label_agreement":null},{"id":"W1793997425","doi":"10.1007/s40257-015-0158-0","title":"Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Pharmacotherapy; Erythroderma; Internal medicine","score_opus":0.1220413872710241,"score_gpt":0.47238018069650023,"score_spread":0.35033879342547614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1793997425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008534765,0.9868433,0.00006615682,0.0020234,0.0012095566,0.00044686603,0.000031609536,0.000049220398,0.0007951305],"genre_scores_gemma":[0.008738956,0.987535,0.0019799862,0.0010303211,0.00050870277,0.000009515906,0.000036076122,0.000104195904,0.000057251804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918598,0.0021501104,0.0043591103,0.00055440655,0.00050446275,0.0005721261],"domain_scores_gemma":[0.99107236,0.0015528906,0.0045940634,0.0007312974,0.00044460766,0.0016048123],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017834109,0.0005797126,0.009644203,0.00067989266,0.000067172565,0.000028483078,0.00040540323,0.00058093906,0.00002126784],"category_scores_gemma":[0.001469243,0.00042950193,0.0014143122,0.00058055733,0.001100758,0.00028397265,0.00013375361,0.002708766,0.00016591088],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037797836,0.0003503876,0.00015392956,0.00084950245,0.0012819755,0.0073334724,0.000017929782,4.3440437e-7,1.651025e-7,0.0000364131,0.00046935747,0.98946863],"study_design_scores_gemma":[0.0009208152,0.0006540839,0.0005582896,0.0023208226,0.0046051797,0.24819925,0.00013786409,0.000008404383,1.2705704e-7,0.000040829236,0.7422875,0.00026680142],"about_ca_topic_score_codex":0.000016319422,"about_ca_topic_score_gemma":0.000004454158,"teacher_disagreement_score":0.98920184,"about_ca_system_score_codex":0.0001187146,"about_ca_system_score_gemma":0.0022032573,"threshold_uncertainty_score":0.9998157},"labels":[],"label_agreement":null},{"id":"W1972569644","doi":"10.2165/00128071-200203010-00004","title":"The Role of Fluoroquinolones in Skin and Skin Structure Infections","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Dermatology; Skin infection; Intensive care medicine; Internal medicine; Staphylococcus aureus","score_opus":0.0338893809488807,"score_gpt":0.4149426798164158,"score_spread":0.3810532988675351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972569644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02017371,0.9785147,0.000009422767,0.0006021638,0.00032999,0.0001939142,0.000009118107,0.0000035106573,0.0001635173],"genre_scores_gemma":[0.12075301,0.87869054,0.00021326054,0.00009035991,0.00021564375,6.689458e-7,0.0000025814984,0.000022841714,0.0000111185755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633044,0.00056551176,0.002510903,0.0001758286,0.0001750847,0.00024225337],"domain_scores_gemma":[0.9950594,0.0021898209,0.0021736445,0.00023921228,0.0001545168,0.00018344265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036063013,0.00022873076,0.0032018938,0.00024910545,0.00004137793,0.0000097382235,0.00022002085,0.0002480523,0.000027522148],"category_scores_gemma":[0.00065784715,0.0001334564,0.00059357873,0.00035235705,0.0011950044,0.000022499402,0.00007706601,0.0014044581,0.0000039661295],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040411513,0.00017137929,0.0035628488,0.0004562317,0.0003343538,0.000098269906,0.000031769978,6.642662e-7,5.306793e-7,0.00017154335,0.00023416225,0.99489784],"study_design_scores_gemma":[0.00072091544,0.0007710845,0.0032689373,0.0017514927,0.000995783,0.008609909,0.00007607399,0.000034168243,0.0000053573526,0.00013061053,0.98351586,0.00011983262],"about_ca_topic_score_codex":0.000013339328,"about_ca_topic_score_gemma":0.000008286185,"teacher_disagreement_score":0.994778,"about_ca_system_score_codex":0.000014269652,"about_ca_system_score_gemma":0.00023076926,"threshold_uncertainty_score":0.61017495},"labels":[],"label_agreement":null},{"id":"W1975795171","doi":"10.2165/00128071-200607030-00004","title":"Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??)","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"","keywords":"Betamethasone dipropionate; Medicine; Dermatology; Psoriasis; Calcipotriol","score_opus":0.03893121790341279,"score_gpt":0.3272870268135607,"score_spread":0.2883558089101479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975795171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228257,0.0038442048,0.00046163157,0.0017201111,0.001057308,0.00041231565,0.000084636464,0.000026012285,0.000111204216],"genre_scores_gemma":[0.9960449,0.0010305956,0.0021612127,0.00012260956,0.00019606882,0.000025351566,0.000055216573,0.000048736347,0.00031532615],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941443,0.0018224203,0.0026319127,0.00052458775,0.00022923287,0.0006474974],"domain_scores_gemma":[0.9916008,0.0039663846,0.0030872992,0.0007554343,0.0004792248,0.00011084691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006859637,0.000522574,0.0029756622,0.00030391468,0.00020300919,0.00001963799,0.00051093433,0.00024897407,0.000051812753],"category_scores_gemma":[0.0002967848,0.00030083835,0.0011598155,0.0006729892,0.0021152142,0.00022161404,0.00007843272,0.00042989122,0.000018263725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021343475,0.014329003,0.5911693,0.00006350275,0.028095374,0.0024696465,0.0012954602,0.00054941035,0.07623606,0.0010502068,0.0030645754,0.260334],"study_design_scores_gemma":[0.041454643,0.03721834,0.27823046,0.00031800644,0.0190838,0.012454603,0.0011264274,0.000028211694,0.51149786,0.00043574002,0.09654659,0.0016053565],"about_ca_topic_score_codex":0.0013953161,"about_ca_topic_score_gemma":0.00012327997,"teacher_disagreement_score":0.4352618,"about_ca_system_score_codex":0.000067141336,"about_ca_system_score_gemma":0.00046133832,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W1977267367","doi":"10.2165/00128071-200001040-00003","title":"Assessment and Clinical Implications of Absorption of Sunscreens Across Skin","year":2000,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cosmetics; Stratum corneum; Dermatology; Absorption (acoustics); Systemic circulation; Medicine; Skin barrier; Ultraviolet radiation; Chemistry; Materials science; Pathology","score_opus":0.12321574120501994,"score_gpt":0.5521958423288226,"score_spread":0.42898010112380264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977267367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045486446,0.9453362,0.0027069699,0.0036086314,0.0007897993,0.00094577845,0.00007273968,0.000023904635,0.0010294867],"genre_scores_gemma":[0.057541348,0.9388601,0.0029628945,0.00029950592,0.0002694286,0.0000060353036,0.00001103772,0.000028201473,0.000021444977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992218,0.0011514747,0.0058532213,0.00029066898,0.0002478191,0.00023879789],"domain_scores_gemma":[0.99012595,0.0029282894,0.0058676307,0.00040950056,0.00035503588,0.00031357715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018158335,0.00024233635,0.005524361,0.00021820022,0.00003730531,0.000006472534,0.00022841006,0.00036217927,0.000080498816],"category_scores_gemma":[0.00070012663,0.00017759248,0.0015615463,0.00037520574,0.0015743385,0.00004746236,0.000066783774,0.0014774525,0.000005545274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000916384,0.00038530215,0.019744148,0.0009442306,0.0006308965,0.000036880072,0.000013672822,1.5865456e-7,3.4293004e-7,0.00013059333,0.00019578403,0.97782636],"study_design_scores_gemma":[0.0021429071,0.0024236976,0.13948962,0.0064037135,0.0026399663,0.014281141,0.00013963094,0.000012068658,0.000001628214,0.00016286013,0.83207387,0.0002289194],"about_ca_topic_score_codex":0.000018239753,"about_ca_topic_score_gemma":0.0000035704388,"teacher_disagreement_score":0.9775974,"about_ca_system_score_codex":0.00002907859,"about_ca_system_score_gemma":0.00080017786,"threshold_uncertainty_score":0.7242011},"labels":[],"label_agreement":null},{"id":"W1979209155","doi":"10.1007/s40257-015-0119-7","title":"Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Women's College Hospital; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Epidermolysis bullosa; Dermatology; Genotype; Mutation; Meta-analysis; Internal medicine; Epidermolysis bullosa simplex; Pathology; Genetics; Gene; Biology","score_opus":0.12387531509326755,"score_gpt":0.4291166032516235,"score_spread":0.30524128815835594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979209155","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022883088,0.9972427,0.00060800236,0.00018883245,0.00079187454,0.0007849724,0.0000109032035,0.000009032015,0.00013487498],"genre_scores_gemma":[0.0004116327,0.9978954,0.0004440389,0.00026885475,0.00058613135,0.00008575895,0.00014250608,0.00006687886,0.00009880054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98922116,0.0049691466,0.00436806,0.00053507247,0.00041715114,0.00048942637],"domain_scores_gemma":[0.99254656,0.00086937513,0.0045471517,0.0008688189,0.0007178654,0.0004502451],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036810783,0.0005037411,0.0071280445,0.00022544012,0.00006060842,0.000019072486,0.00095513003,0.0005432553,0.000029258536],"category_scores_gemma":[0.0056987046,0.00035531717,0.0018942916,0.00044829305,0.00065691804,0.000009681538,0.0002446324,0.0011400053,0.00018628368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001271901,0.00022950846,0.000081966165,0.27439308,0.0032836634,0.00219778,0.0000161089,0.0000013510221,0.0000027909632,0.00006306234,0.0048483545,0.7147552],"study_design_scores_gemma":[0.0004807672,0.0011729279,0.0000027883366,0.10566609,0.0057237917,0.040652655,0.000043088658,0.000006320367,0.000003793135,0.000032712833,0.84567475,0.0005403273],"about_ca_topic_score_codex":0.0000042283573,"about_ca_topic_score_gemma":0.0000010961965,"teacher_disagreement_score":0.8408264,"about_ca_system_score_codex":0.000042466214,"about_ca_system_score_gemma":0.0013434517,"threshold_uncertainty_score":0.9998899},"labels":[],"label_agreement":null},{"id":"W1983541360","doi":"10.2165/00128071-200304120-00005","title":"Cost of Medications in Patients Admitted to a Burn Center","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Burn Injury Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Formulary; Burn center; Toxic epidermal necrolysis; Emergency medicine; Medical record; Retrospective cohort study; Trauma center; Pediatrics; Surgery; Poison control; Family medicine","score_opus":0.04464836051780951,"score_gpt":0.409535332553763,"score_spread":0.3648869720359535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983541360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886058,0.000024571773,0.0006411497,0.008412696,0.00037444875,0.00019217037,0.0000021294736,0.0000041499547,0.0017429137],"genre_scores_gemma":[0.99226296,0.000069301765,0.0023389,0.005234418,0.00003271381,0.0000025239874,0.0000027659732,0.00000874177,0.000047659643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997576,0.00030078526,0.0015878461,0.00011104978,0.00023461513,0.00018973151],"domain_scores_gemma":[0.9981289,0.00045337682,0.0007310265,0.0001865949,0.00023646014,0.00026364854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049014966,0.00008711474,0.00091900805,0.00029092288,0.000011533618,0.0000023115779,0.00014186619,0.00005302013,0.00013818595],"category_scores_gemma":[0.0018813106,0.00006674467,0.00018428371,0.00039193165,0.00025403322,0.000044213553,0.000026744634,0.00031062894,0.000023387398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037392983,0.0006428939,0.9774963,0.000010926673,0.00011664394,0.000052711035,0.00008417667,0.0000010312074,0.0000021221547,0.0003664202,0.0026609956,0.018191826],"study_design_scores_gemma":[0.003906083,0.00113756,0.9466721,0.00007462308,0.00007671293,0.00011367086,0.00021563211,0.000005958238,0.00003787644,0.00007139942,0.047629446,0.00005894576],"about_ca_topic_score_codex":0.0000055345904,"about_ca_topic_score_gemma":0.0000049986975,"teacher_disagreement_score":0.044968452,"about_ca_system_score_codex":0.00001724251,"about_ca_system_score_gemma":0.000117096795,"threshold_uncertainty_score":0.2721769},"labels":[],"label_agreement":null},{"id":"W1984062094","doi":"10.2165/00128071-200304030-00006","title":"Optimizing Treatment with Topical Tazarotene","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Allergan","keywords":"Tazarotene; Medicine; Dermatology; Adapalene; Mometasone furoate; Acne; Tolerability; Psoriasis; Combination therapy; Erythema; Adverse effect; Retinoid; Tretinoin; Irritation; Calcipotriol; Pharmacology; Corticosteroid; Surgery; Retinoic acid; Immunology; Benzoyl peroxide","score_opus":0.08788930886669413,"score_gpt":0.45090600086289373,"score_spread":0.36301669199619957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984062094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010469147,0.9964113,0.0003107298,0.00057451695,0.00039162024,0.0003559782,0.0000035139774,0.000011562831,0.00089384685],"genre_scores_gemma":[0.0004723984,0.9904073,0.007788586,0.0005634592,0.00039886078,0.000013125537,0.000011537567,0.000046466714,0.00029828644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964876,0.0006809232,0.0019560477,0.0002987245,0.00021929562,0.00035736407],"domain_scores_gemma":[0.996266,0.00092508877,0.0018629654,0.00033545351,0.00011198735,0.0004984946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022358494,0.00043836032,0.0067496644,0.00016755056,0.000053593983,0.000012202358,0.00013088883,0.0003052652,0.00007023233],"category_scores_gemma":[0.000053099233,0.00020641291,0.0014927898,0.00019881804,0.0005027018,0.00003903381,0.00002071196,0.0007211549,0.000041574887],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024078946,0.0006135582,0.00048373415,0.0005846202,0.0022407947,0.00613467,0.000020024772,3.8805922e-7,1.6786968e-8,0.00002798939,0.0002922454,0.98936117],"study_design_scores_gemma":[0.0023418816,0.012609404,0.000033930144,0.003047836,0.005371838,0.04443508,0.000049079452,0.0000018606771,5.861986e-7,0.0000031299608,0.9319234,0.00018196122],"about_ca_topic_score_codex":0.000007787088,"about_ca_topic_score_gemma":0.0000010897371,"teacher_disagreement_score":0.9891792,"about_ca_system_score_codex":0.00011348383,"about_ca_system_score_gemma":0.0016045577,"threshold_uncertainty_score":0.84172744},"labels":[],"label_agreement":null},{"id":"W1991330761","doi":"10.2165/00128071-200809050-00001","title":"Can We Define Acne as a Chronic Disease?","year":2008,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Acne; Medicine; Disease; Dermatology; Intensive care medicine; Clinical trial; Epidemiology; Acne treatment; Pathology","score_opus":0.07052480202714943,"score_gpt":0.45619216244835364,"score_spread":0.3856673604212042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991330761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093714625,0.9908584,0.000013945382,0.0067526354,0.00069002545,0.0003605608,0.000018772731,0.000019136749,0.00034940682],"genre_scores_gemma":[0.002623578,0.99415314,0.00023244946,0.0012819881,0.0012476979,0.0000139395925,0.000046125522,0.00006975287,0.00033133672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952672,0.00074578664,0.002761237,0.00037242423,0.0003564217,0.00049688976],"domain_scores_gemma":[0.99400127,0.0014649876,0.0027470826,0.0004815916,0.0001631111,0.0011419479],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020421842,0.0005172038,0.007243195,0.00027483853,0.000087466455,0.000009745508,0.0002962541,0.00032211986,0.00013089164],"category_scores_gemma":[0.00074391975,0.00030187587,0.0026835715,0.0003664415,0.0009602795,0.000042290547,0.000082945655,0.0013919708,0.00022138978],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023060225,0.00045355823,0.0008867942,0.001969295,0.0016340355,0.016103504,0.0000148502295,1.6967617e-7,1.6479795e-8,0.000046463367,0.008878959,0.96978176],"study_design_scores_gemma":[0.0016559548,0.003126062,0.0002869274,0.008112952,0.003940136,0.059427045,0.0000113704045,0.0000020828554,1.2498906e-7,0.000056320096,0.92314625,0.000234798],"about_ca_topic_score_codex":0.000020725181,"about_ca_topic_score_gemma":0.000003598564,"teacher_disagreement_score":0.969547,"about_ca_system_score_codex":0.00012567196,"about_ca_system_score_gemma":0.004520003,"threshold_uncertainty_score":0.9999433},"labels":[],"label_agreement":null},{"id":"W1995325931","doi":"10.2165/00128071-200809040-00004","title":"Ceftobiprole","year":2008,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Bacteroides fragilis; Microbiology; Cefepime; Cephalosporin; Enterococcus faecalis; Ceftazidime; Medicine; Antibiotics; Pharmacology; Biology; Pseudomonas aeruginosa; Staphylococcus aureus; Imipenem; Antibiotic resistance; Bacteria","score_opus":0.12093585059013945,"score_gpt":0.5077251777660386,"score_spread":0.3867893271758992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995325931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027694192,0.99637496,0.00014224222,0.0007774951,0.00093695987,0.0002018881,0.0000051081747,0.0000139759,0.0012704002],"genre_scores_gemma":[0.0009696066,0.99471533,0.0020455676,0.0010142501,0.001075175,8.3345395e-7,0.000010018555,0.000064447675,0.0001047617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947492,0.00054189475,0.0037714497,0.0002672981,0.00031729194,0.0003528811],"domain_scores_gemma":[0.99383897,0.0014021286,0.0035097927,0.00036473727,0.00030880686,0.0005755655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034329438,0.0003533946,0.0071435627,0.0003045456,0.000037266684,0.0000076073497,0.00036752067,0.00032199334,0.00007917697],"category_scores_gemma":[0.00081263785,0.00023742519,0.0024601384,0.0003609368,0.0011123896,0.000027741271,0.00008253862,0.0019570552,0.00020028223],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008743474,0.00033520203,0.00033540663,0.0010054798,0.0007745113,0.0035587368,0.0000079317815,2.126156e-7,4.3385086e-8,0.000041189105,0.013596406,0.98025745],"study_design_scores_gemma":[0.0008281535,0.001014223,0.00012849178,0.0027485145,0.001714579,0.08004967,0.000008874727,0.000007734567,3.9383195e-7,0.000007320602,0.9133157,0.00017631038],"about_ca_topic_score_codex":0.0000018518003,"about_ca_topic_score_gemma":9.906017e-8,"teacher_disagreement_score":0.98008114,"about_ca_system_score_codex":0.00002381336,"about_ca_system_score_gemma":0.0012733057,"threshold_uncertainty_score":0.96819186},"labels":[],"label_agreement":null},{"id":"W1996532601","doi":"10.2165/00128071-200405040-00006","title":"Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; PharmIdeas (Canada); Health Sciences Centre; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Pimecrolimus; Tacrolimus; Medicine; Calcineurin; Atopic dermatitis; Placebo; Eczema Area and Severity Index; Randomized controlled trial; Dermatology; Internal medicine; Transplantation; Pathology","score_opus":0.06726534287392007,"score_gpt":0.44266883156699377,"score_spread":0.3754034886930737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996532601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02486171,0.9709385,0.00001191262,0.0029163782,0.00058114645,0.00044099923,0.0000084481335,0.0000071160703,0.0002337991],"genre_scores_gemma":[0.06311151,0.93556076,0.00020177654,0.0007635425,0.0002975372,0.000018445771,0.000011760378,0.000021729515,0.000012946909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99361736,0.0015795948,0.00394757,0.00024169506,0.0002968852,0.0003169066],"domain_scores_gemma":[0.9940495,0.0029235936,0.002223219,0.00045755747,0.00011372267,0.0002324197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029404165,0.00035617632,0.0058366046,0.00033555864,0.00002751948,0.000006340914,0.0003760871,0.0003745767,0.000038769598],"category_scores_gemma":[0.0006106088,0.0001937506,0.0019302166,0.0004165055,0.0012182331,0.00004279669,0.000026103262,0.00082312163,0.000021167543],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068087036,0.0018897533,0.028668145,0.0027369678,0.0005013076,0.0084313,0.00021278292,3.7449254e-7,7.844746e-9,0.00015578972,0.0011329438,0.95620257],"study_design_scores_gemma":[0.0022165072,0.0019373727,0.015599176,0.005370145,0.0019010114,0.03949476,0.00015984502,6.591875e-7,0.000001414995,0.00013674957,0.93302685,0.00015552253],"about_ca_topic_score_codex":0.00004312992,"about_ca_topic_score_gemma":0.000017055647,"teacher_disagreement_score":0.956047,"about_ca_system_score_codex":0.00007506844,"about_ca_system_score_gemma":0.0014298181,"threshold_uncertainty_score":0.790092},"labels":[],"label_agreement":null},{"id":"W1999541518","doi":"10.2165/00128071-200405060-00006","title":"Role of Antifungal Agents in the Treatment of Seborrheic Dermatitis","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Seborrheic dermatitis; Terbinafine; Malassezia; Pimecrolimus; Ketoconazole; Dermatology; Itraconazole; Medicine; Seborrhoeic dermatitis; Dermatomycosis; Tea tree oil; Antifungal; Shampoo; Tacrolimus; Biology; Essential oil; Surgery; Pathology; Botany","score_opus":0.08453442629024796,"score_gpt":0.4672681617179624,"score_spread":0.3827337354277145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999541518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043224383,0.95556366,0.000003879441,0.00023770657,0.00017546701,0.00050107,0.00006120899,0.0000029380278,0.00022966074],"genre_scores_gemma":[0.13596778,0.86349046,0.0002596361,0.00013606808,0.00007891295,0.000010746044,0.000026719581,0.000023134264,0.0000065125123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99476844,0.00091975485,0.003506863,0.00019687922,0.0003527853,0.00025526053],"domain_scores_gemma":[0.99420315,0.001327469,0.003706143,0.00041485214,0.00014808815,0.00020031352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024395734,0.00031910758,0.005527093,0.00029649443,0.000017127624,0.0000042943598,0.00029895612,0.00018663601,0.000055561344],"category_scores_gemma":[0.00022124957,0.00017153015,0.0020445904,0.00041600122,0.00060796336,0.000035954494,0.000020731304,0.00036971705,0.000014348501],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012787149,0.0037173373,0.034843076,0.0020566958,0.0015270691,0.0018908738,0.00012016851,5.7681916e-7,6.191104e-8,0.000048465656,0.00009790249,0.9555699],"study_design_scores_gemma":[0.008304685,0.011469874,0.08074772,0.018256411,0.012239522,0.017236818,0.00043814204,0.000004816846,0.000006243619,0.00025525317,0.85074264,0.00029789735],"about_ca_topic_score_codex":0.000086744694,"about_ca_topic_score_gemma":0.0000063944453,"teacher_disagreement_score":0.955272,"about_ca_system_score_codex":0.000084651605,"about_ca_system_score_gemma":0.0011494794,"threshold_uncertainty_score":0.69947964},"labels":[],"label_agreement":null},{"id":"W2000347666","doi":"10.2165/00128071-200506060-00003","title":"Monitoring Liver Function during Methotrexate Therapy for Psoriasis","year":2005,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Methotrexate; Medicine; Psoriasis; Liver biopsy; Biopsy; Pharmacotherapy; Liver function; Liver function tests; Internal medicine; Liver disease; Dermatology","score_opus":0.4229021072902276,"score_gpt":0.5805141046800265,"score_spread":0.15761199738979892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000347666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010678381,0.97729087,0.0008448518,0.00031192647,0.009676619,0.0009560454,0.00003433515,0.000056503213,0.00015049076],"genre_scores_gemma":[0.00737018,0.9845273,0.00164572,0.00041515974,0.0057377513,0.000117862175,0.0000066349817,0.000087115375,0.00009231393],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903164,0.0048979316,0.003458409,0.00047503403,0.0002249573,0.0006272891],"domain_scores_gemma":[0.9884573,0.0057427087,0.004716838,0.00028397134,0.00036210284,0.00043704011],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0030299602,0.00056173967,0.0042317873,0.00046502007,0.0003015514,0.000027349783,0.00058799767,0.0012984424,0.00015611618],"category_scores_gemma":[0.0008149966,0.00045930487,0.0021965695,0.00043229744,0.000502405,0.00021308943,0.00006876153,0.003923311,0.000095321644],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095760974,0.00031415583,0.00041642674,0.00090826204,0.00173911,0.00010144801,0.0000662421,0.000010428462,0.000009218204,0.00003398158,0.00020238945,0.99524075],"study_design_scores_gemma":[0.0020933247,0.0008938217,0.0002025104,0.0008584536,0.0019413966,0.002072603,0.000073950796,0.000025845744,0.00015382301,0.00007654753,0.991199,0.00040873175],"about_ca_topic_score_codex":0.0000089884725,"about_ca_topic_score_gemma":0.0000020961518,"teacher_disagreement_score":0.994832,"about_ca_system_score_codex":0.00012607871,"about_ca_system_score_gemma":0.00048088797,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2001132015","doi":"10.2165/00128071-200203020-00001","title":"Six Novel Antimycotics","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Dermatology; Tinea capitis; Bifonazole; Voriconazole; Antifungal; Seborrheic dermatitis; Pharmacology; Tinea versicolor; Clinical trial; Drug; Pathology","score_opus":0.16305742141623916,"score_gpt":0.4834526691126559,"score_spread":0.3203952476964167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001132015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005908758,0.99572587,0.0006135024,0.0006928761,0.00088996824,0.00023579023,0.000015583824,0.000016473392,0.001219031],"genre_scores_gemma":[0.0035592588,0.990878,0.0036488995,0.00088667654,0.0006959466,0.0000014717904,0.000008383521,0.000054243792,0.00026711333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99338925,0.00059000193,0.004765178,0.00037505737,0.00044768868,0.00043284416],"domain_scores_gemma":[0.9914217,0.002965347,0.0040057297,0.00060864195,0.00044022992,0.00055836845],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00089734484,0.00041103738,0.008910219,0.00024858344,0.000041878022,0.000013344211,0.0004220831,0.00049314735,0.00020162074],"category_scores_gemma":[0.0034213092,0.00027554453,0.0028905103,0.00046533358,0.0014101389,0.000060893864,0.00007148773,0.0023023174,0.00020717233],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011987035,0.00063004147,0.0049091834,0.0028614127,0.0007052579,0.0013821376,0.0000093354565,6.3507315e-8,1.2873613e-7,0.00009214995,0.0045101284,0.9847803],"study_design_scores_gemma":[0.00075937173,0.0010746103,0.00096886896,0.005250435,0.0025784792,0.015987031,0.000034562654,0.000007162468,1.7699638e-7,0.000011003995,0.97310865,0.00021965776],"about_ca_topic_score_codex":0.0000029465639,"about_ca_topic_score_gemma":0.0000020099712,"teacher_disagreement_score":0.9845606,"about_ca_system_score_codex":0.000053653166,"about_ca_system_score_gemma":0.0010134581,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2001264462","doi":"10.2165/00128071-200607020-00005","title":"Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pimecrolimus; Medicine; Tolerability; Atopic dermatitis; Discontinuation; Adverse effect; Dermatology; Regimen; Clinical trial; Calcineurin; Internal medicine; Transplantation","score_opus":0.022337140062407928,"score_gpt":0.3775678081110146,"score_spread":0.35523066804860665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001264462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776651,0.0053574443,0.00053107075,0.015307868,0.00017604817,0.00032990065,0.00001397453,0.000004790803,0.00061375083],"genre_scores_gemma":[0.9925487,0.0044589816,0.0018341969,0.0010335717,0.00008718057,0.000006888326,0.000004297463,0.000010748634,0.000015409278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971952,0.0004383087,0.0018816021,0.00013581781,0.0001492179,0.0001998851],"domain_scores_gemma":[0.98758584,0.010420674,0.0014339209,0.00022628088,0.0002225143,0.0001107579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003734298,0.00013514135,0.0013770064,0.0001236056,0.000036434172,0.000003668248,0.0001260308,0.0001023904,0.000016626369],"category_scores_gemma":[0.0013295996,0.000085645064,0.0002838529,0.00016010311,0.0012283585,0.00007319735,0.000018804067,0.00018086267,0.0000013026809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062152413,0.0066740275,0.84493554,0.00013802588,0.0009168291,0.0011418322,0.00043026626,0.000039896277,0.000042325402,0.0012105426,0.004186825,0.13406864],"study_design_scores_gemma":[0.0109891435,0.0035133762,0.9332544,0.000106337124,0.00088765996,0.007331743,0.00052891724,0.00013117676,0.00042215016,0.00054743816,0.042201083,0.00008657866],"about_ca_topic_score_codex":0.00013975507,"about_ca_topic_score_gemma":0.000031033964,"teacher_disagreement_score":0.13398206,"about_ca_system_score_codex":0.00001494842,"about_ca_system_score_gemma":0.00022239122,"threshold_uncertainty_score":0.45259377},"labels":[],"label_agreement":null},{"id":"W2016198078","doi":"10.2165/00128071-200405010-00011","title":"Azelaic Acid","year":2004,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Essential Oils and Antimicrobial Activity","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Azelaic acid; Dermatology; Pharmacotherapy; Pharmacology; Internal medicine; Biochemistry; Chemistry","score_opus":0.031474940603011314,"score_gpt":0.3089048803974129,"score_spread":0.27742993979440156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016198078","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3023053,0.00017821149,0.000015112512,0.69572186,0.0013927508,0.00006034804,0.00003054624,0.000019285411,0.00027654605],"genre_scores_gemma":[0.52358973,0.0006095573,0.0002516857,0.4683485,0.0070877816,9.874495e-7,0.000035139237,0.000003737508,0.00007290282],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962081,0.00074725377,0.0018424237,0.0003491884,0.0003519418,0.0005011305],"domain_scores_gemma":[0.99526507,0.0014011004,0.0027904864,0.00009840655,0.00025923635,0.00018567407],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00042440052,0.0003193386,0.0019914305,0.00003604728,0.00009526429,0.0000518922,0.0007998732,0.0007022144,0.00031685672],"category_scores_gemma":[0.00026457815,0.00011816585,0.001152429,0.00029859736,0.00092148845,0.00013138147,0.000107119355,0.0033617509,0.00010586624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012467225,0.0002693314,0.0016454383,0.000031200325,0.0002630022,0.0047965134,0.000012431985,5.233248e-7,0.004797041,0.000022842609,0.61582106,0.37221596],"study_design_scores_gemma":[0.00029787875,0.0013882664,0.0020354905,0.00011537813,0.000121690944,0.0034251856,0.00001652645,0.0000010194988,0.00087356125,0.0006929702,0.99071264,0.00031938113],"about_ca_topic_score_codex":0.00013239458,"about_ca_topic_score_gemma":0.000044775537,"teacher_disagreement_score":0.3748916,"about_ca_system_score_codex":0.000023512901,"about_ca_system_score_gemma":0.00013851334,"threshold_uncertainty_score":0.99893755},"labels":[],"label_agreement":null},{"id":"W2020502963","doi":"10.2165/00128071-200405020-00001","title":"Fixed-Dose Combination Therapy for Psoriasis","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre","funders":"LEO Pharma","keywords":"Medicine; Psoriasis; Pharmacotherapy; Combination therapy; Fixed-dose combination; Dermatology; Pharmacology; Internal medicine","score_opus":0.0788575514855078,"score_gpt":0.4060985113205483,"score_spread":0.32724095983504053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020502963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013750399,0.99217486,0.00023584232,0.00038858934,0.004983069,0.00064843026,0.00008267915,0.00002752635,0.00008397794],"genre_scores_gemma":[0.0020120787,0.9962543,0.00070719264,0.00022457479,0.00028733563,0.00007136738,0.00019809764,0.00006486739,0.00018015601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937952,0.0019213746,0.0033177799,0.00041156175,0.00007311691,0.00048092374],"domain_scores_gemma":[0.9898756,0.004702875,0.0046052346,0.00039756403,0.00032250973,0.00009619117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009415277,0.00053062435,0.005673704,0.0003799315,0.00012994447,0.000015848724,0.00068341667,0.00087178266,0.00011142694],"category_scores_gemma":[0.00071589474,0.00037195112,0.0027682309,0.00031625136,0.0007899383,0.00008696424,0.00004880985,0.00081623,0.00020752977],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044588192,0.0006771129,0.00012669152,0.0005000198,0.002934413,0.00006557731,0.00003658611,1.8490383e-7,8.6928543e-7,0.00063718273,0.001501761,0.9930737],"study_design_scores_gemma":[0.0062501617,0.0026738264,0.00012941699,0.0015180801,0.0021187915,0.0032830664,0.000044880253,8.066444e-8,0.000017940545,0.00032115853,0.9833112,0.00033141492],"about_ca_topic_score_codex":0.00001211316,"about_ca_topic_score_gemma":0.0000022925758,"teacher_disagreement_score":0.9927423,"about_ca_system_score_codex":0.000073290765,"about_ca_system_score_gemma":0.0013542868,"threshold_uncertainty_score":0.9998732},"labels":[],"label_agreement":null},{"id":"W2032390761","doi":"10.1007/s40257-014-0105-5","title":"Quality-of-Life Impairment in Patients with Hidradenitis Suppurativa: A Canadian Study","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Disease; Population; SF-36; Severity of illness; Adverse effect; Internal medicine; Prospective cohort study; Dermatology; Physical therapy; Surgery; Health related quality of life; Environmental health","score_opus":0.029863496921496216,"score_gpt":0.37528096420020396,"score_spread":0.34541746727870776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032390761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864902,0.000015395412,0.00004016492,0.012450767,0.00015500655,0.00039503464,0.000009368007,0.0000053456947,0.00043871702],"genre_scores_gemma":[0.9990373,0.000009494483,0.00068494934,0.00016012469,0.000060174327,0.000006307537,0.0000089816385,0.000020509777,0.000012117974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953305,0.0013870972,0.0022627546,0.00021669555,0.00044187356,0.00036109428],"domain_scores_gemma":[0.99646556,0.000954965,0.0011786241,0.00027771413,0.000335861,0.00078725145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086540385,0.00019880824,0.0019516998,0.0003705845,0.000039627022,0.000007596139,0.00016699615,0.00008066714,0.00008557933],"category_scores_gemma":[0.0011353659,0.0001362055,0.00019732465,0.00035057976,0.00047929748,0.000115475326,0.000022050403,0.00048560006,0.000015547517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016604348,0.002466326,0.97866595,0.000013861109,0.00033644357,0.005569877,0.00047316813,2.8275727e-7,5.3082937e-7,0.000055693876,0.00009331984,0.010664123],"study_design_scores_gemma":[0.013763706,0.0134100905,0.964707,0.00006890194,0.00010539685,0.0063660047,0.0010953106,0.0000064946885,0.0000036284832,0.000032816442,0.00031832882,0.00012231473],"about_ca_topic_score_codex":0.007886729,"about_ca_topic_score_gemma":0.013016108,"teacher_disagreement_score":0.013958933,"about_ca_system_score_codex":0.00007618103,"about_ca_system_score_gemma":0.0008132712,"threshold_uncertainty_score":0.9987198},"labels":[],"label_agreement":null},{"id":"W2032434473","doi":"10.2165/00128071-200708020-00005","title":"Placebo Response in Two Long-Term Randomized Psoriasis Studies that were Negative for Rosiglitazone","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rosiglitazone; Psoriasis; Placebo; Placebo response; Pharmacotherapy; Randomized controlled trial; Term (time); Internal medicine; Dermatology; Alternative medicine; Pathology; Receptor","score_opus":0.061996705573639385,"score_gpt":0.41234882713377624,"score_spread":0.35035212156013684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032434473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668844,0.00579943,0.0018622864,0.0024318427,0.0025305154,0.00058062124,0.000017761475,0.000020735779,0.00006839332],"genre_scores_gemma":[0.99572897,0.0017777317,0.0016136224,0.00049396104,0.00015022859,0.000039906972,0.000009132848,0.000026307463,0.00016011117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918467,0.004570135,0.0025434445,0.0003448014,0.00008173027,0.00061318744],"domain_scores_gemma":[0.95434034,0.043054886,0.001964259,0.00025547092,0.00028964548,0.000095408584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074604684,0.00032601767,0.0033599355,0.0004257536,0.000114574446,0.000009148532,0.00035428553,0.00022565207,0.000049549966],"category_scores_gemma":[0.0066541745,0.0002342446,0.0009399063,0.00022842587,0.0021191917,0.00013080986,0.00007058596,0.0005356659,0.000041387368],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75936145,0.0005051346,0.13628256,0.000017875824,0.0032815258,0.0005313077,0.0010725738,0.0000037189614,0.00048779705,0.0002256363,0.0004663205,0.09776407],"study_design_scores_gemma":[0.6499374,0.004231721,0.3100588,0.00030201054,0.0018352665,0.0041722953,0.0057449844,0.0000037903014,0.018322041,0.0014540561,0.0032438494,0.00069379434],"about_ca_topic_score_codex":0.000022014885,"about_ca_topic_score_gemma":0.00013723866,"teacher_disagreement_score":0.17377625,"about_ca_system_score_codex":0.00006974788,"about_ca_system_score_gemma":0.00023448015,"threshold_uncertainty_score":0.9552218},"labels":[],"label_agreement":null},{"id":"W2036513731","doi":"10.1007/s40257-014-0092-6","title":"Neutrophilic Dermatoses: An Update","year":2014,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Neutrophilic dermatosis; Dermatology; Sweet Syndrome; Vasculitis; Rheumatoid arthritis; Histopathology; Pathology; Immunology; Disease","score_opus":0.06273859119424635,"score_gpt":0.4598545913332222,"score_spread":0.39711600013897586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036513731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022648103,0.9943474,0.00020467072,0.0012242193,0.0009443248,0.0003339977,0.000005156445,0.00004644594,0.0006290036],"genre_scores_gemma":[0.0016334214,0.99249524,0.0008648318,0.0040923725,0.00071652286,0.0000089405,0.000041527663,0.000114753995,0.000032365366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902538,0.0021080603,0.006276953,0.00043310845,0.00038893873,0.0005391273],"domain_scores_gemma":[0.9905383,0.0010825898,0.0063969186,0.0009295398,0.0003344904,0.000718172],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001083217,0.00058989174,0.010977758,0.00048789894,0.000070272836,0.000025518531,0.00075614156,0.00056199776,0.00015536376],"category_scores_gemma":[0.00092006015,0.00041435898,0.0027110672,0.0004238711,0.0013925604,0.00019141869,0.00010699435,0.0023282655,0.00042408885],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011971922,0.0002737454,0.00042330034,0.002491788,0.00078217033,0.0011212261,0.000018147128,4.2035254e-7,5.683188e-8,0.00023088623,0.0028521915,0.99168634],"study_design_scores_gemma":[0.0011144091,0.0015564528,0.00020837875,0.0032972475,0.0026790213,0.032366294,0.00006664578,0.000011819108,2.1148115e-7,0.00006033486,0.9583023,0.00033689686],"about_ca_topic_score_codex":0.0000039530028,"about_ca_topic_score_gemma":0.0000010704512,"teacher_disagreement_score":0.99134946,"about_ca_system_score_codex":0.00003696344,"about_ca_system_score_gemma":0.001728957,"threshold_uncertainty_score":0.9999734},"labels":[],"label_agreement":null},{"id":"W2036643986","doi":"10.2165/00128071-200405040-00003","title":"Optimal Management of Fungal Infections of the Skin, Hair, and Nails","year":2004,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Tinea capitis; Dermatology; Terbinafine; Seborrheic dermatitis; Pityriasis; Medicine; Itraconazole; Malassezia; Fluconazole; Scalp; Nail (fastener); Mycosis; Dermatophyte; Antifungal; Tinea versicolor; Skin infection; Trichophyton; Biology; Immunology","score_opus":0.046393686904856825,"score_gpt":0.44196638411290157,"score_spread":0.3955726972080447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036643986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019649483,0.97872233,0.00005981501,0.00035528536,0.0004037578,0.00040539462,0.000026491678,0.0000042065,0.00037323704],"genre_scores_gemma":[0.05434471,0.9444428,0.0010130076,0.00007716422,0.000062266605,0.000005561343,0.00000302437,0.000019570842,0.00003187919],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679637,0.0003627769,0.0022513343,0.00017026154,0.00024643482,0.00017281222],"domain_scores_gemma":[0.9958236,0.000528399,0.002955485,0.0003192708,0.00015938605,0.00021383812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021760401,0.00021793593,0.0032807256,0.00014443882,0.000030860487,0.0000035492615,0.00018565482,0.00013371525,0.000027532695],"category_scores_gemma":[0.00015134824,0.0001220748,0.0014799379,0.00030635908,0.0010365658,0.000029281815,0.00011030239,0.0005029683,0.000003988171],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001301294,0.0011357623,0.014395184,0.0069518406,0.0039994596,0.0006215383,0.000012810633,0.000002477663,1.5910326e-8,0.00033999997,0.00018244503,0.97222835],"study_design_scores_gemma":[0.008530289,0.006548174,0.078743204,0.052890867,0.038774002,0.035807364,0.00027204663,0.0000036249778,0.000003310748,0.00022058078,0.77778846,0.00041805737],"about_ca_topic_score_codex":0.000015229827,"about_ca_topic_score_gemma":8.7504674e-7,"teacher_disagreement_score":0.9718103,"about_ca_system_score_codex":0.000032069373,"about_ca_system_score_gemma":0.0005390267,"threshold_uncertainty_score":0.49780658},"labels":[],"label_agreement":null},{"id":"W206428459","doi":"10.2165/00128071-200910020-00002","title":"Botulinum Toxin for Hyperhidrosis","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Allergan","keywords":"Medicine; Hyperhidrosis; Botulinum toxin; Anticholinergic; Adverse effect; Dermatology; Incidence (geometry); Population; Intensive care medicine; Surgery; Anesthesia; Internal medicine","score_opus":0.13655625956931386,"score_gpt":0.4944703802542588,"score_spread":0.357914120684945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W206428459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065297965,0.9957931,0.00015834683,0.0014615923,0.0008442974,0.00068530935,0.000030892257,0.000025528194,0.00034794235],"genre_scores_gemma":[0.0008310998,0.98806465,0.0078046285,0.0019799313,0.0010525322,0.00003117351,0.00003588623,0.000072132985,0.00012793952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400544,0.000634452,0.0041391375,0.00041834835,0.0003076865,0.0004949452],"domain_scores_gemma":[0.99166137,0.0032225493,0.003722235,0.0004961517,0.0003308457,0.0005668289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000696966,0.0005197004,0.009924638,0.00036669997,0.000064703054,0.000018064622,0.0003990599,0.0005542552,0.000044602035],"category_scores_gemma":[0.0015224701,0.0003451989,0.0042214794,0.00034848563,0.0005121735,0.000068168934,0.000037567486,0.001073529,0.0000790463],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000302645,0.0008061386,0.0005347953,0.001078199,0.0014128725,0.0005915614,0.000013980567,3.4699614e-8,1.1093843e-7,0.000060792427,0.00332382,0.99187505],"study_design_scores_gemma":[0.0026625935,0.004623251,0.00019178064,0.005165152,0.0076412573,0.021928566,0.00002573569,0.0000023467824,0.0000016078905,0.00008351966,0.95741427,0.00025991045],"about_ca_topic_score_codex":0.0000028435009,"about_ca_topic_score_gemma":8.3007876e-7,"teacher_disagreement_score":0.9916151,"about_ca_system_score_codex":0.000077990015,"about_ca_system_score_gemma":0.0011687326,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W2065178330","doi":"10.1007/s40257-013-0033-9","title":"Barrier Repair Therapy in Atopic Dermatitis: An Overview","year":2013,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Filaggrin; Atopic dermatitis; Medicine; Moisturizer; Dermatology; Transepidermal water loss; Calcineurin; Stratum corneum; Atopy; Immunology; Allergy; Internal medicine; Transplantation; Pathology; Biology","score_opus":0.13413799665809717,"score_gpt":0.474881235003281,"score_spread":0.34074323834518383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065178330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008039,0.9894068,0.000006522464,0.0007828259,0.00074588,0.0005848772,0.000009558295,0.000046906935,0.00037759516],"genre_scores_gemma":[0.0027673768,0.9900978,0.0009966434,0.0055738892,0.00036712567,0.000045172797,0.000026795045,0.000069866095,0.00005532105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899877,0.0034481843,0.005220028,0.000461605,0.00034823446,0.0005342696],"domain_scores_gemma":[0.99289286,0.0020929906,0.0031159092,0.00080261915,0.00028912936,0.000806509],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007804456,0.00055250723,0.008791041,0.0005629917,0.00004539834,0.000019408037,0.00056497945,0.00068517425,0.00058428757],"category_scores_gemma":[0.0012696619,0.00038222614,0.0025587548,0.00050890236,0.0011809415,0.00025051014,0.00007643982,0.001993035,0.00020718378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005758775,0.00061369507,0.027981555,0.0025368482,0.00079304405,0.004939041,0.000035296733,7.1107095e-8,1.1367336e-8,0.000106469844,0.011309458,0.9516269],"study_design_scores_gemma":[0.0015807134,0.00082253857,0.013319182,0.006278185,0.0009205833,0.03627887,0.00006715594,0.000007205347,2.5211475e-7,0.00021237839,0.9401974,0.00031554827],"about_ca_topic_score_codex":0.000019560941,"about_ca_topic_score_gemma":0.000006902779,"teacher_disagreement_score":0.95131135,"about_ca_system_score_codex":0.000048326965,"about_ca_system_score_gemma":0.0017032177,"threshold_uncertainty_score":0.99986297},"labels":[],"label_agreement":null},{"id":"W2065469937","doi":"10.2165/00128071-200607060-00004","title":"Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alethia Biotherapeutics (Canada); Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Retrospective cohort study; Antibody; Intravenous Immunoglobulins; Intravenous Immunoglobulin Therapy; Pediatrics; Internal medicine; Immunology","score_opus":0.0416261387925516,"score_gpt":0.364829249563414,"score_spread":0.3232031107708624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065469937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4046856,0.5927394,0.00006436132,0.0005286362,0.0006412895,0.0010140989,0.00005638785,0.000031318068,0.00023893839],"genre_scores_gemma":[0.1038967,0.8937666,0.0017004617,0.0003135424,0.00012392506,0.000010275631,0.000056494184,0.00009652835,0.000035470002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99321264,0.0012080311,0.0041005593,0.00048074996,0.0004371662,0.0005608619],"domain_scores_gemma":[0.9922204,0.0026242777,0.0038917165,0.00051338715,0.00028732393,0.00046288507],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005871546,0.00054860325,0.0076725613,0.0008302334,0.00004990966,0.00002884477,0.00024989014,0.00046056163,0.000008215892],"category_scores_gemma":[0.0010482819,0.0003894001,0.00085985364,0.00078533945,0.0008788096,0.00023136704,0.000084981046,0.00245806,0.000028030978],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013605914,0.0009845853,0.035521235,0.000760073,0.000975802,0.0048502474,0.0000112977095,0.0000024859723,3.758488e-8,0.000006692844,0.00005869193,0.9566928],"study_design_scores_gemma":[0.0040592914,0.0015850721,0.38159353,0.0076357783,0.003981077,0.054528315,0.00004747286,0.0000033362512,1.149954e-7,0.0000072625535,0.546091,0.0004677327],"about_ca_topic_score_codex":0.00014395805,"about_ca_topic_score_gemma":0.000028288574,"teacher_disagreement_score":0.95622504,"about_ca_system_score_codex":0.00018213443,"about_ca_system_score_gemma":0.0009909909,"threshold_uncertainty_score":0.9998558},"labels":[],"label_agreement":null},{"id":"W2071154269","doi":"10.2165/00128071-200304120-00003","title":"Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Western University","funders":"","keywords":"Medicine; Psychosocial; Psychiatry; Biopsychosocial model; Comorbidity; Psychological intervention; Quality of life (healthcare); Depression (economics)","score_opus":0.06162790824897608,"score_gpt":0.4460504208589782,"score_spread":0.38442251261000215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071154269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.092373915,0.90456164,0.000031256084,0.00073750166,0.00056025735,0.0006816555,0.000016711889,0.000022381895,0.0010146919],"genre_scores_gemma":[0.05606003,0.94126636,0.00097393384,0.0015333386,0.000064105356,0.000015694435,0.000031502008,0.000047293743,0.000007715377],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926926,0.0022344931,0.0035487958,0.0005954166,0.00036353138,0.0005651741],"domain_scores_gemma":[0.9938957,0.0018729687,0.0030088876,0.00046913046,0.00015969879,0.0005936144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051801186,0.0005974253,0.0072928104,0.00065522984,0.00006237114,0.000014781453,0.00035820002,0.00069774326,0.00007083487],"category_scores_gemma":[0.00085210026,0.0003680803,0.0008989182,0.0007101031,0.0022413232,0.000098250865,0.000048760423,0.0021966118,0.000036473626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006186564,0.0018992213,0.6192274,0.001105417,0.00032332184,0.0008745379,0.000005493874,6.985718e-8,2.7186703e-10,0.000031427,0.0044987835,0.37141567],"study_design_scores_gemma":[0.005835903,0.0026895027,0.2884162,0.001693725,0.0019785909,0.018961132,0.00003190927,6.776457e-7,1.2488216e-8,0.0001881225,0.6797435,0.00046067254],"about_ca_topic_score_codex":0.000002488836,"about_ca_topic_score_gemma":0.000004382222,"teacher_disagreement_score":0.67524475,"about_ca_system_score_codex":0.00003098538,"about_ca_system_score_gemma":0.000495328,"threshold_uncertainty_score":0.9998771},"labels":[],"label_agreement":null},{"id":"W2072507718","doi":"10.2165/00128071-200304070-00005","title":"Isotretinoin Use and Subsequent Depression and Suicide","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Isotretinoin; Medicine; Depression (economics); Acne; Psychiatry; Adverse effect; Dermatology; Internal medicine","score_opus":0.10421975516233965,"score_gpt":0.45094814125794763,"score_spread":0.34672838609560797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072507718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03454487,0.9645493,0.00003442048,0.00031509818,0.00024250375,0.00022851287,0.000004504576,0.0000060329894,0.00007474685],"genre_scores_gemma":[0.0046542534,0.9931965,0.0011377988,0.00077133486,0.00012570237,0.0000035037358,0.000007879426,0.000031262625,0.000071790455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967967,0.0008375791,0.0016796244,0.00027843003,0.0001540579,0.00025360822],"domain_scores_gemma":[0.99571836,0.0018804688,0.0016069292,0.00021099467,0.00009840155,0.0004848608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041374567,0.000309541,0.0043291207,0.00015711345,0.000051378516,0.00002149255,0.00006974462,0.00029219082,0.000017280274],"category_scores_gemma":[0.0006401116,0.00017230866,0.0005387059,0.00012297848,0.00064924743,0.000074365606,0.000053447613,0.00078501756,0.000006498205],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011139298,0.00013726883,0.049999196,0.0010469203,0.00052455795,0.0022606405,0.0000116848505,1.6272002e-8,1.0649975e-7,0.000018218028,0.0009857614,0.9449042],"study_design_scores_gemma":[0.0013593665,0.0012844097,0.0047138967,0.005681057,0.0030855336,0.054809332,0.00002224057,0.0000018794616,7.7554586e-7,0.000014856013,0.92885566,0.00017097146],"about_ca_topic_score_codex":0.000015533156,"about_ca_topic_score_gemma":0.0000013071291,"teacher_disagreement_score":0.94473326,"about_ca_system_score_codex":0.000017175258,"about_ca_system_score_gemma":0.00028461576,"threshold_uncertainty_score":0.7026543},"labels":[],"label_agreement":null},{"id":"W2073969222","doi":"10.2165/00128071-200203080-00007","title":"Acne","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Acne; Dermatology; Pharmacotherapy; Internal medicine","score_opus":0.13474005083165275,"score_gpt":0.4998010469784984,"score_spread":0.3650609961468457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073969222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002186469,0.9964124,0.000031581305,0.00086094864,0.00078915874,0.00019860106,0.0000043081186,0.0000117635755,0.0014725787],"genre_scores_gemma":[0.0003955539,0.9966374,0.0008006266,0.00087068195,0.00082556787,0.000003847122,0.000009218866,0.00004220804,0.00041487347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959542,0.00062168593,0.0026624445,0.0002276122,0.00022688498,0.00030712763],"domain_scores_gemma":[0.9949161,0.001449508,0.0027130283,0.0003232967,0.0001368093,0.00046129318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035294195,0.00033255827,0.007369388,0.00021801803,0.000037988273,0.00000859301,0.00020892717,0.00034976276,0.00020199486],"category_scores_gemma":[0.0005237967,0.00018266488,0.0022913446,0.000275556,0.00053748256,0.000040116152,0.00004739131,0.0012107173,0.0002887087],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053558088,0.00036871244,0.00037880236,0.0012568239,0.001292888,0.004376898,0.000008733058,1.7593091e-8,5.937839e-9,0.000017763514,0.012452365,0.9797934],"study_design_scores_gemma":[0.00094699924,0.0021116664,0.000074253796,0.0045410274,0.004064107,0.0427777,0.000012467973,0.0000016378611,7.810281e-8,0.000008125873,0.9453222,0.00013969823],"about_ca_topic_score_codex":0.0000026147952,"about_ca_topic_score_gemma":1.964768e-7,"teacher_disagreement_score":0.9796537,"about_ca_system_score_codex":0.000029163557,"about_ca_system_score_gemma":0.00042212295,"threshold_uncertainty_score":0.74488574},"labels":[],"label_agreement":null},{"id":"W2079167414","doi":"10.1007/s40257-014-0096-2","title":"Topical Therapy for Toenail Onychomycosis: An Evidence-Based Review","year":2014,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dermatology; Pharmacotherapy; Terbinafine; MEDLINE; Itraconazole; Antifungal; Internal medicine","score_opus":0.23906717294927118,"score_gpt":0.5481755244134014,"score_spread":0.3091083514641303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079167414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016501217,0.9925448,0.00030288615,0.0051606605,0.00053967093,0.0012161515,0.000015142447,0.000018260496,0.000037430265],"genre_scores_gemma":[0.00040128568,0.9824081,0.0023949214,0.013660511,0.00089629315,0.000108608816,0.00004447247,0.0000627358,0.000023035951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993297,0.0017081609,0.0037759573,0.00045536016,0.0003747005,0.00038884775],"domain_scores_gemma":[0.98938704,0.0049711782,0.003594811,0.0007160783,0.0004839772,0.0008469318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009977173,0.00046992672,0.008826693,0.0001732481,0.000047708076,0.000017013712,0.0004648466,0.0002861043,0.00011984344],"category_scores_gemma":[0.0029439577,0.00028193824,0.003941238,0.00026233454,0.00047071997,0.00009867541,0.00002517023,0.0007621541,0.000041651674],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067920337,0.0008445017,0.0011136506,0.013962,0.0009156608,0.00028171716,0.0000013808968,2.8777494e-8,8.760514e-9,0.00004194197,0.0057880622,0.9763718],"study_design_scores_gemma":[0.0023654392,0.0076790517,0.00038828788,0.082594976,0.005805619,0.0019757643,0.0000034871744,0.0000039293104,1.3895995e-7,0.000034138237,0.8989366,0.000212527],"about_ca_topic_score_codex":0.000004992199,"about_ca_topic_score_gemma":7.005024e-7,"teacher_disagreement_score":0.97615933,"about_ca_system_score_codex":0.000056682842,"about_ca_system_score_gemma":0.0018547205,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null},{"id":"W2080670285","doi":"10.1007/s40257-014-0090-8","title":"Isotretinoin Use and Celiac Disease: A Population-Based Cross-Sectional Study","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Isotretinoin; Cross-sectional study; Pharmacotherapy; Dermatology; Population; Disease; Internal medicine; Acne; Environmental health; Pathology","score_opus":0.03873147865122249,"score_gpt":0.40728961119893337,"score_spread":0.36855813254771086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080670285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748796,0.000070596034,0.00044243512,0.0015617424,0.00026607426,0.00013579965,0.0000031870886,0.000010535954,0.000021639751],"genre_scores_gemma":[0.9971441,0.000029925142,0.00076963403,0.0017563256,0.00023237092,0.0000025953198,0.000008216461,0.000011965086,0.000044865363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808544,0.00043180166,0.00093413936,0.00017921912,0.00020912234,0.00016029559],"domain_scores_gemma":[0.99730146,0.0014233063,0.0005486882,0.00015943532,0.00016764228,0.00039948817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043842534,0.00012004826,0.00072737125,0.00009056593,0.00008273223,0.000029160601,0.000053598826,0.000055804656,0.000028562876],"category_scores_gemma":[0.0012542557,0.000079151425,0.00021043149,0.000092883405,0.00027622367,0.00008538797,0.000019055959,0.00026268343,0.0000079861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012645304,0.00072963664,0.9910747,0.000012389984,0.0001370364,0.00027140678,0.000015047152,0.000024027915,0.0000016991706,0.000028076845,0.0002224765,0.0062190094],"study_design_scores_gemma":[0.0037298184,0.0025484993,0.99044764,0.000024701563,0.00019050179,0.0004428605,0.000024311214,0.0006930973,0.000002057038,0.0000452411,0.0017776956,0.00007359583],"about_ca_topic_score_codex":0.000072146155,"about_ca_topic_score_gemma":0.000003669707,"teacher_disagreement_score":0.0061454135,"about_ca_system_score_codex":0.000011840202,"about_ca_system_score_gemma":0.00012557973,"threshold_uncertainty_score":0.32277012},"labels":[],"label_agreement":null},{"id":"W2083686968","doi":"10.2165/00128071-200001030-00002","title":"Management of Androgenetic Alopecia","year":2000,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Minoxidil; Medicine; Finasteride; Hair loss; Hair transplantation; Dermatology; Psychosocial; Adverse effect; Hair growth; Male-pattern baldness; Internal medicine; Scalp; Physiology; Psychiatry","score_opus":0.06373997544627455,"score_gpt":0.451548055582704,"score_spread":0.3878080801364294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083686968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009741038,0.9916805,0.00005848218,0.00030661796,0.00029974006,0.00027304498,0.000007058274,0.000007216742,0.0063932035],"genre_scores_gemma":[0.0015512268,0.9959867,0.0017815932,0.00038170905,0.0001592421,0.000004434604,0.000011240398,0.000037362617,0.00008647314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947568,0.0005407575,0.0038512684,0.00023602518,0.00031455766,0.0003005815],"domain_scores_gemma":[0.9961156,0.0005878501,0.0023820552,0.00038154802,0.00012129865,0.00041162796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004090035,0.0002908914,0.006051187,0.00030384123,0.000016553313,0.0000039058996,0.0003393728,0.00023450669,0.00027676712],"category_scores_gemma":[0.00012588513,0.00020436807,0.0017756539,0.0004436828,0.000804031,0.000023836803,0.00004814354,0.00072993786,0.000114125934],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017255219,0.00027858643,0.0006312498,0.004291868,0.0012588651,0.002205446,0.000008485674,2.2132899e-7,3.0521565e-9,0.000055471395,0.0012723547,0.9898249],"study_design_scores_gemma":[0.0011621752,0.0010582595,0.00032984518,0.006519332,0.0034782127,0.009343388,0.00006340786,8.15159e-7,1.4819275e-7,0.00003725194,0.9778592,0.00014797077],"about_ca_topic_score_codex":0.0000024068086,"about_ca_topic_score_gemma":5.927692e-7,"teacher_disagreement_score":0.98967695,"about_ca_system_score_codex":0.000016646361,"about_ca_system_score_gemma":0.0006109641,"threshold_uncertainty_score":0.8333888},"labels":[],"label_agreement":null},{"id":"W2088380888","doi":"10.1007/s40257-013-0019-7","title":"Psychiatric Comorbidities and Alexithymia in Patients with Seborrheic Dermatitis: A Questionnaire Study in Turkey","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Yeditepe Üniversitesi","keywords":"Alexithymia; Toronto Alexithymia Scale; Medicine; Anxiety; Seborrheic dermatitis; Depression (economics); Psychiatry; Internal medicine; Hospital Anxiety and Depression Scale; Clinical psychology; Dermatology","score_opus":0.011634153830529669,"score_gpt":0.3170101317609963,"score_spread":0.3053759779304666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088380888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962139,0.00032757522,0.000020026033,0.0025957134,0.00015742527,0.00048809152,0.0000011837029,0.0000071021464,0.0001889936],"genre_scores_gemma":[0.99795085,0.00019009755,0.0008803207,0.00091348164,0.00002449779,0.000018381968,0.0000020430496,0.000014334442,0.0000059786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977687,0.00037268377,0.001267016,0.00016600183,0.00020936002,0.00021622704],"domain_scores_gemma":[0.99866503,0.00024066652,0.0006251399,0.00016561396,0.00012316236,0.0001804082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018477831,0.00015880074,0.0010249713,0.0002944444,0.000022065586,0.000014006257,0.00009520219,0.00005656011,0.000027702477],"category_scores_gemma":[0.00015374484,0.00010596614,0.00006767638,0.00030796256,0.00033043022,0.00015685141,0.000020265894,0.00035807985,0.00001185914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029925833,0.0026522395,0.98687303,0.00002909759,0.00013441725,0.00016824364,0.000504614,0.000002177575,3.2895834e-8,0.00002568594,0.00025115162,0.009060053],"study_design_scores_gemma":[0.011456727,0.00396933,0.98124844,0.00048274366,0.000060319355,0.0004042984,0.0016132256,0.00008632861,1.6817438e-7,0.00054619246,0.000035634886,0.00009661607],"about_ca_topic_score_codex":0.00042924433,"about_ca_topic_score_gemma":0.00011214577,"teacher_disagreement_score":0.011157469,"about_ca_system_score_codex":0.00002142994,"about_ca_system_score_gemma":0.000111208035,"threshold_uncertainty_score":0.43211737},"labels":[],"label_agreement":null},{"id":"W2095814285","doi":"10.1007/s40257-015-0140-x","title":"Reply to Frane: Epidermolysis Bullosa Pruriginosa: A Systematic Review Exploring Genotype–Phenotype Correlation","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Women's College Hospital; SickKids Foundation; University of Toronto","funders":"University of Toronto","keywords":"Epidermolysis bullosa; Medicine; Heuristics; MEDLINE; Statistics; Computer science; Pathology; Biology; Mathematics","score_opus":0.10501032219478432,"score_gpt":0.42271207310579456,"score_spread":0.31770175091101027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095814285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031316475,0.9959477,0.0010154163,0.0006671636,0.00082067796,0.0011046513,0.000012798933,0.000010594444,0.00010781416],"genre_scores_gemma":[0.00032641858,0.9962538,0.0008172881,0.0015662977,0.00060932257,0.00012649567,0.00011098713,0.00007355552,0.0001158579],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98932964,0.0044708867,0.0045431484,0.0006563081,0.0004607644,0.0005392834],"domain_scores_gemma":[0.9929246,0.00089547737,0.003631865,0.0010765641,0.00082047255,0.0006510349],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004035332,0.00052599504,0.0070232893,0.00028001514,0.00006579891,0.000021834594,0.001046336,0.00045392555,0.00003051704],"category_scores_gemma":[0.008528498,0.00038088608,0.0016758192,0.00060548965,0.00044049064,0.0000092178325,0.0002935397,0.0010720527,0.0002955386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024693194,0.00025919662,0.0001001863,0.23361431,0.0032809237,0.002712618,0.00003656385,0.000003712383,0.0000058651044,0.000045043053,0.017159155,0.7425355],"study_design_scores_gemma":[0.00032106994,0.0012257291,0.000003232089,0.07222814,0.0031151278,0.022930691,0.000036043937,0.0000029525154,0.0000046770865,0.000015748592,0.89967555,0.0004410253],"about_ca_topic_score_codex":0.000010261855,"about_ca_topic_score_gemma":0.0000011539346,"teacher_disagreement_score":0.8825164,"about_ca_system_score_codex":0.00004804641,"about_ca_system_score_gemma":0.0012017383,"threshold_uncertainty_score":0.9998643},"labels":[],"label_agreement":null},{"id":"W2176024536","doi":"10.2165/00128071-200607030-00003","title":"Hydroxychloroquine-Induced Retinopathy","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hydroxychloroquine; Medicine; Maculopathy; Chloroquine; Retinopathy; Adverse effect; Ophthalmology; Pharmacotherapy; Drug; Retinal; Dermatology; Pharmacology; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Pathology; Endocrinology","score_opus":0.10989843420129636,"score_gpt":0.47732079610149536,"score_spread":0.367422361900199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176024536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0097482195,0.98161805,0.000094038725,0.0013520353,0.002495419,0.0005894986,0.000016037482,0.000059191163,0.0040274984],"genre_scores_gemma":[0.007315024,0.9873259,0.0019883465,0.0011321823,0.0018881595,0.000009809466,0.00003264696,0.00015959969,0.00014833208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885125,0.0021603177,0.0072283237,0.00062767044,0.0007485742,0.0007225951],"domain_scores_gemma":[0.9873369,0.0024443432,0.007901437,0.0009891854,0.0004939393,0.0008342339],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018167628,0.0007508196,0.0126026,0.0006526457,0.000058200763,0.000022976015,0.0007742561,0.00091487914,0.000046649413],"category_scores_gemma":[0.0033309222,0.00054690737,0.004119298,0.0008271796,0.0009317689,0.000096277465,0.0001615019,0.004086427,0.0002801093],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009153572,0.00049722876,0.00043111132,0.0018141253,0.0007807574,0.006913389,0.000008482156,1.236949e-7,0.0000017658923,0.000046218,0.0024475509,0.9869677],"study_design_scores_gemma":[0.0013552613,0.0014400788,0.00039420015,0.0058464534,0.003687244,0.060284927,0.00002309015,0.0000044353756,0.0000074233944,0.00004546914,0.9264867,0.00042473455],"about_ca_topic_score_codex":0.000022416907,"about_ca_topic_score_gemma":0.000003541025,"teacher_disagreement_score":0.986543,"about_ca_system_score_codex":0.00014271207,"about_ca_system_score_gemma":0.0022819014,"threshold_uncertainty_score":0.9996982},"labels":[],"label_agreement":null},{"id":"W2209243252","doi":"10.2165/00128071-200304090-00005","title":"Drug Interactions of Clinical Significance for the Dermatologist","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Drug; Medicine; Drug interaction; Pharmacogenetics; Intensive care medicine; Pharmacotherapy; Clinical Practice; Pharmacology; Psychiatry; Family medicine; Biology","score_opus":0.4406664389583803,"score_gpt":0.636099180920618,"score_spread":0.1954327419622377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209243252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006406892,0.97790205,0.0014317008,0.0019162135,0.016036801,0.0010506345,0.00022440164,0.000017924298,0.0007795857],"genre_scores_gemma":[0.0050313226,0.988194,0.0016918806,0.0032001203,0.0014475749,0.00009887448,0.000014782588,0.00008149187,0.00023994046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9790111,0.009450981,0.00996011,0.00055369065,0.00031212706,0.0007119993],"domain_scores_gemma":[0.9399848,0.045896377,0.012080162,0.0006145926,0.00079861394,0.00062545296],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0071994592,0.00065253273,0.008261282,0.00028919138,0.00023299536,0.000020302645,0.0018611815,0.0005926463,0.00028661004],"category_scores_gemma":[0.004125844,0.00041756584,0.004520859,0.00056171365,0.004126211,0.00009344535,0.00017112891,0.00500559,0.000058318627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040458335,0.0007782489,0.0010193046,0.0010345381,0.0030596443,0.00011227097,0.000047251466,0.000019591214,8.072521e-7,0.00075872656,0.032165434,0.9605996],"study_design_scores_gemma":[0.001765189,0.0002222815,0.000060280792,0.00040876504,0.006907746,0.0024633326,0.00012186595,0.00013541925,0.000022050759,0.0002333717,0.9872893,0.00037040212],"about_ca_topic_score_codex":0.00001012897,"about_ca_topic_score_gemma":0.000009841037,"teacher_disagreement_score":0.9602292,"about_ca_system_score_codex":0.000028104409,"about_ca_system_score_gemma":0.0020302583,"threshold_uncertainty_score":0.9998276},"labels":[],"label_agreement":null},{"id":"W2220339981","doi":"10.2165/00128071-200304090-00003","title":"Botulinum Toxin A","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Botulinum toxin; Clostridium botulinum; Tolerability; Blepharospasm; Flaccid paralysis; Anesthesia; Dermatology; Surgery; Paralysis; Toxin; Adverse effect; Pharmacology; Microbiology","score_opus":0.10821853953778518,"score_gpt":0.46736001827310353,"score_spread":0.3591414787353183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220339981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002711472,0.9928012,0.00009844981,0.0022218337,0.001489589,0.00034805865,0.0000050341064,0.000029788845,0.0027348858],"genre_scores_gemma":[0.00029049875,0.9921141,0.0013088504,0.005610696,0.00032006015,0.000006114094,0.000007336718,0.00007712827,0.000265162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99140066,0.0021360752,0.0050637117,0.0004632413,0.00038877394,0.00054755434],"domain_scores_gemma":[0.99183756,0.0025878607,0.0040606703,0.0005061634,0.00022798518,0.0007797781],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008504327,0.0005429479,0.009336172,0.00034744202,0.00004572905,0.000013524868,0.00045702423,0.0010626551,0.00027355293],"category_scores_gemma":[0.0017818037,0.0003310373,0.0037493445,0.0007118212,0.0014734401,0.000045491794,0.00007153296,0.004291496,0.0003118341],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018944575,0.0005410271,0.00015977302,0.0011909668,0.0010427246,0.004246942,0.0000062747695,2.1192629e-7,5.428456e-8,0.00013448288,0.006657763,0.9858303],"study_design_scores_gemma":[0.0013556594,0.0025794588,0.00004840294,0.0024015855,0.0029771107,0.049431134,0.000021540838,0.0000021500525,1.4291781e-7,0.00014450212,0.9407714,0.00026689155],"about_ca_topic_score_codex":0.0000011858558,"about_ca_topic_score_gemma":3.2184718e-7,"teacher_disagreement_score":0.98556346,"about_ca_system_score_codex":0.00003013849,"about_ca_system_score_gemma":0.0011937071,"threshold_uncertainty_score":0.99991417},"labels":[],"label_agreement":null},{"id":"W2224097706","doi":"10.1007/s40257-015-0161-5","title":"Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Adalimumab; Psoriasis; Placebo; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Post-hoc analysis; Clinical trial; Discontinuation; Population; Dermatology; Rheumatoid arthritis","score_opus":0.11885768880016609,"score_gpt":0.3976571667334317,"score_spread":0.27879947793326565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224097706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403584,0.00072168006,0.00007493443,0.0017212827,0.001373879,0.0016320669,0.00038097348,0.000023781173,0.000035577323],"genre_scores_gemma":[0.99780697,0.00047398522,0.0006104587,0.0006230959,0.0001610822,0.000045503806,0.00017409853,0.000042094394,0.00006269082],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9761924,0.012935322,0.009165968,0.00078992144,0.00031706947,0.0005992766],"domain_scores_gemma":[0.96137226,0.028456446,0.0076814634,0.0008756099,0.0012577226,0.00035647504],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010940213,0.00053940667,0.009402485,0.0012190313,0.00007776739,0.000026752925,0.00086738693,0.00068873574,0.000089411275],"category_scores_gemma":[0.0153714605,0.0003208893,0.0016645333,0.001536384,0.0006950695,0.00014864848,0.0001105031,0.0008219621,0.000056287117],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74724215,0.0019804535,0.14656188,0.0000031990733,0.018462958,0.00011655716,0.0006944092,0.000075263306,0.00010933026,0.0000051574016,0.0002332951,0.08451535],"study_design_scores_gemma":[0.5477309,0.017722057,0.4245068,0.00020692367,0.0077430094,0.00007234379,0.0006384336,0.000014447805,0.00029216195,0.0000071346367,0.00066796277,0.00039781161],"about_ca_topic_score_codex":0.00028284712,"about_ca_topic_score_gemma":0.00072464364,"teacher_disagreement_score":0.27794492,"about_ca_system_score_codex":0.000083169674,"about_ca_system_score_gemma":0.0012544391,"threshold_uncertainty_score":0.9999243},"labels":[],"label_agreement":null},{"id":"W2224929295","doi":"10.2165/11539770-000000000-00000","title":"Pseudomonas Skin Infection","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pseudomonas aeruginosa; Medicine; Intensive care medicine; Antimicrobial; Disease; Skin infection; Pharmacotherapy; Antibiotics; Dermatology; Microbiology; Internal medicine; Bacteria; Staphylococcus aureus; Biology","score_opus":0.14117046303926725,"score_gpt":0.48883982594412767,"score_spread":0.3476693629048604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224929295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013814477,0.9932473,0.00022035562,0.00011212371,0.001587012,0.00041601455,0.000005160764,0.000028240787,0.0030023837],"genre_scores_gemma":[0.0021011133,0.99604183,0.0009038472,0.00020347835,0.00057869643,0.000019748846,0.000011140912,0.000046321788,0.000093791474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955591,0.0007164815,0.0030319574,0.00026947766,0.0001507302,0.00027222917],"domain_scores_gemma":[0.99466354,0.0009979239,0.003298143,0.0003606337,0.0002710124,0.00040878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036771438,0.00034811703,0.005342872,0.00042014185,0.000044198732,0.000009219379,0.00013304058,0.00038817927,0.0003391855],"category_scores_gemma":[0.00056433736,0.00022646721,0.0025398545,0.0004466151,0.00062922435,0.00006253374,0.000048021397,0.0013106373,0.00030835363],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000587968,0.0006408476,0.015503401,0.0006353859,0.0016149649,0.00063684466,0.000007139996,1.6507805e-8,9.397998e-9,0.00011598921,0.0008006043,0.979986],"study_design_scores_gemma":[0.0008940763,0.0021557133,0.002624598,0.0027326308,0.003985774,0.042180367,0.000004991826,3.2890773e-7,8.133397e-7,0.000077780394,0.9451901,0.00015285981],"about_ca_topic_score_codex":0.00007035413,"about_ca_topic_score_gemma":0.0000041064673,"teacher_disagreement_score":0.9798331,"about_ca_system_score_codex":0.000061504914,"about_ca_system_score_gemma":0.00068897824,"threshold_uncertainty_score":0.9235065},"labels":[],"label_agreement":null},{"id":"W2229458843","doi":"10.1007/s40257-013-0010-3","title":"Health Status, Coping Strategies, and Alexithymia in Subjects with Androgenetic Alopecia","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Forskningsrådet om Hälsa, Arbetsliv och Välfärd; Ministero della Salute","keywords":"Alexithymia; Medicine; Coping (psychology); Anxiety; General Health Questionnaire; Toronto Alexithymia Scale; Clinical psychology; Logistic regression; Psychiatry; Internal medicine","score_opus":0.022180066614334307,"score_gpt":0.35015424731431666,"score_spread":0.32797418069998235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2229458843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557305,0.0017722046,0.00036272677,0.0114364335,0.00006850104,0.00019218797,8.028011e-7,0.000007787453,0.0005863316],"genre_scores_gemma":[0.9895181,0.001934006,0.0031461562,0.0053240396,0.000052654617,0.000003218004,0.0000024479193,0.000014361102,0.000005015685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780536,0.00030686945,0.0011312577,0.00017104704,0.00017067479,0.0004148072],"domain_scores_gemma":[0.9981783,0.00039350594,0.0005787442,0.00013097122,0.000114950664,0.0006035341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027782822,0.00013210959,0.0011475998,0.00016304142,0.000028368646,0.000023286988,0.000072562005,0.00006194146,0.000040213417],"category_scores_gemma":[0.00020492861,0.00009371354,0.00006815232,0.0002513453,0.0006765011,0.00016166687,0.0000190045,0.00045432022,0.000011767161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041613626,0.00012806914,0.939819,0.0000548932,0.000059774495,0.00023142238,0.00022316839,0.000005587889,0.0000049679657,0.00013955432,0.000649998,0.05826745],"study_design_scores_gemma":[0.004234735,0.0035099904,0.9812881,0.00020759614,0.000024031902,0.0034979202,0.0033262507,0.000062882,0.0000065338986,0.00022062007,0.0035132747,0.0001081163],"about_ca_topic_score_codex":0.00048928225,"about_ca_topic_score_gemma":0.00044001918,"teacher_disagreement_score":0.058159336,"about_ca_system_score_codex":0.000019888037,"about_ca_system_score_gemma":0.0013772637,"threshold_uncertainty_score":0.38215274},"labels":[],"label_agreement":null},{"id":"W2247667909","doi":"10.2165/11589040-000000000-00000","title":"Pediatric Psychocutaneous Disorders","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Psychopathology; Psychiatry; Psychogenic disease; Psychosis; Eating disorders; Comorbidity; Body dysmorphic disorder; Anxiety; Dermatology","score_opus":0.053594653762756364,"score_gpt":0.44185717270717356,"score_spread":0.3882625189444172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247667909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037234955,0.976885,0.00035229145,0.00034971902,0.009247225,0.00046709055,0.00002408561,0.000057811772,0.012244409],"genre_scores_gemma":[0.0012757479,0.995532,0.00076484994,0.0005282515,0.0014548874,0.000026171549,0.000011389593,0.00020938525,0.00019731504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866456,0.004227617,0.0067694867,0.0009089054,0.00037793926,0.0010704648],"domain_scores_gemma":[0.98183125,0.0048181214,0.0112774735,0.0011347653,0.000231798,0.0007065843],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00087221613,0.00096481736,0.009264419,0.0010751153,0.00009023671,0.000028114842,0.0022210176,0.0009110742,0.0022331593],"category_scores_gemma":[0.00093523896,0.00076548295,0.0039942786,0.0012412173,0.0018160164,0.000107132204,0.00017176777,0.0036575398,0.002393458],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016351439,0.0007615935,0.0028103865,0.00064401154,0.001388737,0.0013703476,0.00015085474,1.5480333e-7,8.138101e-10,0.0016755048,0.008429816,0.9826051],"study_design_scores_gemma":[0.0010020178,0.00170948,0.0007313787,0.00052511174,0.0029384631,0.01695031,0.00022814439,2.802902e-7,3.7708863e-9,0.0010735847,0.97413903,0.00070218736],"about_ca_topic_score_codex":0.00005390332,"about_ca_topic_score_gemma":0.00002016377,"teacher_disagreement_score":0.9819029,"about_ca_system_score_codex":0.00005573852,"about_ca_system_score_gemma":0.00085153134,"threshold_uncertainty_score":0.9994796},"labels":[],"label_agreement":null},{"id":"W2308193643","doi":"10.1007/s40257-016-0187-3","title":"Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bozok Üniversitesi","keywords":"Psoriasis; Medicine; Montreal Cognitive Assessment; Odds ratio; Internal medicine; Cognition; Cross-sectional study; Beck Depression Inventory; Physical therapy; Psychiatry; Dementia; Disease; Dermatology; Pathology; Anxiety","score_opus":0.03376329744548311,"score_gpt":0.3681341402364533,"score_spread":0.3343708427909702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308193643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980011,0.00009311045,0.0002954554,0.00018536726,0.0007999148,0.00048389385,0.00005679495,0.000009430607,0.00007494755],"genre_scores_gemma":[0.9995489,0.000036443147,0.000075114214,0.00018785936,0.00007779055,0.000024138215,0.000009062877,0.00001721738,0.000023437822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547434,0.0021843049,0.0014773046,0.00032353707,0.00014907776,0.00039141616],"domain_scores_gemma":[0.99457896,0.003329063,0.0013549931,0.00015338844,0.00051727437,0.00006631129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089245645,0.0002434449,0.00093469716,0.00016818772,0.00015098344,0.000016982644,0.00023674198,0.0001402161,0.0001092583],"category_scores_gemma":[0.00031043217,0.000116675496,0.0002408174,0.0002218678,0.0011287705,0.00015148902,0.00007162178,0.0004145765,0.000028326855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007875336,0.0028332719,0.9457283,0.0000014647363,0.0016403998,0.00012032976,0.000254638,0.0000013531378,0.000010834657,0.0000083607765,0.000017142545,0.041508585],"study_design_scores_gemma":[0.024394289,0.005949207,0.966973,0.00007927025,0.0003927371,0.00036533774,0.001577067,8.506332e-7,0.000057339308,0.000028585633,0.000029112183,0.00015321361],"about_ca_topic_score_codex":0.00012852006,"about_ca_topic_score_gemma":0.00009988623,"teacher_disagreement_score":0.04135537,"about_ca_system_score_codex":0.00007672764,"about_ca_system_score_gemma":0.0003830236,"threshold_uncertainty_score":0.47578886},"labels":[],"label_agreement":null},{"id":"W2327510397","doi":"10.2165/11310950-000000000-00000","title":"The Authorsʼ Reply","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Ipsen; Allergan; University of Toronto","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Medical physics; Internal medicine","score_opus":0.0320205664539577,"score_gpt":0.3980484929112934,"score_spread":0.36602792645733573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327510397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71015686,0.0006409838,0.00021292338,0.28434622,0.00057496736,0.00007860133,2.397773e-7,0.00002388715,0.0039653],"genre_scores_gemma":[0.952525,0.0027953316,0.0006360991,0.043710735,0.00017287435,3.883579e-7,3.0718493e-7,0.0000073352717,0.00015188119],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973627,0.00049125083,0.0014910379,0.00015068761,0.00022186361,0.00028251254],"domain_scores_gemma":[0.99680704,0.0016078798,0.0008368597,0.00026011406,0.00016570925,0.0003224089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007202822,0.00011385858,0.00081878115,0.000051965362,0.000095819945,0.000010961182,0.00023573905,0.00012367667,0.000028120126],"category_scores_gemma":[0.0022446655,0.00005677435,0.00048369096,0.0002446522,0.0010249815,0.000034870765,0.000018988996,0.0012374403,0.00004480506],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033893401,0.0006310331,0.037500765,0.0000040040013,0.0002828094,0.0025486788,0.000060043403,0.000007117864,0.0001058417,0.00299582,0.028640043,0.9238345],"study_design_scores_gemma":[0.0032387301,0.011401193,0.5131694,0.000043274365,0.00026605802,0.02086659,0.000252799,0.0001998869,0.00008200662,0.008522321,0.4417926,0.00016513359],"about_ca_topic_score_codex":0.0000012063022,"about_ca_topic_score_gemma":3.3759432e-7,"teacher_disagreement_score":0.9236694,"about_ca_system_score_codex":0.000005783968,"about_ca_system_score_gemma":0.00013649635,"threshold_uncertainty_score":0.5376131},"labels":[],"label_agreement":null},{"id":"W2328064285","doi":"10.1007/s40257-016-0186-4","title":"Radiodermatitis: A Review of Our Current Understanding","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":388,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radiodermatitis; Medicine; Erythema; Desquamation; Radiation therapy; Dermatology; Ionizing radiation; Surgery; Irradiation","score_opus":0.1577204286299851,"score_gpt":0.517902556431205,"score_spread":0.3601821278012199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328064285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004744123,0.9900315,0.0016414961,0.0058380617,0.0016290565,0.00054377376,0.000024218993,0.000014968331,0.00027222518],"genre_scores_gemma":[0.0002576463,0.9968409,0.00082645856,0.0012249807,0.00075900095,0.000008714968,0.000012107674,0.00005738544,0.0000128031015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99035555,0.0022590163,0.0061794063,0.0002854333,0.00057868275,0.00034189524],"domain_scores_gemma":[0.9849444,0.0032904805,0.010290965,0.0005414338,0.00044018598,0.00049252063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019026058,0.0004154809,0.0103408005,0.00046406747,0.000026366684,0.000006113201,0.000450661,0.00026575485,0.00006454571],"category_scores_gemma":[0.0055110897,0.0002549431,0.0027795155,0.00046572502,0.00050329394,0.00010451222,0.00006352714,0.0014419043,0.00007286241],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034163946,0.0001347891,0.00022594303,0.09296628,0.0007946425,0.0003306106,0.0000074291625,1.28042705e-8,2.3956806e-8,0.00027831367,0.0278771,0.8773507],"study_design_scores_gemma":[0.00074484193,0.0006937377,0.000019751664,0.2871438,0.0022599846,0.013727681,0.000021519996,5.926883e-7,1.5058512e-7,0.0000571778,0.69517726,0.00015351787],"about_ca_topic_score_codex":7.621992e-7,"about_ca_topic_score_gemma":1.9140225e-7,"teacher_disagreement_score":0.87719715,"about_ca_system_score_codex":0.00017851843,"about_ca_system_score_gemma":0.0020036236,"threshold_uncertainty_score":0.9999903},"labels":[],"label_agreement":null},{"id":"W2329343309","doi":"10.2165/11539080-000000000-00000","title":"A Systematic Approach to Systemic Contact Dermatitis and Symmetric Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Intertriginous; Medicine; Dermatology; Contact dermatitis; Erythema; Erythroderma; Buttocks; Allergic contact dermatitis; Allergy; Immunology; Surgery; Pathology","score_opus":0.04973093199240814,"score_gpt":0.365835247372309,"score_spread":0.31610431537990086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329343309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012639329,0.98366517,0.0002060774,0.00032213694,0.00060988375,0.0016046606,0.000013270458,0.000040844472,0.0008986031],"genre_scores_gemma":[0.16328627,0.8350132,0.0007607404,0.00061480294,0.00011817858,0.000047381232,0.0000083289215,0.00007187873,0.00007919315],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9902428,0.0019351143,0.006438356,0.0005154115,0.0003517004,0.00051666837],"domain_scores_gemma":[0.98996896,0.0034950147,0.0047918893,0.0005116655,0.0003278855,0.00090457685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012068383,0.00070358685,0.011933664,0.0011939283,0.00007486696,0.00007348204,0.0004172017,0.000389127,0.000014937289],"category_scores_gemma":[0.0017279739,0.0004646884,0.001132999,0.0006912105,0.000494788,0.0001530427,0.00019971143,0.0014437062,0.00004128647],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099160796,0.0003811788,0.0012674412,0.19479887,0.0044670757,0.0017967338,0.000949297,6.909968e-8,2.2568176e-7,0.0014004419,0.0012141614,0.79362535],"study_design_scores_gemma":[0.0035933093,0.002224699,0.0019497907,0.28393382,0.010667941,0.56463474,0.0017439529,0.000106553634,4.8912295e-7,0.000058269317,0.13004753,0.0010389172],"about_ca_topic_score_codex":0.000046648405,"about_ca_topic_score_gemma":0.000003219213,"teacher_disagreement_score":0.79258645,"about_ca_system_score_codex":0.00007942293,"about_ca_system_score_gemma":0.0005274604,"threshold_uncertainty_score":0.9997805},"labels":[],"label_agreement":null},{"id":"W2416195067","doi":"10.1007/s40257-016-0200-x","title":"Management of Pain Associated with Selected Conditions in Dermatology","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of Alberta; University of Ottawa; Ottawa Hospital; Children's Hospital of Eastern Ontario; McGill University","funders":"","keywords":"Medicine; Dermatology; Pharmacotherapy; MEDLINE; Pain management; Physical therapy; Internal medicine","score_opus":0.050425995450952076,"score_gpt":0.4191167259120384,"score_spread":0.36869073046108636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416195067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026437389,0.9700072,0.00017114737,0.0014121908,0.00029309856,0.00090994354,0.000062949235,0.000032132255,0.00067397184],"genre_scores_gemma":[0.075528935,0.92340374,0.00057499163,0.00026609286,0.00004567911,0.00003239096,0.000058423342,0.000047791185,0.000041981628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99264187,0.002791666,0.0035291035,0.00031243212,0.0002998078,0.00042510417],"domain_scores_gemma":[0.99062943,0.0042445716,0.0041506644,0.00034196794,0.00037403405,0.00025933454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080273097,0.00038944793,0.006950232,0.00056832173,0.000029761692,0.000004107918,0.00028409672,0.000398844,0.000086946435],"category_scores_gemma":[0.00093677157,0.00023036223,0.0007936894,0.0009142239,0.00095835945,0.000051603496,0.000045405654,0.00082040654,0.000025715857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003458391,0.0019637519,0.053517897,0.0021186122,0.0074564093,0.012192255,0.000033154985,1.07537126e-7,1.7170352e-7,0.00020302675,0.00064423925,0.9215245],"study_design_scores_gemma":[0.019418547,0.007866427,0.055820603,0.13446966,0.016264103,0.058435135,0.00030814722,0.000008322064,0.000006354813,0.00020690411,0.7062678,0.0009280253],"about_ca_topic_score_codex":0.000005054147,"about_ca_topic_score_gemma":0.000008312452,"teacher_disagreement_score":0.92059654,"about_ca_system_score_codex":0.000108536515,"about_ca_system_score_gemma":0.0007844558,"threshold_uncertainty_score":0.9393899},"labels":[],"label_agreement":null},{"id":"W2494434948","doi":"10.1007/s40257-016-0214-4","title":"Critical Evaluation of Delayed Healing of Venous Leg Ulcers: A Retrospective Analysis in Canadian Patients","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Retrospective cohort study; Varicose Ulcer; Venous leg ulcer; Surgery; Intensive care medicine; Internal medicine","score_opus":0.03837903412437305,"score_gpt":0.42373610280507074,"score_spread":0.3853570686806977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494434948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578077,0.00029149905,0.00006458423,0.003354652,0.0001326204,0.000116352065,0.000043812423,0.000002095004,0.00021359512],"genre_scores_gemma":[0.9991314,0.0001960438,0.00036198884,0.00025747163,0.000035124052,0.0000035359017,0.000004983899,0.000008780256,6.878155e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704516,0.00047453778,0.001554228,0.00016484271,0.00049965753,0.00026159227],"domain_scores_gemma":[0.9952312,0.0017833523,0.00088689936,0.00018387662,0.0014869603,0.00042771138],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0009804165,0.000103139006,0.0014510062,0.00057183026,0.000019948746,0.00000268945,0.000095064686,0.000072812196,0.000118105425],"category_scores_gemma":[0.008905866,0.00006987419,0.00044546567,0.00050528947,0.00060933735,0.000083586776,0.000011596081,0.00013744205,0.000002681385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005074656,0.0044199824,0.9597489,0.000012237954,0.0011506296,0.000113684335,0.00008667092,0.000011820012,0.0000035682383,0.00019945222,0.00006028141,0.033685263],"study_design_scores_gemma":[0.0029632926,0.007813372,0.98475915,0.00019095303,0.0032986372,0.000054588458,0.0001377377,0.00013889033,0.000058327772,0.00049005565,0.000033404445,0.00006159614],"about_ca_topic_score_codex":0.011124634,"about_ca_topic_score_gemma":0.011175689,"teacher_disagreement_score":0.033623666,"about_ca_system_score_codex":0.00021134342,"about_ca_system_score_gemma":0.0012636702,"threshold_uncertainty_score":0.9994425},"labels":[],"label_agreement":null},{"id":"W2525858747","doi":"10.1007/s40257-016-0226-0","title":"Relapsing Polychondritis: A Review and Guide for the Dermatologist","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Toronto; University of Alberta","keywords":"Medicine; Relapsing polychondritis; Dermatology; Disease; Treatment modality; Therapeutic modalities; Pathology; Surgery; Internal medicine","score_opus":0.06749774066486361,"score_gpt":0.46959064946279083,"score_spread":0.40209290879792725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525858747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000024065166,0.9615162,0.0008482891,0.026770368,0.009587406,0.0009746991,0.000036950878,0.000022684271,0.00024101093],"genre_scores_gemma":[0.0000046368664,0.9866727,0.0034417347,0.0068497974,0.0008072443,0.000049359616,0.000008717255,0.00008946003,0.0020763422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99287367,0.0009865891,0.004865467,0.00043261526,0.00029898935,0.00054267555],"domain_scores_gemma":[0.9834581,0.010687471,0.004366348,0.0006027641,0.0003605533,0.0005247342],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0012370495,0.00049150304,0.008319348,0.00022332846,0.00014372006,0.000026164455,0.0004951425,0.0004720141,0.000050639963],"category_scores_gemma":[0.0066678375,0.00023996527,0.0021799032,0.00030385813,0.002834989,0.00007776193,0.000102192855,0.0015054153,0.000036001045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003967062,0.00005675186,0.00007601912,0.010275035,0.00082959194,0.00062375853,0.0000062927725,1.0663027e-9,5.6028597e-8,0.0000996081,0.17697783,0.81101537],"study_design_scores_gemma":[0.0010167527,0.00055155467,0.000013130039,0.08879062,0.007698869,0.13215579,0.000021700975,3.665442e-7,1.1248932e-7,0.000041263673,0.769509,0.00020082176],"about_ca_topic_score_codex":0.000005411435,"about_ca_topic_score_gemma":0.0000027681313,"teacher_disagreement_score":0.81081456,"about_ca_system_score_codex":0.00004503281,"about_ca_system_score_gemma":0.001206249,"threshold_uncertainty_score":0.9998787},"labels":[],"label_agreement":null},{"id":"W2536945044","doi":"10.1007/s40257-016-0230-4","title":"Treating Alopecia Areata: Current Practices Versus New Directions","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Alopecia areata; Medicine; Hair loss; Minoxidil; Dermatology; Scalp","score_opus":0.2002524330469345,"score_gpt":0.5407466972916677,"score_spread":0.34049426424473317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536945044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011288819,0.98943704,0.00023545706,0.0024195635,0.0033215047,0.00024434485,0.000010478241,0.000028852526,0.0041898787],"genre_scores_gemma":[0.00014807825,0.9961985,0.00088364974,0.00019650783,0.0023348604,0.0000073554743,0.00001398577,0.00005092319,0.00016617334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945363,0.001017115,0.0032992845,0.00037436275,0.00034185627,0.0004311052],"domain_scores_gemma":[0.9827639,0.007836218,0.0077990456,0.00041287142,0.0002635803,0.0009244109],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055428024,0.00040842922,0.005310805,0.0003853308,0.00007260602,0.000021853992,0.00032757065,0.0002709593,0.00019290634],"category_scores_gemma":[0.01326519,0.00024667438,0.001818644,0.00047978095,0.00058426865,0.00016171782,0.00006655454,0.0015310905,0.00025411634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045264195,0.00023491785,0.0012257347,0.0007402491,0.00087039283,0.00034628483,0.000019161247,1.8037543e-8,9.169997e-9,0.000053981053,0.01026419,0.9857924],"study_design_scores_gemma":[0.0025297794,0.0012559546,0.0001585395,0.0074278633,0.0032542513,0.0057991766,0.00009129935,5.135966e-7,7.886553e-8,0.000025284517,0.97923875,0.00021853502],"about_ca_topic_score_codex":0.000030324964,"about_ca_topic_score_gemma":0.000019982055,"teacher_disagreement_score":0.9855739,"about_ca_system_score_codex":0.0000713846,"about_ca_system_score_gemma":0.0035115527,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W2548177504","doi":"10.1007/s40257-016-0232-2","title":"Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Pimecrolimus; Medicine; Dermatology; Seborrheic dermatitis; Cochrane Library; Randomized controlled trial; Mometasone furoate; MEDLINE; Tacrolimus; Corticosteroid; Internal medicine","score_opus":0.07574893999910119,"score_gpt":0.47351716075296685,"score_spread":0.39776822075386564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548177504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081865706,0.99673593,0.00003386727,0.0011351634,0.00039153983,0.0013850926,0.0000669515,0.0000111659565,0.00015842944],"genre_scores_gemma":[0.000433003,0.9979877,0.0002688077,0.0008359595,0.0002584222,0.00006672079,0.000020320136,0.00004078237,0.000088292625],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99121743,0.0015506294,0.006208744,0.00028864318,0.00040862343,0.00032594285],"domain_scores_gemma":[0.9894669,0.0028415667,0.0062187356,0.0006051818,0.00030702483,0.00056061446],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00028194778,0.00048986595,0.01559961,0.00022113684,0.000025552596,0.000006201663,0.00027773052,0.00024849095,0.00014291918],"category_scores_gemma":[0.00181107,0.00024338682,0.004226767,0.0002556522,0.0005424211,0.00004842728,0.00003850298,0.0003023635,0.00014715614],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044995773,0.00071022374,0.00040553408,0.3603844,0.0030506572,0.0018182917,0.000006487299,1.4317543e-9,3.9986214e-9,0.000032947755,0.0005207373,0.6330257],"study_design_scores_gemma":[0.0016720404,0.003018653,0.00009670919,0.5252074,0.0243407,0.016598236,0.000009409288,2.0773808e-7,1.6755423e-7,0.00001973423,0.42887,0.00016674993],"about_ca_topic_score_codex":0.0000055602345,"about_ca_topic_score_gemma":7.5761994e-7,"teacher_disagreement_score":0.632859,"about_ca_system_score_codex":0.00012793066,"about_ca_system_score_gemma":0.0012866318,"threshold_uncertainty_score":0.99901485},"labels":[],"label_agreement":null},{"id":"W2570401170","doi":"10.1007/s40257-016-0246-9","title":"Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)","year":2017,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Etanercept; Plaque psoriasis; Randomized controlled trial; Psoriasis; Pharmacotherapy; Clinical trial; Internal medicine; Dermatology; Psoriatic arthritis; Secukinumab; Tumor necrosis factor alpha","score_opus":0.06534057836563588,"score_gpt":0.4286594761625303,"score_spread":0.3633188977968944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570401170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921649,0.0007693544,0.002266195,0.0032841156,0.00074288755,0.0006551763,0.000051588057,0.0000067251844,0.000059076883],"genre_scores_gemma":[0.9953949,0.002229203,0.0016090695,0.00056398736,0.00012886107,0.000015930254,0.000014631815,0.000022873226,0.00002056677],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9807137,0.011680673,0.0064257514,0.0006135544,0.00011196082,0.0004543504],"domain_scores_gemma":[0.9642026,0.030857144,0.0039655822,0.00057013176,0.0001511524,0.00025342716],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013905615,0.00038211496,0.008181487,0.0006261823,0.00015651745,0.000045689358,0.000549446,0.00042461566,0.000082134895],"category_scores_gemma":[0.02079785,0.00029088487,0.00087012764,0.00025040013,0.0009175844,0.00021084401,0.00022044592,0.00082467886,0.000015832298],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53357005,0.0006773206,0.048576243,0.0000072811,0.0023203702,0.0002867378,0.0012118194,0.00008561164,0.00088927225,0.00004663362,0.00008735265,0.4122413],"study_design_scores_gemma":[0.844457,0.002274402,0.14542656,0.0004024945,0.0023789061,0.000536521,0.001329562,0.00042870882,0.00083368394,0.0006831823,0.0006644493,0.000584588],"about_ca_topic_score_codex":0.0013077175,"about_ca_topic_score_gemma":0.0007797664,"teacher_disagreement_score":0.41165674,"about_ca_system_score_codex":0.000034954577,"about_ca_system_score_gemma":0.00033085325,"threshold_uncertainty_score":0.99995434},"labels":[],"label_agreement":null},{"id":"W2590362558","doi":"10.1007/s40257-017-0251-7","title":"Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment","year":2017,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":316,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Women's College Hospital","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Disease; Intensive care medicine; Neutrophilic dermatosis; Inflammation; Pathophysiology; Dermatology; Pharmacotherapy; Bioinformatics; Immunology; Pathology; Internal medicine","score_opus":0.16858302196326444,"score_gpt":0.4904569408922327,"score_spread":0.3218739189289682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590362558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01546961,0.9814211,0.0000042507268,0.001738326,0.0006106331,0.00041440118,0.000021112686,0.000021118389,0.0002994485],"genre_scores_gemma":[0.0021793048,0.99521327,0.00024568243,0.0017578573,0.00042018128,0.000035517536,0.00004129816,0.00006653981,0.000040335366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99476296,0.0011907376,0.0030099778,0.00045346894,0.00019207185,0.0003907765],"domain_scores_gemma":[0.99247324,0.0011587898,0.004862632,0.0008765218,0.00014212876,0.00048668115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044828068,0.00054967083,0.008118786,0.00030581033,0.00013114413,0.000026770942,0.00039692697,0.0004582957,0.000060689435],"category_scores_gemma":[0.00066598284,0.00034817358,0.0014701396,0.0000907737,0.0016778383,0.00012644545,0.00007603698,0.0010478155,0.000094831186],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023809233,0.00057474856,0.0017799779,0.00050004374,0.00091704493,0.0019048804,0.000029156807,1.0445625e-7,4.93807e-8,0.000058405094,0.0011679479,0.99282956],"study_design_scores_gemma":[0.001564719,0.0073294984,0.0020835702,0.0029571098,0.002434246,0.004097143,0.000053289627,0.0000029237021,5.136059e-7,0.00008816273,0.9791087,0.00028012536],"about_ca_topic_score_codex":0.000013138999,"about_ca_topic_score_gemma":0.000003549709,"teacher_disagreement_score":0.9925494,"about_ca_system_score_codex":0.000048115395,"about_ca_system_score_gemma":0.00085356826,"threshold_uncertainty_score":0.999897},"labels":[],"label_agreement":null},{"id":"W2626152381","doi":"10.1007/s40257-017-0308-7","title":"Drug-Induced Pyoderma Gangrenosum: A Review","year":2017,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Assembly of First Nations; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Isotretinoin; Pyoderma gangrenosum; Drug; Propylthiouracil; Dermatology; Adverse effect; Adverse drug reaction; Sunitinib; Pharmacotherapy; MEDLINE; Internal medicine; Pharmacology; Cancer; Acne","score_opus":0.188495914818479,"score_gpt":0.5189946154213417,"score_spread":0.33049870060286274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626152381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111053945,0.99055636,0.000010001409,0.0045169615,0.0012153118,0.00063313864,0.0000054052025,0.000028572276,0.0029232032],"genre_scores_gemma":[0.00014172144,0.9940124,0.00025970233,0.0045868177,0.0005405378,0.000018338911,0.000021597214,0.00010057626,0.00031831904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900932,0.0015474429,0.0068786684,0.00044331915,0.0004936092,0.000543765],"domain_scores_gemma":[0.98397696,0.0012864283,0.012323252,0.0013746074,0.000486628,0.0005521211],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017377296,0.0006436553,0.014963137,0.00033890968,0.00011846314,0.000024950947,0.0010713295,0.0004324935,0.00019400356],"category_scores_gemma":[0.0038583407,0.00044186527,0.0043798885,0.00027698866,0.0011512199,0.00015902058,0.00016827698,0.0028046865,0.00043181513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048660648,0.00016678568,0.00016854043,0.018303096,0.0010529045,0.0023326739,0.000012452301,4.972575e-9,3.0252462e-8,0.000026723339,0.030571785,0.94731635],"study_design_scores_gemma":[0.0008894034,0.00052931265,0.0001206808,0.07848772,0.0051853806,0.024411075,0.00002502556,5.2880506e-7,1.8046569e-7,0.000017533768,0.8900021,0.0003310991],"about_ca_topic_score_codex":0.000008799841,"about_ca_topic_score_gemma":0.0000019641352,"teacher_disagreement_score":0.94698524,"about_ca_system_score_codex":0.00005008981,"about_ca_system_score_gemma":0.003277512,"threshold_uncertainty_score":0.9998033},"labels":[],"label_agreement":null},{"id":"W2785647181","doi":"10.1007/s40257-017-0341-6","title":"Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"AbbVie","keywords":"Hidradenitis suppurativa; Medicine; Adalimumab; Psoriasis; Dermatology; Pharmacotherapy; Internal medicine; Disease","score_opus":0.030188051055915807,"score_gpt":0.3360196623802492,"score_spread":0.3058316113243334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785647181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98388714,0.000054051776,0.00015710304,0.014172644,0.0003580615,0.00029314472,0.00005387037,0.000015246055,0.0010087255],"genre_scores_gemma":[0.9972625,0.00014662887,0.0018787427,0.0002565743,0.00027216878,0.000003873257,0.0000076263564,0.00004428897,0.00012764246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639064,0.0006408471,0.0017716637,0.00031862519,0.00051261287,0.0003656287],"domain_scores_gemma":[0.9955247,0.001764526,0.001450103,0.000327399,0.00051746186,0.00041578204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003803953,0.00030321983,0.0018502482,0.00023130173,0.00008850244,0.000011856535,0.00016748004,0.00015900879,0.0003985968],"category_scores_gemma":[0.0006576905,0.00018166748,0.00024479855,0.00032438705,0.0018549879,0.00020482465,0.000042969685,0.00046723106,0.000034498982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03451016,0.003103412,0.8331568,0.000036936744,0.001523138,0.014054985,0.00057445915,8.393027e-8,0.000019599664,0.00012865092,0.0011649928,0.111726776],"study_design_scores_gemma":[0.040372755,0.08215661,0.7422177,0.0008686473,0.0012508358,0.12247983,0.001220445,0.000019881607,0.0011382052,0.0003090162,0.0074478863,0.00051817665],"about_ca_topic_score_codex":0.00006480981,"about_ca_topic_score_gemma":0.00004359701,"teacher_disagreement_score":0.111208595,"about_ca_system_score_codex":0.00004227956,"about_ca_system_score_gemma":0.00041519626,"threshold_uncertainty_score":0.74081844},"labels":[],"label_agreement":null},{"id":"W2794146536","doi":"10.1007/s40257-018-0352-y","title":"Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Windsor Clinical Research; Occupational Cancer Research Centre; Western University; Innovaderm (Canada)","funders":"Galderma","keywords":"Medicine; Acne; Tolerability; Benzoyl peroxide; Dermatology; Adapalene; Acne scars; Randomized controlled trial; Clinical trial; Scars; Surgery; Internal medicine; Adverse effect","score_opus":0.06676159548000438,"score_gpt":0.40594074792914714,"score_spread":0.33917915244914276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794146536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672204,0.0002305102,0.00033069105,0.0010024871,0.00016798654,0.0014456355,0.000008669718,0.000006573019,0.000085396925],"genre_scores_gemma":[0.9939173,0.00032534252,0.0054819332,0.00003752725,0.00017180233,0.000012737392,0.0000055367673,0.000019856487,0.000027953483],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99390686,0.0018830461,0.0029325709,0.00032394964,0.00059797696,0.00035560052],"domain_scores_gemma":[0.9947344,0.0013021138,0.002909961,0.00022509224,0.0006011079,0.000227313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001777726,0.00025244476,0.004059944,0.00037345994,0.00006421645,0.000015310836,0.00014755674,0.00019133158,0.0000138655905],"category_scores_gemma":[0.001003522,0.00013415693,0.00029167355,0.00039899917,0.0026220833,0.00015907931,0.000046159694,0.0006007958,6.292986e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96565443,0.0013601129,0.0166253,0.00005521331,0.0013440582,0.00034934003,0.00056454743,0.00012752558,0.00022117895,0.000011241743,0.00003064131,0.0136564],"study_design_scores_gemma":[0.950298,0.022707768,0.010953183,0.0005789118,0.0012227175,0.00867477,0.0012355414,0.0031342236,0.0009553832,0.00006914794,0.000010955511,0.00015940245],"about_ca_topic_score_codex":0.00014339293,"about_ca_topic_score_gemma":0.00012521274,"teacher_disagreement_score":0.021347655,"about_ca_system_score_codex":0.000036635207,"about_ca_system_score_gemma":0.00095499505,"threshold_uncertainty_score":0.9661175},"labels":[],"label_agreement":null},{"id":"W2893494515","doi":"10.1007/s40257-018-0388-z","title":"Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Janssen Scientific Affairs; University of Pennsylvania","keywords":"Medicine; Psoriasis; Etanercept; Infliximab; Adalimumab; Internal medicine; Odds ratio; Confidence interval; Psoriasis Area and Severity Index; Methotrexate; Ustekinumab; Surgery; Dermatology; Rheumatoid arthritis; Disease","score_opus":0.04066805683277146,"score_gpt":0.39020595001039104,"score_spread":0.3495378931776196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893494515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978619,0.0004837025,0.000056922603,0.00039765215,0.00070453715,0.0002940542,0.000040316092,0.0000048649754,0.00015600762],"genre_scores_gemma":[0.9985632,0.0008656077,0.00036181667,0.00008310862,0.00007096938,0.000012628159,0.00001092122,0.0000146575185,0.000017120128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916146,0.0049744304,0.002671206,0.0003100229,0.00014060977,0.00028916838],"domain_scores_gemma":[0.9856841,0.010552379,0.002991943,0.0005286524,0.00018289067,0.000060040282],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002560411,0.0003039091,0.0029129009,0.00021331615,0.000052794243,0.0000048011225,0.00040458122,0.00027999535,0.000023408407],"category_scores_gemma":[0.0006319332,0.0001564116,0.0005813235,0.00025217354,0.0027345805,0.00004862191,0.00004557831,0.00041547272,0.0000051902994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070108143,0.0010754152,0.9269936,0.000051423525,0.002132119,0.0002496747,0.0002455913,0.000001225858,0.00014793068,0.00011486729,0.00009712829,0.061880223],"study_design_scores_gemma":[0.01029385,0.04446566,0.93729633,0.00025094426,0.0013584379,0.0027393415,0.0005736433,0.0000011663573,0.0025119877,0.000024534931,0.00034240648,0.00014166525],"about_ca_topic_score_codex":0.0001497238,"about_ca_topic_score_gemma":0.00007474863,"teacher_disagreement_score":0.061738558,"about_ca_system_score_codex":0.000031183223,"about_ca_system_score_gemma":0.00029310558,"threshold_uncertainty_score":0.9999794},"labels":[],"label_agreement":null},{"id":"W2900867377","doi":"10.1007/s40257-018-0403-4","title":"A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Dermatophyte; Cure rate; Antifungal; Organism; Disease; Dermatology; Surgery; Internal medicine","score_opus":0.12369268240485418,"score_gpt":0.4623947374434581,"score_spread":0.33870205503860396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900867377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029478803,0.94221115,0.00022771658,0.024896156,0.0007847692,0.0018545078,0.0003648841,0.00002183212,0.00016019164],"genre_scores_gemma":[0.0060961638,0.9856473,0.004421973,0.0028278003,0.00045381687,0.000052360254,0.00003599238,0.000082470826,0.00038211493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595654,0.0007932394,0.0018942046,0.0005445793,0.0003455349,0.0004658727],"domain_scores_gemma":[0.99460924,0.0016895203,0.0018008194,0.0005852922,0.000076744705,0.0012383573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024494753,0.00053619547,0.003739924,0.00017907613,0.0001322118,0.00003786219,0.00021622425,0.00021338856,0.00014351087],"category_scores_gemma":[0.0009993686,0.00028980634,0.001062089,0.00022115497,0.0006192968,0.00006924752,0.0002800835,0.00050953205,0.0002448448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007106596,0.0010602606,0.006544535,0.0002574284,0.0026005674,0.0021925007,0.00009700821,4.468948e-8,4.911545e-7,0.000007354581,0.04809137,0.93843776],"study_design_scores_gemma":[0.0016202774,0.0057531553,0.001002392,0.0015505423,0.005197965,0.023043418,0.0002447902,5.7722264e-7,0.0000035223266,0.0000046613773,0.9613473,0.00023140947],"about_ca_topic_score_codex":0.000014788815,"about_ca_topic_score_gemma":0.000009425593,"teacher_disagreement_score":0.9382064,"about_ca_system_score_codex":0.0003033379,"about_ca_system_score_gemma":0.00056171353,"threshold_uncertainty_score":0.9999554},"labels":[],"label_agreement":null},{"id":"W2901523494","doi":"10.1007/s40257-018-0396-z","title":"Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Dermatology Life Quality Index; Medicine; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Placebo; Quality of life (healthcare); Internal medicine; Minimal clinically important difference; Dermatology; Randomized controlled trial; Disease; Pathology","score_opus":0.03698518268949746,"score_gpt":0.34539625998573364,"score_spread":0.3084110772962362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901523494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440266,0.0027822994,0.00009614873,0.01143515,0.0006043302,0.0005588081,0.00007174758,0.00001527089,0.000033614],"genre_scores_gemma":[0.9947069,0.001972725,0.00012105109,0.0030398061,0.00006762385,0.00004117499,0.000014065706,0.000020949661,0.000015661375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925611,0.003338287,0.0028845314,0.000586563,0.00012301038,0.0005064946],"domain_scores_gemma":[0.9874306,0.009911392,0.0018356675,0.0004548833,0.00022592154,0.00014159108],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0016797632,0.0004188465,0.0024093792,0.00020192629,0.00023828493,0.0000320207,0.0003018354,0.00028392146,0.000011303848],"category_scores_gemma":[0.0026755042,0.00021857866,0.00014337517,0.00029567588,0.0033009525,0.00015055409,0.00025068672,0.000676181,0.000004266109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09820367,0.0011453462,0.71025866,0.000021572281,0.0067288303,0.0008101888,0.015895851,0.000010562008,0.00028007504,0.00032328797,0.0010015455,0.16532044],"study_design_scores_gemma":[0.24616924,0.009188466,0.70438534,0.00034260855,0.0018350428,0.003927455,0.0261067,0.000112679496,0.0019141794,0.0017342662,0.003084304,0.0011997294],"about_ca_topic_score_codex":0.0011360337,"about_ca_topic_score_gemma":0.0014470966,"teacher_disagreement_score":0.1641207,"about_ca_system_score_codex":0.000030267467,"about_ca_system_score_gemma":0.00021906788,"threshold_uncertainty_score":0.99941146},"labels":[],"label_agreement":null},{"id":"W2911080709","doi":"10.1007/s40257-018-00416-4","title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Drug; Dermatology; Eosinophilia; Pharmacotherapy; Adverse drug reaction; Intensive care medicine; Immunology; Antibody; Internal medicine; Pharmacology","score_opus":0.06548412371774488,"score_gpt":0.40122810467147463,"score_spread":0.33574398095372976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911080709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006251636,0.985089,0.00008126167,0.004782371,0.0017161887,0.00097155775,0.00002704466,0.000049455888,0.001031484],"genre_scores_gemma":[0.0447599,0.9535871,0.00028373025,0.0003081308,0.00053364557,0.000013101855,0.000020197323,0.000104413295,0.00038975917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464923,0.0011921115,0.0026388438,0.00054539286,0.00051266287,0.00046176658],"domain_scores_gemma":[0.98965913,0.0028370945,0.0057752402,0.00067723525,0.00042081415,0.0006305079],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006914194,0.0005927787,0.007918169,0.000614978,0.00006885253,0.000035633755,0.00030150966,0.00046793805,0.0000037174573],"category_scores_gemma":[0.00056610245,0.00038923704,0.0010514603,0.00039050786,0.0010825902,0.00020488781,0.0000808926,0.0029067588,0.00007375391],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074530915,0.00019016869,0.0012892064,0.0052867597,0.0018458678,0.0012298754,0.000049893795,2.9779397e-7,0.000001963476,0.000058343074,0.00037215525,0.98960096],"study_design_scores_gemma":[0.0014819982,0.00051230943,0.00065719476,0.0189606,0.0060870517,0.17247586,0.00069275737,0.000007415019,5.306588e-7,0.000006238999,0.7988001,0.00031791814],"about_ca_topic_score_codex":0.000019318435,"about_ca_topic_score_gemma":0.0000062353793,"teacher_disagreement_score":0.989283,"about_ca_system_score_codex":0.00018024236,"about_ca_system_score_gemma":0.0013402383,"threshold_uncertainty_score":0.99985594},"labels":[],"label_agreement":null},{"id":"W2937897222","doi":"10.1007/s40257-019-00441-x","title":"Vascular Tests for Dermatologists","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Arterial insufficiency; Ankle; Duplex ultrasonography; Vascular Medicine; Vascular disease; Arterial disease; Critical limb ischemia; Intensive care medicine; Radiology; Surgery","score_opus":0.17649225607597663,"score_gpt":0.5082409295017222,"score_spread":0.33174867342574554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937897222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031896224,0.99452573,0.0007814303,0.0015282478,0.0012182866,0.0012204133,0.00002067687,0.000031244672,0.00035503184],"genre_scores_gemma":[0.00053045136,0.9920428,0.0038801283,0.0027557036,0.0005087016,0.000048144047,0.000042533662,0.000084672545,0.0001069061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99353206,0.0008308583,0.00426051,0.0004668948,0.00038543518,0.00052424875],"domain_scores_gemma":[0.9918315,0.002500693,0.0039902534,0.00074522657,0.00037815815,0.0005541825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007896589,0.00050465815,0.00941687,0.00035382414,0.000037266735,0.000021578915,0.00058181264,0.00034562827,0.00006439991],"category_scores_gemma":[0.001716832,0.00034701472,0.004334913,0.00032125122,0.00069661083,0.000078471974,0.00013466051,0.0009634734,0.00021094712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015073044,0.00037586715,0.0012099915,0.011408236,0.0023112705,0.0009466682,0.0000059663107,4.975206e-7,2.5809907e-8,0.000096689735,0.014634168,0.9688599],"study_design_scores_gemma":[0.0016588428,0.001283109,0.0005251182,0.004946227,0.007404373,0.009235438,0.000020343587,0.000016670454,8.003344e-8,0.00005141122,0.97456366,0.0002947336],"about_ca_topic_score_codex":0.0000018351752,"about_ca_topic_score_gemma":6.911749e-7,"teacher_disagreement_score":0.96856517,"about_ca_system_score_codex":0.00007840739,"about_ca_system_score_gemma":0.0012269722,"threshold_uncertainty_score":0.9998982},"labels":[],"label_agreement":null},{"id":"W2949528356","doi":"10.1007/s40257-019-00458-2","title":"Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Probity Medical Research","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research; Amgen","keywords":"Psoriasis; Medicine; Pharmacotherapy; Intensive care medicine; Dermatology; Psychiatry","score_opus":0.062405782343731356,"score_gpt":0.3399270085649656,"score_spread":0.27752122622123426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949528356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055433,0.002278644,0.0000029194957,0.0018150087,0.0045637684,0.0004305794,0.000069545225,0.000008375453,0.00027684102],"genre_scores_gemma":[0.9984974,0.00046067964,0.000060148548,0.00078387425,0.00014231216,0.0000068650274,0.0000072903335,0.00001235593,0.000029059765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99196696,0.0044218176,0.0026572174,0.00044107274,0.00024003927,0.00027288805],"domain_scores_gemma":[0.99124265,0.005502247,0.0020002155,0.000664092,0.0005297952,0.00006100412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003677538,0.00023182959,0.0014506271,0.000056832694,0.00008174663,0.000012912319,0.00095359585,0.00027090838,0.00019172009],"category_scores_gemma":[0.003238322,0.00013348462,0.00058575725,0.00022020277,0.0013550994,0.000093096154,0.00030387286,0.00091252424,0.00002696927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017503824,0.0008523468,0.9436614,0.0000070751707,0.0009333772,0.000015795913,0.0020556217,7.045739e-7,0.00002857181,0.000018749146,0.0010189759,0.04965703],"study_design_scores_gemma":[0.0070981407,0.0007171537,0.97257054,0.00005747659,0.00035781955,0.000113470334,0.010208406,0.0000074987724,0.00007792262,0.0001314919,0.008541109,0.000118954966],"about_ca_topic_score_codex":0.00044053863,"about_ca_topic_score_gemma":0.0005945057,"teacher_disagreement_score":0.049538072,"about_ca_system_score_codex":0.000086672575,"about_ca_system_score_gemma":0.0008364444,"threshold_uncertainty_score":0.5443345},"labels":[],"label_agreement":null},{"id":"W2950914207","doi":"10.1007/s40257-019-00454-6","title":"Long-Term Effectiveness and Safety of Up to 48 Weeks’ Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Windsor Clinical Research; Occupational Cancer Research Centre; Western University; Innovaderm (Canada)","funders":"Galderma","keywords":"Medicine; Acne; Adapalene; Tolerability; Benzoyl peroxide; Dermatology; Scars; Acne scars; Surgery; Adverse effect; Internal medicine","score_opus":0.01885888520017651,"score_gpt":0.3446266133717555,"score_spread":0.32576772817157895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950914207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794096,0.0003958577,0.00008631194,0.0010365155,0.000078681274,0.0004411754,0.0000025278982,0.0000013125413,0.000016676418],"genre_scores_gemma":[0.9983611,0.0013063608,0.00021647094,0.00005334437,0.00003358253,0.000004707238,0.0000019147633,0.000006754968,0.000015763431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840856,0.00050894445,0.0006399928,0.00017918352,0.00012451953,0.0001387745],"domain_scores_gemma":[0.99902767,0.0003661108,0.00034422005,0.000110621135,0.00005391922,0.00009746104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034642316,0.00012941462,0.0009981018,0.00010608551,0.000020701009,0.0000045371153,0.00004035174,0.000082188286,0.00000470626],"category_scores_gemma":[0.000034581015,0.00007150039,0.000075946,0.00011144317,0.0002836926,0.000071201706,0.000023212673,0.00018556685,4.5548583e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013051321,0.00037768128,0.8677002,0.00011704384,0.00019432537,0.00013302437,0.0006851819,0.000031569423,0.0005981851,0.000022730406,0.000002255847,0.11708647],"study_design_scores_gemma":[0.008780514,0.010065006,0.9755191,0.0004020291,0.00018847965,0.0038386409,0.0004814629,0.000057492598,0.0005352142,0.00005077393,0.000012276029,0.00006897998],"about_ca_topic_score_codex":0.00005812587,"about_ca_topic_score_gemma":0.000044335105,"teacher_disagreement_score":0.11701749,"about_ca_system_score_codex":0.000024603789,"about_ca_system_score_gemma":0.00009007091,"threshold_uncertainty_score":0.29157013},"labels":[],"label_agreement":null},{"id":"W2955778729","doi":"10.1007/s40257-019-00460-8","title":"Authors’ Reply to Laneelle et al.: “Vascular Tests for Dermatologists”","year":2019,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacotherapy; Dermatology; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.061218713995391943,"score_gpt":0.42163564696742384,"score_spread":0.3604169329720319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955778729","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017800687,0.00025480404,0.0024952223,0.9757227,0.0019717726,0.0010140848,0.00004188219,0.000056038578,0.00064284325],"genre_scores_gemma":[0.01144977,0.00029509273,0.010517209,0.9752765,0.0013831622,0.000044790835,0.000120386925,0.00011424097,0.0007987927],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934767,0.0011526173,0.0031603493,0.0007160842,0.00071304874,0.00078120444],"domain_scores_gemma":[0.99257827,0.0029819016,0.0022700522,0.0010865591,0.00057264155,0.0005105865],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014015206,0.0005266853,0.0038788589,0.00044472452,0.000052012685,0.00004157798,0.00070442236,0.00042326687,0.00014137517],"category_scores_gemma":[0.0033069386,0.00041727917,0.0016743846,0.00028591836,0.0005559437,0.000091576556,0.00020983213,0.0027913146,0.00026861136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005731824,0.00021613584,0.013585327,0.00025409498,0.0011476451,0.005321791,0.000037653957,0.000011016754,0.0000050401295,0.000020584119,0.97102416,0.0078033702],"study_design_scores_gemma":[0.0023906468,0.0024778014,0.0076638083,0.00032950373,0.0008042497,0.0052304245,0.000053351618,0.000072617084,0.0000055637383,0.00009263616,0.9804825,0.00039688474],"about_ca_topic_score_codex":0.000024014073,"about_ca_topic_score_gemma":0.0000027182805,"teacher_disagreement_score":0.009458354,"about_ca_system_score_codex":0.00007805082,"about_ca_system_score_gemma":0.00063245307,"threshold_uncertainty_score":0.9998279},"labels":[],"label_agreement":null},{"id":"W2972256509","doi":"10.1007/s40257-019-00466-2","title":"Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Bausch Health; Ortho Dermatologics; AstraZeneca; Amgen","keywords":"Medicine; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Tolerability; Psoriasis; Adverse effect; Internal medicine; Quality of life (healthcare); Dermatology","score_opus":0.025764928863366485,"score_gpt":0.3379926812463918,"score_spread":0.3122277523830253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972256509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738574,0.00006549243,0.000022106708,0.00031099305,0.00023524334,0.0019070483,0.000043153334,0.000010806117,0.000019402098],"genre_scores_gemma":[0.99916786,0.000034566154,0.00033107572,0.00028597706,0.0000071493178,0.00004150311,0.000049527534,0.00003331168,0.000049008377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965045,0.00077935646,0.0017023874,0.0004869931,0.00009276719,0.00043402787],"domain_scores_gemma":[0.9972428,0.001003583,0.0011267794,0.00032802467,0.00018890214,0.000109888504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034295654,0.00031766813,0.0020636448,0.00033220925,0.00007507661,0.000021409667,0.00033497054,0.00017512201,0.000033302877],"category_scores_gemma":[0.00017595197,0.00021808122,0.000081511964,0.00034806883,0.00023777808,0.00017844411,0.00014472292,0.00035458637,0.000011562244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08350902,0.009490399,0.80671537,0.0000050995804,0.0011485692,0.00027100486,0.000515755,0.000018623852,0.000014000978,0.000004317437,0.00002769722,0.09828017],"study_design_scores_gemma":[0.13673307,0.039493192,0.82250106,0.00008140373,0.0002644208,0.00025152002,0.00026595738,0.0000026190655,0.000040590916,0.0000035190712,0.00011781753,0.00024480213],"about_ca_topic_score_codex":0.000115559735,"about_ca_topic_score_gemma":0.0002692518,"teacher_disagreement_score":0.098035365,"about_ca_system_score_codex":0.000044768534,"about_ca_system_score_gemma":0.00021688832,"threshold_uncertainty_score":0.8893094},"labels":[],"label_agreement":null},{"id":"W2985449845","doi":"10.1007/s40257-019-00480-4","title":"Twenty Clinically Pertinent Factors/Observations for Percutaneous Absorption in Humans","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Neonatal skin health care","field":"Health Professions","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Stratum corneum; Human skin; Medicine; Drug; Toxicokinetics; Pharmacokinetics; Absorption (acoustics); Pharmacology; Population; Toxicity; Dermatology; Physiology; Toxicology; Pathology; Internal medicine; Biology; Environmental health; Materials science","score_opus":0.35643886279236486,"score_gpt":0.5815073270385457,"score_spread":0.22506846424618082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985449845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021959418,0.95804906,0.00063087704,0.0030519785,0.010759621,0.0049017975,0.00037466676,0.00006089439,0.00021167907],"genre_scores_gemma":[0.0017734237,0.9913768,0.0025754222,0.0024759667,0.0011295924,0.00012251579,0.00018661894,0.00013556369,0.0002240641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9784098,0.0056649284,0.013736332,0.0006667377,0.00047261608,0.0010495733],"domain_scores_gemma":[0.9477529,0.03834755,0.01168819,0.0007270767,0.0009394711,0.0005448023],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003667256,0.0005964101,0.008652634,0.0005140366,0.00025060997,0.0000108361355,0.0010656992,0.0012904101,0.0001644822],"category_scores_gemma":[0.010214908,0.00044549676,0.002359332,0.00051556464,0.0004977098,0.00013990406,0.00021213677,0.005325508,0.00020396606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004603163,0.0004308097,0.06938515,0.019049684,0.00036228544,0.00031040123,0.00060680864,0.000005511988,1.13895005e-7,0.00028056113,0.0066743987,0.90243393],"study_design_scores_gemma":[0.0010046788,0.0012477111,0.0053079566,0.009704022,0.0006587511,0.00051995454,0.00072581717,0.000023318747,5.2885425e-9,0.00015504539,0.9802738,0.00037898257],"about_ca_topic_score_codex":0.0000928768,"about_ca_topic_score_gemma":0.00011287476,"teacher_disagreement_score":0.9735994,"about_ca_system_score_codex":0.00043896577,"about_ca_system_score_gemma":0.0042764964,"threshold_uncertainty_score":0.99979967},"labels":[],"label_agreement":null},{"id":"W2986842764","doi":"10.1007/s40257-019-00485-z","title":"Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Medicine; Drug; Pharmacotherapy; Intensive care medicine; Systematic review; Pharmacology; MEDLINE; Internal medicine","score_opus":0.10905418606962518,"score_gpt":0.4622674421520058,"score_spread":0.35321325608238063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986842764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008413952,0.9839493,0.000013603702,0.0041955933,0.0011435096,0.0021144424,0.000018591036,0.000022900495,0.00012810368],"genre_scores_gemma":[0.040939037,0.95446897,0.0014417289,0.002675472,0.0003153555,0.000029401624,0.000008533814,0.00010551024,0.000015983223],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98525923,0.003912406,0.008793214,0.00062642014,0.0008289299,0.0005797912],"domain_scores_gemma":[0.9801547,0.01028355,0.006650886,0.0010144679,0.001153148,0.0007432535],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025620568,0.0007484836,0.02617846,0.0004299438,0.000060646624,0.000021792379,0.00055163435,0.0004474064,0.00008061618],"category_scores_gemma":[0.00875698,0.0004962803,0.0023425666,0.00059836585,0.00095690106,0.00012024256,0.00022446486,0.0025474583,0.000044392025],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043027365,0.00091029063,0.00031458374,0.9152559,0.0026436879,0.0017425746,0.00003565398,1.0609238e-8,0.0000039723777,0.00014905132,0.0009025449,0.07799869],"study_design_scores_gemma":[0.0018443954,0.0032217633,0.00066846766,0.7731087,0.08482151,0.123650424,0.0002260759,0.000013216741,0.0000022908991,0.000026152331,0.011694081,0.0007228743],"about_ca_topic_score_codex":0.000036503523,"about_ca_topic_score_gemma":0.000007421687,"teacher_disagreement_score":0.14214717,"about_ca_system_score_codex":0.00012981053,"about_ca_system_score_gemma":0.0026539655,"threshold_uncertainty_score":0.9997537},"labels":[],"label_agreement":null},{"id":"W2989913215","doi":"10.1007/s40257-019-00487-x","title":"Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"Paracelsus Medizinische Privatuniversität","keywords":"Medicine; Epidemiology; Lymphadenectomy; Population; Confidence interval; Lymph node; Oncology; Internal medicine; Proportional hazards model; Univariate analysis; Surgery; Multivariate analysis","score_opus":0.014053972914830631,"score_gpt":0.31501555023831695,"score_spread":0.30096157732348633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989913215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981539,0.000021289481,0.000023218827,0.0008420523,0.000474288,0.0003222457,0.0000015938643,0.0000034764082,0.00015788106],"genre_scores_gemma":[0.9991662,0.000010317371,0.00015164078,0.0006026207,0.000024117393,0.0000011307486,6.933216e-7,0.000008603544,0.0000346945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979397,0.00033918882,0.0012239137,0.00012000085,0.0002707701,0.00010641472],"domain_scores_gemma":[0.99759346,0.00042057212,0.0013995996,0.00024309663,0.00025309256,0.00009020194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002605726,0.00008753844,0.00085126364,0.000113187605,0.00001888348,0.000002564404,0.00011326027,0.000039996747,0.00003908852],"category_scores_gemma":[0.0003456158,0.00005408839,0.00014159264,0.00016221663,0.00014505102,0.000020838397,0.000046923218,0.0002013151,0.0000026369569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066193176,0.00085615343,0.9882384,0.000035401245,0.00016790142,0.00004198241,0.00009958272,0.000015238037,0.00002695479,0.00002086381,0.000060502214,0.009775106],"study_design_scores_gemma":[0.003634524,0.0054474175,0.9887669,0.00006055862,0.00020968003,0.00032059225,0.00046284264,0.00013725118,0.00006668228,0.000015661544,0.0008295162,0.000048369464],"about_ca_topic_score_codex":0.00016680748,"about_ca_topic_score_gemma":0.000031389616,"teacher_disagreement_score":0.009726737,"about_ca_system_score_codex":0.000012489001,"about_ca_system_score_gemma":0.00007478944,"threshold_uncertainty_score":0.22056605},"labels":[],"label_agreement":null},{"id":"W2991114477","doi":"10.1007/s40257-019-00482-2","title":"Updates on Botulinum Neurotoxins in Dermatology","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Botulinum neurotoxin; Botulinum toxin; Neurotoxin; Dermatology; Surgery; Internal medicine; Biology; Toxin","score_opus":0.11962505094078946,"score_gpt":0.46365578601605417,"score_spread":0.3440307350752647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991114477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073358444,0.97898144,0.000017819508,0.008741501,0.0021808983,0.0010293346,0.0000118220105,0.000045651785,0.001655685],"genre_scores_gemma":[0.009265254,0.9815428,0.00021554121,0.008540094,0.00022369773,0.000014720933,0.000019283549,0.00010240282,0.00007618463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895901,0.0027432344,0.0057453597,0.0007238858,0.00041736232,0.00078006164],"domain_scores_gemma":[0.9892942,0.0054736165,0.0038025994,0.0007107923,0.00015487222,0.000563926],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00058126164,0.00072617596,0.010960983,0.00089092343,0.000035142315,0.000015101618,0.0007342536,0.0013801618,0.0001502975],"category_scores_gemma":[0.0020194643,0.00047103682,0.0026492544,0.00090785994,0.0013145123,0.000065232874,0.00014438377,0.0063387775,0.00077579095],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091874186,0.0013279875,0.0027227479,0.0025344507,0.00070496445,0.014851493,0.00001821942,0.000004911717,2.5329808e-7,0.00030885972,0.0033348922,0.9732725],"study_design_scores_gemma":[0.0025998189,0.0038180242,0.0008912666,0.0039579365,0.0013504442,0.043429106,0.00002233002,0.000023889397,8.2596665e-7,0.00012591257,0.94340193,0.000378532],"about_ca_topic_score_codex":0.000004487606,"about_ca_topic_score_gemma":0.0000024730855,"teacher_disagreement_score":0.97289395,"about_ca_system_score_codex":0.000045457084,"about_ca_system_score_gemma":0.0010269886,"threshold_uncertainty_score":0.99991626},"labels":[],"label_agreement":null},{"id":"W3012736954","doi":"10.1007/s40257-020-00512-4","title":"Malignancy Rates in Brodalumab Clinical Studies for Psoriasis","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics; Amgen","keywords":"Medicine; Ustekinumab; Psoriasis; Internal medicine; Ixekizumab; Psoriasis Area and Severity Index; Dermatology; Secukinumab; Psoriatic arthritis; Adalimumab","score_opus":0.11959967372461948,"score_gpt":0.4233082742569633,"score_spread":0.30370860053234383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012736954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97490865,0.008413526,0.00026588576,0.013184315,0.0028731823,0.00022926295,0.000023470096,0.00002251293,0.000079200065],"genre_scores_gemma":[0.98954463,0.004866052,0.0019017255,0.0031741245,0.00041343295,0.000017780048,0.000011306009,0.000023876857,0.000047082875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99408174,0.0018201818,0.0032156182,0.00038578504,0.000055212346,0.00044149457],"domain_scores_gemma":[0.99139553,0.00633189,0.0016378883,0.00020266094,0.00030673,0.00012532707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010520035,0.0002552977,0.002519749,0.00012721028,0.00007233312,0.0000075332778,0.00042133927,0.00029478065,0.0000615532],"category_scores_gemma":[0.0047289575,0.00019542871,0.0008246223,0.00029497754,0.0010658246,0.00010319822,0.000081580045,0.0005597057,0.00012568504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048114583,0.00070684316,0.5378715,0.000044883065,0.0027675796,0.00035161842,0.0006648893,0.000004882192,0.0003095044,0.00061035773,0.014362732,0.43749377],"study_design_scores_gemma":[0.0631568,0.025719034,0.4917903,0.00042734027,0.002832581,0.0036884432,0.01276625,0.000044229968,0.0074622435,0.002940133,0.387648,0.0015246695],"about_ca_topic_score_codex":0.000008704623,"about_ca_topic_score_gemma":0.000016052114,"teacher_disagreement_score":0.43596908,"about_ca_system_score_codex":0.000017233211,"about_ca_system_score_gemma":0.000287895,"threshold_uncertainty_score":0.79693514},"labels":[],"label_agreement":null},{"id":"W3013797294","doi":"10.1007/s40257-020-00510-6","title":"Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Pharmacokinetics; Open label; Pharmacotherapy; Dermatology; Anesthesia; Adverse effect; Pharmacology; Internal medicine","score_opus":0.04448782415435957,"score_gpt":0.4222697355113028,"score_spread":0.3777819113569432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013797294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877786,0.0010984265,0.0004694867,0.009140584,0.00016050016,0.0012102026,0.000031112882,0.000013835369,0.000097276294],"genre_scores_gemma":[0.9868763,0.0003048516,0.0018112642,0.010876772,0.000063352956,0.000029968263,0.0000046843625,0.000031002743,0.0000018050122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956608,0.0014500768,0.0018345535,0.00039669557,0.0003047796,0.00035308296],"domain_scores_gemma":[0.99662936,0.0012023296,0.00069184334,0.0002658718,0.00035467857,0.0008559466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003929416,0.0002819176,0.002439828,0.00021587628,0.000066609064,0.000021822545,0.00040929753,0.00009963001,0.000020986246],"category_scores_gemma":[0.0011209153,0.0002253633,0.00009655189,0.0005924067,0.00047602426,0.00015463913,0.00023616051,0.0006432201,0.000007382345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027049584,0.0038720842,0.93086123,0.00029444898,0.0007161615,0.0051866267,0.004227459,0.00008173118,0.0002120799,0.000009462469,0.003120755,0.024368359],"study_design_scores_gemma":[0.062127516,0.010243763,0.9178107,0.00052897376,0.00075287774,0.001651028,0.0039296327,0.00028909807,0.0009364757,0.000032513486,0.0013969849,0.00030044877],"about_ca_topic_score_codex":0.000046135596,"about_ca_topic_score_gemma":0.00005543147,"teacher_disagreement_score":0.035077933,"about_ca_system_score_codex":0.0000224832,"about_ca_system_score_gemma":0.00040120212,"threshold_uncertainty_score":0.9190049},"labels":[],"label_agreement":null},{"id":"W3036352764","doi":"10.1007/s40257-020-00527-x","title":"Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Open label; Adverse effect; Internal medicine","score_opus":0.04485148388255634,"score_gpt":0.3839348872599036,"score_spread":0.33908340337734727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036352764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863247,0.000071315844,0.00062728924,0.01137784,0.00006563672,0.0014682712,0.0000116955,0.000011384458,0.000041829237],"genre_scores_gemma":[0.9898097,0.000038046004,0.0033480923,0.0066996566,0.000039238414,0.000023618179,0.0000051250063,0.000024179004,0.000012330654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971303,0.0004884314,0.0015521608,0.00033535768,0.00019177327,0.0003020149],"domain_scores_gemma":[0.99716324,0.00092672533,0.000598284,0.00023443786,0.0003768022,0.0007004901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029671376,0.00017959674,0.0017870505,0.0001570887,0.0000498359,0.000022779215,0.0003477527,0.00008331755,0.0000131273555],"category_scores_gemma":[0.0015541097,0.00014410513,0.00005664761,0.0003743103,0.00026898616,0.0002032817,0.0001330725,0.00032486688,0.0000029613223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07896884,0.0048254416,0.85828936,0.00029640997,0.00046111262,0.002344515,0.008549792,0.00019560613,0.000010880706,0.00011590283,0.0031454405,0.042796712],"study_design_scores_gemma":[0.07761538,0.03268938,0.86324495,0.00042084878,0.00036425743,0.0021457647,0.019974755,0.0015672632,0.00004668849,0.000085136286,0.0015029323,0.00034263034],"about_ca_topic_score_codex":0.00004648419,"about_ca_topic_score_gemma":0.00011611787,"teacher_disagreement_score":0.042454083,"about_ca_system_score_codex":0.000016678028,"about_ca_system_score_gemma":0.00045497532,"threshold_uncertainty_score":0.5876437},"labels":[],"label_agreement":null},{"id":"W3047072658","doi":"10.1007/s40257-020-00542-y","title":"Effects of Diet on Acne and Its Response to Treatment","year":2020,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Medicine; Acne; Pharmacotherapy; Dermatology; Internal medicine; Intensive care medicine","score_opus":0.06127595997462017,"score_gpt":0.4608400220138732,"score_spread":0.39956406203925304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047072658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05231751,0.9431618,0.0000085493,0.0033876451,0.00033251368,0.0007169572,0.000012831895,0.00000819536,0.00005401801],"genre_scores_gemma":[0.021386754,0.97698605,0.00023924772,0.0010295757,0.0002367659,0.000015009212,0.0000036964982,0.000036091627,0.00006682793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962312,0.0013248597,0.0017156136,0.000290759,0.00019997387,0.00023760527],"domain_scores_gemma":[0.9911803,0.0063542067,0.0015078922,0.00019371374,0.0000928279,0.00067104894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031856296,0.00037361422,0.006535948,0.00022600443,0.000029645234,0.000004900738,0.00012269558,0.00022065533,0.000008635899],"category_scores_gemma":[0.0017968557,0.00020291338,0.0010104195,0.00025740487,0.00020383796,0.000020983956,0.000053173968,0.00046752402,0.000046363053],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008948441,0.0006751899,0.00013579447,0.002366524,0.0017404396,0.005802757,0.00007311659,8.5332914e-8,0.0000027635558,0.000013525042,0.0005502912,0.9796911],"study_design_scores_gemma":[0.002658579,0.05799923,0.00082721096,0.006922269,0.0039789416,0.0035909123,0.000016073343,0.0000012252539,0.000031562293,0.0000029012783,0.923825,0.00014606502],"about_ca_topic_score_codex":0.0000027491315,"about_ca_topic_score_gemma":2.6401676e-7,"teacher_disagreement_score":0.979545,"about_ca_system_score_codex":0.000050876162,"about_ca_system_score_gemma":0.00053334277,"threshold_uncertainty_score":0.8274567},"labels":[],"label_agreement":null},{"id":"W3097770867","doi":"10.1007/s40257-020-00566-4","title":"Granulomatous Cutaneous Drug Eruptions: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Granuloma annulare; Medicine; Sarcoidosis; Granulomatous inflammation; Dermatology; Cutaneous Sarcoidosis; Granuloma; Drug eruption; Drug; Pathology; Pharmacology","score_opus":0.0500571691170715,"score_gpt":0.4440620668684573,"score_spread":0.3940048977513858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097770867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002072497,0.99498004,0.00001452119,0.002750832,0.000526362,0.0013895399,0.000025613084,0.000042180458,0.0002502113],"genre_scores_gemma":[0.00015730417,0.99125713,0.00052943826,0.0074209496,0.00044438086,0.000054321106,0.000023418805,0.00008122571,0.00003180991],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9889485,0.0022785577,0.0074436055,0.00039641428,0.0005325636,0.00040032263],"domain_scores_gemma":[0.9849193,0.005611162,0.00735343,0.0006876779,0.00038925547,0.0010391858],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0007086366,0.0005493313,0.019199379,0.0002430981,0.000044180142,0.000021130456,0.0005922907,0.00021472483,0.0001424409],"category_scores_gemma":[0.010901902,0.00034688856,0.004947994,0.00067388994,0.0006406,0.000051947518,0.00009716266,0.001452481,0.00044023487],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036791906,0.00020774435,0.000053337433,0.69326746,0.001563823,0.008688326,0.000007649168,1.2219169e-8,3.134041e-9,0.0000419948,0.0066041974,0.28952867],"study_design_scores_gemma":[0.00030209622,0.00043409964,0.0000033444796,0.47156677,0.022339176,0.085204475,0.00003250678,0.0000016864515,1.3181845e-8,0.000026713906,0.4198995,0.00018961412],"about_ca_topic_score_codex":0.0000030260853,"about_ca_topic_score_gemma":2.9578334e-7,"teacher_disagreement_score":0.4132953,"about_ca_system_score_codex":0.00005577033,"about_ca_system_score_gemma":0.001548425,"threshold_uncertainty_score":0.9998983},"labels":[],"label_agreement":null},{"id":"W3101032247","doi":"10.1007/s40257-020-00564-6","title":"Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Foundation for the National Institutes of Health","keywords":"Acne; Medicine; Psychosocial; Quality of life (healthcare); Dermatology Life Quality Index; Systematic review; MEDLINE; Anxiety; Disease; Patient-reported outcome; Depression (economics); Clinical psychology; Psychiatry; Dermatology; Pathology","score_opus":0.06450156165055514,"score_gpt":0.4056603684713844,"score_spread":0.3411588068208293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101032247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.835396,0.105115816,0.0004430766,0.058198176,0.000113537004,0.0007166534,0.0000047471153,0.0000053163703,0.0000067013525],"genre_scores_gemma":[0.92941016,0.057748392,0.0006094357,0.01214696,0.00006944861,0.0000041529597,5.269163e-7,0.000008563349,0.0000023472628],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99680847,0.0012414092,0.0014935377,0.00010207608,0.00021291678,0.00014156582],"domain_scores_gemma":[0.99427336,0.0034671267,0.0015164578,0.00023064649,0.00025489926,0.00025748217],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0009841204,0.00012942805,0.0018280161,0.000048912487,0.000034267505,0.000017173024,0.00014442761,0.00005128191,0.0000040132186],"category_scores_gemma":[0.010620826,0.000047763315,0.00037665138,0.00034737145,0.0005343862,0.00009137013,0.000054427997,0.00034155365,0.00000184344],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036644,0.0014997398,0.25622618,0.42023078,0.018715065,0.007114339,0.049537938,0.000044650078,0.0028933315,0.0015686983,0.04832138,0.15720388],"study_design_scores_gemma":[0.02182455,0.022630837,0.19461083,0.68077064,0.016001487,0.0525212,0.0032604642,0.0007001786,0.0017711956,0.00050721015,0.0047573913,0.0006440327],"about_ca_topic_score_codex":0.00001969855,"about_ca_topic_score_gemma":0.0000024331684,"teacher_disagreement_score":0.26053983,"about_ca_system_score_codex":0.0000059954136,"about_ca_system_score_gemma":0.000099218014,"threshold_uncertainty_score":0.99771315},"labels":[],"label_agreement":null},{"id":"W3107149649","doi":"10.1007/s40257-020-00575-3","title":"Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"LEO Fondet","keywords":"Adalimumab; Medicine; Interquartile range; Hidradenitis suppurativa; Therapeutic drug monitoring; Internal medicine; Retrospective cohort study; Trough level; Gastroenterology; Surgery; Tumor necrosis factor alpha; Pharmacokinetics; Tacrolimus; Disease; Transplantation","score_opus":0.029982540375932516,"score_gpt":0.3561905999709441,"score_spread":0.3262080595950116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107149649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9167748,0.000040610023,0.00024363172,0.08219576,0.00016053914,0.0005205209,0.000028707651,0.000015977004,0.000019437599],"genre_scores_gemma":[0.99328667,0.000015375412,0.0062208567,0.00021946357,0.00016956076,0.000023900331,0.000004272606,0.00003951277,0.00002040571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971722,0.00062307494,0.0012345406,0.00030690513,0.00029934788,0.0003639716],"domain_scores_gemma":[0.9971482,0.001134168,0.0005784079,0.0001697618,0.00043021038,0.0005392281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004240492,0.0002389106,0.0014203931,0.00016900284,0.00007194668,0.000019585948,0.00012632803,0.00006468889,0.000022592096],"category_scores_gemma":[0.0011194568,0.00017440457,0.00022180998,0.00043760613,0.0003597465,0.00024692554,0.000032612494,0.0005082847,0.000009382938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04942985,0.0003778672,0.79926527,0.000014207495,0.0002870901,0.14376053,0.001787102,9.250828e-7,0.000023334227,0.000015856145,0.00007082109,0.0049671256],"study_design_scores_gemma":[0.015399188,0.025253877,0.59569395,0.00015007421,0.00028593262,0.35902944,0.003018491,0.00002007466,0.00035934086,0.000041804597,0.00050189835,0.0002459361],"about_ca_topic_score_codex":0.000015522759,"about_ca_topic_score_gemma":0.000011819833,"teacher_disagreement_score":0.21526892,"about_ca_system_score_codex":0.0000956779,"about_ca_system_score_gemma":0.00032816295,"threshold_uncertainty_score":0.7112012},"labels":[],"label_agreement":null},{"id":"W3115626074","doi":"10.1007/s40257-020-00580-6","title":"The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Mediprobe Research (Canada)","funders":"","keywords":"Terbinafine; Medicine; Dermatophyte; Drug resistance; Itraconazole; Antifungal drugs; Antifungal; Antifungal drug; Intensive care medicine; Flucytosine; Fluconazole; Dermatology; Microbiology; Biology","score_opus":0.038019462035501314,"score_gpt":0.3681311113761409,"score_spread":0.3301116493406396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115626074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97935957,0.0017341798,0.000019706365,0.018369976,0.000055186498,0.0000904695,0.0000044596954,0.0000035242779,0.0003629473],"genre_scores_gemma":[0.9948479,0.0007852317,0.0013209896,0.0029397926,0.000088432054,0.0000013214775,3.3430416e-7,0.000010226758,0.0000057581533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826515,0.00025110279,0.0010472492,0.00012208227,0.00015806062,0.00015638754],"domain_scores_gemma":[0.9982022,0.00092596567,0.00050228485,0.00008968448,0.00008335499,0.00019652165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022774623,0.000087018445,0.0007516034,0.000040799918,0.00003206052,0.000006233196,0.00009586761,0.000040026378,0.000010999399],"category_scores_gemma":[0.00052968797,0.000053369753,0.00017372532,0.00018391419,0.0004899295,0.00006866632,0.000025998319,0.00025293435,0.0000020783284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002830655,0.00023661891,0.9705428,0.00004071327,0.0002100782,0.0003820689,0.00020333327,5.624366e-7,0.000065385415,0.0008779869,0.00045633633,0.024153473],"study_design_scores_gemma":[0.005978589,0.0023446179,0.9539028,0.00031703146,0.0003742395,0.0005466082,0.0016588023,0.000033758293,0.00030224235,0.00068606785,0.03372599,0.00012925784],"about_ca_topic_score_codex":0.000016956625,"about_ca_topic_score_gemma":0.000021105612,"teacher_disagreement_score":0.033269655,"about_ca_system_score_codex":0.00000717659,"about_ca_system_score_gemma":0.0001423307,"threshold_uncertainty_score":0.21763554},"labels":[],"label_agreement":null},{"id":"W3115765278","doi":"10.1007/s40257-020-00576-2","title":"Correction to: Effects of Diet on Acne and Its Response to Treatment","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"","keywords":"Medicine; Acne; Pharmacotherapy; Dermatology; MEDLINE; Information retrieval; Internal medicine; Computer science","score_opus":0.031674636017969576,"score_gpt":0.392325629300335,"score_spread":0.3606509932823654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115765278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692053,0.00014431291,0.00011949967,0.029633584,0.00056989247,0.00023583416,0.0000017128939,0.0000072193316,0.00008263427],"genre_scores_gemma":[0.9912368,0.00026593037,0.0003313097,0.007923089,0.00015461716,0.0000040412915,6.429712e-7,0.000010716652,0.00007286368],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857295,0.00038144903,0.0006114759,0.00015786759,0.00012808655,0.0001481665],"domain_scores_gemma":[0.99650705,0.002401644,0.00031801572,0.000093097544,0.00009022315,0.00058999215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017110215,0.00012393102,0.001021885,0.000088563334,0.000027014532,0.000003138607,0.0000468763,0.000048660568,0.000008239981],"category_scores_gemma":[0.0024568657,0.00007693609,0.00017528565,0.00018424698,0.00007858791,0.000023108647,0.000022950513,0.00016393936,0.00002858998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2385292,0.002877409,0.14797194,0.00016952258,0.0017275675,0.0056875446,0.003127687,0.00006791561,0.012044647,0.00004508821,0.025769372,0.5619821],"study_design_scores_gemma":[0.011537017,0.3474274,0.5636125,0.0006190385,0.0008042734,0.0021773325,0.00038308147,0.00026445198,0.029247338,0.000008723997,0.043689903,0.00022889854],"about_ca_topic_score_codex":0.0000074331565,"about_ca_topic_score_gemma":0.0000011043676,"teacher_disagreement_score":0.5617532,"about_ca_system_score_codex":0.000020693346,"about_ca_system_score_gemma":0.000099394645,"threshold_uncertainty_score":0.3137363},"labels":[],"label_agreement":null},{"id":"W3118484490","doi":"10.1007/s40257-020-00579-z","title":"Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Pharmacotherapy; Tumor necrosis factor alpha; Drug; Tumor necrosis factor α; Adalimumab; Therapeutic drug monitoring; Dermatology; Pharmacology; Internal medicine; Intensive care medicine; Oncology; Disease","score_opus":0.028422700596694415,"score_gpt":0.35073154960687297,"score_spread":0.32230884901017853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118484490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757202,0.00019678383,0.00002736069,0.023257272,0.00033050287,0.00028973268,0.000030177136,0.000011548549,0.0001363722],"genre_scores_gemma":[0.99833095,0.00008926441,0.0010034955,0.00024122838,0.00019223144,0.000016374464,0.000010683559,0.000043275002,0.000072513445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972613,0.00039838743,0.0012750651,0.00030931586,0.00037796516,0.0003779832],"domain_scores_gemma":[0.99709773,0.0011971445,0.0007612479,0.0002514793,0.00040815078,0.00028421843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000017854542,0.00025852912,0.0013600038,0.0001548069,0.00006596372,0.000027109285,0.00012962345,0.00008461505,0.00008701927],"category_scores_gemma":[0.00025142936,0.000178832,0.00036162027,0.00030634183,0.00029045492,0.00016494401,0.000025122821,0.0005833853,0.000015052338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018318174,0.0012173466,0.95457023,0.000020323308,0.00036738606,0.0106261885,0.00062340463,1.4211689e-7,0.000040079958,0.000020905487,0.00010640869,0.030575752],"study_design_scores_gemma":[0.012279781,0.0049471934,0.9540439,0.0005172321,0.00023028401,0.018970767,0.0014717194,0.000011487271,0.0057626693,0.0002166056,0.0013066572,0.00024168918],"about_ca_topic_score_codex":0.000019175324,"about_ca_topic_score_gemma":0.000008573022,"teacher_disagreement_score":0.030334063,"about_ca_system_score_codex":0.00007012678,"about_ca_system_score_gemma":0.00037636372,"threshold_uncertainty_score":0.7292557},"labels":[],"label_agreement":null},{"id":"W3137117524","doi":"10.1007/s40257-021-00595-7","title":"Rosacea: New Concepts in Classification and Treatment","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Rosacea; Medicine; Dermatology; Erythema; Telangiectasia; Acne","score_opus":0.15782163217570577,"score_gpt":0.5170822609389268,"score_spread":0.35926062876322107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137117524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047536385,0.99301755,0.000019483125,0.0014665085,0.000301039,0.00025717588,0.000002906946,0.0000050244225,0.00017666958],"genre_scores_gemma":[0.0032743954,0.9950788,0.0007334396,0.00029413612,0.00034081584,0.000005772523,0.000023736264,0.000023854309,0.0002250733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683297,0.00068958185,0.0018594112,0.00027111627,0.00012945548,0.00021749789],"domain_scores_gemma":[0.99665916,0.0012221624,0.0014424331,0.00021764063,0.00007292728,0.00038568737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023397764,0.00027791556,0.0051895427,0.00017225917,0.000023229693,0.000012011626,0.00007362935,0.0002776147,0.00003257582],"category_scores_gemma":[0.00032199026,0.00016339132,0.0007545984,0.0002454681,0.0003433414,0.00003968234,0.000026204547,0.0005290972,0.0000143424395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061452614,0.00031723187,0.005637718,0.00028321156,0.00058616884,0.0021283093,0.000043487493,6.619185e-8,4.7727788e-8,0.00004670875,0.0010511472,0.98984444],"study_design_scores_gemma":[0.0023001293,0.002122855,0.0028214017,0.004381922,0.0018611595,0.0088251885,0.00011118834,0.000005176163,2.4933237e-7,0.0000067091955,0.9774379,0.00012609804],"about_ca_topic_score_codex":0.000031819363,"about_ca_topic_score_gemma":0.000008159119,"teacher_disagreement_score":0.9897184,"about_ca_system_score_codex":0.00007952971,"about_ca_system_score_gemma":0.0014871688,"threshold_uncertainty_score":0.66629046},"labels":[],"label_agreement":null},{"id":"W3143775625","doi":"10.1007/s40257-021-00598-4","title":"Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Hamilton Health Sciences; University of Toronto; Lynde Centre for Dermatology; McMaster University","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Ustekinumab; Psoriatic arthritis; Internal medicine; Retrospective cohort study; Psoriasis; Hazard ratio; Proportional hazards model; Oncology; Dermatology; Adalimumab; Confidence interval; Disease","score_opus":0.028362322672536147,"score_gpt":0.32671167242351506,"score_spread":0.29834934975097893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143775625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936275,0.0018101871,0.00013573395,0.0005925316,0.0027063517,0.0006584085,0.00037188662,0.000022452341,0.000074974814],"genre_scores_gemma":[0.9959959,0.002157049,0.00092245964,0.00011503502,0.0002070527,0.00004003397,0.000078163364,0.000038159553,0.00044616722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946505,0.0018729651,0.0022013483,0.00060119707,0.0001329188,0.0005411166],"domain_scores_gemma":[0.99372697,0.003151583,0.0019599413,0.0004160522,0.00059466,0.00015080377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009503806,0.00041818141,0.0027561544,0.00023880451,0.00018575253,0.00001775069,0.00026250567,0.0002881152,0.000049156963],"category_scores_gemma":[0.0014004408,0.00033156332,0.0006552505,0.00038421774,0.0011850533,0.00011773274,0.00009975457,0.00039274638,0.000021032636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023023067,0.0038590236,0.9593765,0.000017158543,0.0050280555,0.00035115652,0.0010332717,0.000002615436,0.0005312237,0.000063469495,0.0008511617,0.026584035],"study_design_scores_gemma":[0.028407179,0.0053521655,0.9340799,0.00005644003,0.0034875611,0.0014756832,0.007579342,0.000019403366,0.0064153178,0.000053785425,0.012613181,0.0004600832],"about_ca_topic_score_codex":0.0001766648,"about_ca_topic_score_gemma":0.00042721993,"teacher_disagreement_score":0.02612395,"about_ca_system_score_codex":0.00009102833,"about_ca_system_score_gemma":0.00042421467,"threshold_uncertainty_score":0.99991363},"labels":[],"label_agreement":null},{"id":"W3152146207","doi":"10.1007/s40257-021-00602-x","title":"Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Incyte; National Center for Advancing Translational Sciences; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Randomized controlled trial; Pharmacotherapy; Safety profile; Pooled analysis; Clinical trial; Internal medicine; Meta-analysis; Adverse effect","score_opus":0.0316521412114653,"score_gpt":0.40420677146655387,"score_spread":0.37255463025508856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152146207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910266,0.00047887655,0.007327997,0.002125417,0.00029394904,0.00030269747,0.00018917125,0.000015435522,0.00016379097],"genre_scores_gemma":[0.98876745,0.0011481141,0.005373381,0.0037821487,0.00008091127,0.000009254656,0.00080921914,0.000020549496,0.000008999551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96831846,0.020224294,0.009952678,0.00054909097,0.0005750535,0.00038042225],"domain_scores_gemma":[0.96674687,0.023910198,0.0058130347,0.0007438639,0.0021117053,0.00067433016],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005092653,0.00035075058,0.013222291,0.0012125055,0.00004705396,0.000018406656,0.00034683515,0.0003857562,0.0008444645],"category_scores_gemma":[0.031540304,0.00023281956,0.003581268,0.0036566493,0.0019353138,0.00019216228,0.000060409384,0.0010775358,0.0000054244247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044762492,0.0027884482,0.891752,0.000016562148,0.036020577,0.0016907504,0.00012942501,0.0000550449,9.647445e-7,0.00008380243,0.00022804749,0.022471884],"study_design_scores_gemma":[0.102581725,0.00039011388,0.84943324,0.000119502474,0.04300417,0.00014281919,0.00058898807,0.0030828381,0.000033165208,0.00015402444,0.00027523606,0.00019420104],"about_ca_topic_score_codex":0.00015478698,"about_ca_topic_score_gemma":0.0003688391,"teacher_disagreement_score":0.05781923,"about_ca_system_score_codex":0.000030557916,"about_ca_system_score_gemma":0.0009408266,"threshold_uncertainty_score":0.97661746},"labels":[],"label_agreement":null},{"id":"W3164927049","doi":"10.1007/s40257-021-00607-6","title":"Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Vaccination; Dermatology; Immunology","score_opus":0.02317668804624801,"score_gpt":0.354628461929032,"score_spread":0.331451773882784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164927049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603686,0.00038455217,0.000423868,0.038087197,0.00006842562,0.00024005292,0.000012739273,0.000016414338,0.000398158],"genre_scores_gemma":[0.98718005,0.00032674405,0.00878859,0.0035089448,0.00006743828,0.000016133443,0.000056096193,0.000018683133,0.000037294456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770665,0.00049976737,0.001195296,0.0002157087,0.00013953986,0.00024303471],"domain_scores_gemma":[0.9970105,0.0011800178,0.00087790366,0.00018719866,0.0005320314,0.00021232318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021730349,0.00015037661,0.0010663228,0.00013621121,0.000059455568,0.000011126831,0.000091022375,0.00009883249,0.00008692661],"category_scores_gemma":[0.0009820599,0.000110722896,0.00016597618,0.00037505224,0.00030368185,0.00006335105,0.000016957174,0.00036824247,0.000004817486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056399324,0.00044706263,0.9697406,0.000023467086,0.00049573183,0.0012468576,0.000046798366,0.000007074055,0.000001940607,0.00007664485,0.011086677,0.016263096],"study_design_scores_gemma":[0.00810494,0.00086724485,0.9374854,0.00019242671,0.00041353801,0.047785103,0.0003466746,0.00010352299,0.00020274162,0.00011746866,0.0042543,0.0001266529],"about_ca_topic_score_codex":0.000019092196,"about_ca_topic_score_gemma":0.00009337365,"teacher_disagreement_score":0.04653825,"about_ca_system_score_codex":0.000023815954,"about_ca_system_score_gemma":0.00057877245,"threshold_uncertainty_score":0.45151487},"labels":[],"label_agreement":null},{"id":"W3170274915","doi":"10.1007/s40257-021-00614-7","title":"Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Paracelsus Medizinische Privatuniversität; Austrian Science Fund","keywords":"Medicine; Melanoma; Vulva; Dermatology; Disease; Mortality rate; Oncology; Mucosal melanoma; Internal medicine; Cancer research","score_opus":0.04183455519324062,"score_gpt":0.40501753318479955,"score_spread":0.3631829779915589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170274915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024767094,0.99314207,0.000110200024,0.0016680948,0.0011208939,0.00047794313,0.000011761338,0.000026254362,0.0009660539],"genre_scores_gemma":[0.0019289132,0.9956932,0.00067687716,0.00072494725,0.0005453275,0.000042226453,0.00004269882,0.00006005413,0.0002857688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939243,0.0012257205,0.0033512758,0.00052097294,0.00058341236,0.00039432198],"domain_scores_gemma":[0.9949232,0.0014918324,0.0020286692,0.00046031247,0.00015625019,0.00093978056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006270083,0.0004992298,0.00695633,0.00036578157,0.000048731847,0.00003155525,0.00024876447,0.00041437976,0.0004534374],"category_scores_gemma":[0.00058644987,0.00035208435,0.00153795,0.00031574164,0.0006965133,0.000027696911,0.00020317134,0.0009775386,0.00004994049],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009384486,0.00059537543,0.0014902652,0.001367106,0.002786698,0.13481472,0.0000066765356,1.0719909e-8,4.7862017e-9,0.00040770567,0.0008925275,0.8575451],"study_design_scores_gemma":[0.0015584567,0.0016363254,0.00019898999,0.0038184673,0.0046812007,0.1443504,0.00004216605,0.0000023518091,3.4196123e-7,0.000006426608,0.84348226,0.00022262809],"about_ca_topic_score_codex":0.000008161334,"about_ca_topic_score_gemma":0.0000022475406,"teacher_disagreement_score":0.85732245,"about_ca_system_score_codex":0.00010235355,"about_ca_system_score_gemma":0.00050289585,"threshold_uncertainty_score":0.9998931},"labels":[],"label_agreement":null},{"id":"W3183902277","doi":"10.1007/s40257-021-00624-5","title":"The Use of Lasers and Light Devices in Acne Management: An Update","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"","keywords":"Medicine; Acne; Intense pulsed light; Light therapy; Randomized controlled trial; Ablative case; Adverse effect; Dermatology; Intensive care medicine; Surgery; Internal medicine; Radiation therapy","score_opus":0.11084621743028521,"score_gpt":0.45886559661832327,"score_spread":0.34801937918803805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183902277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010354925,0.9874369,0.00000862119,0.0016704149,0.0002347024,0.00021227078,0.00000400911,0.0000029162309,0.0000752576],"genre_scores_gemma":[0.0021760496,0.996155,0.00085773424,0.0006472304,0.00008079941,0.0000039221495,0.000012144316,0.00001928024,0.000047797723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660337,0.0009543652,0.0018707431,0.00020072416,0.00015561852,0.00021519409],"domain_scores_gemma":[0.99620783,0.0015083516,0.0016998178,0.00028908378,0.0000878939,0.00020704088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048460218,0.00021428209,0.003431751,0.00015175994,0.000042864565,0.000019923576,0.0001590847,0.0001510593,0.0000090604],"category_scores_gemma":[0.00020983336,0.00010611389,0.000490168,0.00027270208,0.00044450304,0.000089045105,0.00008168503,0.000532516,0.0000032929988],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010077664,0.00022585265,0.0035977096,0.0011621091,0.0010887242,0.0028707369,0.000017542854,2.0208823e-7,1.6439378e-8,0.000107301435,0.0009787416,0.9898503],"study_design_scores_gemma":[0.0008356452,0.0007035481,0.0011136581,0.00496612,0.0019705917,0.0029544104,0.000119306445,0.0000041607645,3.19479e-7,0.0000075365124,0.987235,0.000089705885],"about_ca_topic_score_codex":0.000009640662,"about_ca_topic_score_gemma":0.000016393256,"teacher_disagreement_score":0.9897606,"about_ca_system_score_codex":0.000012464295,"about_ca_system_score_gemma":0.0001867229,"threshold_uncertainty_score":0.4327199},"labels":[],"label_agreement":null},{"id":"W3206427606","doi":"10.1007/s40257-021-00650-3","title":"Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Adapalene; Tolerability; Medicine; Benzoyl peroxide; Acne; Clindamycin; Adverse effect; Dermatology; Internal medicine; Randomized controlled trial; Antibiotics","score_opus":0.021191720390857805,"score_gpt":0.35778936719485693,"score_spread":0.3365976468039991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206427606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896606,0.0009767468,0.00024435486,0.007539843,0.0002277285,0.0013093017,0.000015515827,0.0000041937246,0.000021689564],"genre_scores_gemma":[0.997243,0.0009195842,0.00072373543,0.00092950294,0.00005073495,0.000017313772,0.000004480178,0.000018071825,0.00009356012],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99670506,0.00067340746,0.0019090197,0.00026233937,0.00023758638,0.0002125875],"domain_scores_gemma":[0.99436665,0.00332572,0.0013765994,0.00024978322,0.00045069525,0.00023057731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010905649,0.00020230921,0.0025356447,0.00009142986,0.00016178012,0.000008604347,0.000111586276,0.00008728813,0.000013866054],"category_scores_gemma":[0.0020096838,0.00011829628,0.00038467158,0.00023699498,0.00047473432,0.00006870845,0.00011134184,0.00029526852,3.759836e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7950015,0.020447714,0.068334624,0.0003449894,0.0041121263,0.00040506173,0.0075739576,0.00010314694,0.0003638482,0.00019192297,0.0018009102,0.10132019],"study_design_scores_gemma":[0.91058123,0.016891155,0.05939214,0.00053604925,0.0028505805,0.0015434898,0.0027431261,0.0017124498,0.002348177,0.00018011592,0.0009949848,0.00022650362],"about_ca_topic_score_codex":0.000027892218,"about_ca_topic_score_gemma":0.000025475714,"teacher_disagreement_score":0.115579724,"about_ca_system_score_codex":0.000013424043,"about_ca_system_score_gemma":0.0002454421,"threshold_uncertainty_score":0.4823982},"labels":[],"label_agreement":null},{"id":"W3214446229","doi":"10.1007/s40257-021-00643-2","title":"Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Acne; Medicine; Dermatology; Hyperpigmentation; Melasma; Irritation; Adapalene; Benzoyl peroxide","score_opus":0.0276044791232484,"score_gpt":0.4469005382715478,"score_spread":0.41929605914829937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214446229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19813545,0.7983565,0.000028872337,0.0019225914,0.000094592586,0.0014207135,0.000017324728,0.0000022545694,0.000021713971],"genre_scores_gemma":[0.010970693,0.98577356,0.0018758384,0.0012288897,0.000056389243,0.00003575382,0.000034678993,0.000019437286,0.0000047646213],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99586743,0.0011174289,0.0024684211,0.00025806783,0.00014174033,0.00014691647],"domain_scores_gemma":[0.98785704,0.008346488,0.002961471,0.00019657414,0.00045794813,0.00018044708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007164741,0.00021298547,0.0044007287,0.00011065116,0.000022377379,0.0000032754501,0.00007718532,0.00021755211,0.0000019593228],"category_scores_gemma":[0.0036908537,0.000128602,0.00041836672,0.00016667563,0.0005216399,0.000053893546,0.000039559847,0.0004858011,3.592519e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009544961,0.0014469556,0.08217168,0.017960355,0.0009544003,0.00007543184,0.000027795591,2.5251193e-8,2.9466725e-7,0.00011938227,0.00019637405,0.89609283],"study_design_scores_gemma":[0.0108448565,0.02974591,0.7416703,0.050716065,0.017545559,0.0017941523,0.000086608015,7.5609427e-7,0.000004565587,0.000011878421,0.14730069,0.0002786168],"about_ca_topic_score_codex":0.0000045498477,"about_ca_topic_score_gemma":0.0000015320314,"teacher_disagreement_score":0.8958142,"about_ca_system_score_codex":0.00002230618,"about_ca_system_score_gemma":0.0004432761,"threshold_uncertainty_score":0.5244237},"labels":[],"label_agreement":null},{"id":"W4200583694","doi":"10.1007/s40257-021-00660-1","title":"Efinaconazole in Onychomycosis","year":2021,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Itraconazole; Terbinafine; Antifungal","score_opus":0.11933609478193363,"score_gpt":0.525844527942879,"score_spread":0.4065084331609453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200583694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025682454,0.9955888,0.000006376816,0.00064542925,0.00049069227,0.00018415652,0.000012358825,0.0000059464846,0.0004980061],"genre_scores_gemma":[0.0023795424,0.9958958,0.0006441066,0.0007167123,0.00023267079,0.000009468944,0.000028700157,0.000038896913,0.00005408206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949705,0.0008915636,0.0032861512,0.00029242967,0.0002501149,0.00030921787],"domain_scores_gemma":[0.99510765,0.0016714137,0.0022354522,0.0003528065,0.00017683422,0.00045585883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032824982,0.00030825209,0.007730169,0.000334448,0.000015834301,0.000009750146,0.00020784968,0.0002581439,0.00016118663],"category_scores_gemma":[0.0009867513,0.00021468167,0.0023750374,0.00052890775,0.0003450495,0.000039369625,0.000064745596,0.001136231,0.000084165964],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008116626,0.00091754115,0.01079516,0.0011170345,0.0009922525,0.012644605,0.000007947594,4.2435783e-8,3.1317278e-9,0.000047630005,0.0012674852,0.9721291],"study_design_scores_gemma":[0.0017617856,0.00071436394,0.0024548739,0.0105174985,0.003172708,0.016471395,0.00006226316,5.9805257e-7,7.834973e-8,0.000020493206,0.9646712,0.00015276861],"about_ca_topic_score_codex":0.000012543916,"about_ca_topic_score_gemma":0.0000031260588,"teacher_disagreement_score":0.97197634,"about_ca_system_score_codex":0.000076009004,"about_ca_system_score_gemma":0.0017581864,"threshold_uncertainty_score":0.87544644},"labels":[],"label_agreement":null},{"id":"W4206267503","doi":"10.1007/s40257-021-00652-1","title":"Diagnosis of Generalized Pustular Psoriasis","year":2022,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"Boehringer Ingelheim","keywords":"Medicine; Disease; Generalized pustular psoriasis; Psoriasis; Differential diagnosis; Intensive care medicine; Dermatology; Pathology","score_opus":0.09468950018906415,"score_gpt":0.39441803776924406,"score_spread":0.2997285375801799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206267503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056825127,0.9887922,0.0000139564,0.00016556472,0.004720571,0.00028512997,0.00014589228,0.000018542836,0.00017565831],"genre_scores_gemma":[0.001191806,0.99755967,0.00045101575,0.00015535441,0.00022794018,0.00008676101,0.0001379144,0.000066626555,0.000122904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875503,0.0062769186,0.005075933,0.0004532228,0.00014087892,0.0005027023],"domain_scores_gemma":[0.98467195,0.0068942816,0.0075272364,0.00062711403,0.00016393368,0.00011550475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012921289,0.00057054515,0.009030437,0.0005645272,0.00011951706,0.0000073312135,0.0011215735,0.0006530124,0.0026216256],"category_scores_gemma":[0.0012922601,0.00042541948,0.0037791133,0.00063590857,0.0011271756,0.00006604601,0.0002460654,0.0013292625,0.00013616617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020477513,0.0005882592,0.0018096052,0.00058252894,0.005557115,0.00036501326,0.00004455364,4.1911704e-7,5.7920477e-7,0.00014203756,0.0046324143,0.9860727],"study_design_scores_gemma":[0.0019038253,0.0010866836,0.00010629416,0.0006740418,0.0065218317,0.0047901976,0.000108403176,5.6359546e-8,0.00002310971,0.000038750157,0.9844175,0.0003293355],"about_ca_topic_score_codex":0.00005239083,"about_ca_topic_score_gemma":0.0000039693605,"teacher_disagreement_score":0.98574334,"about_ca_system_score_codex":0.000057988596,"about_ca_system_score_gemma":0.0009942227,"threshold_uncertainty_score":0.99981976},"labels":[],"label_agreement":null},{"id":"W4211167150","doi":"10.1007/s40257-018-0353-x","title":"Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)","year":2018,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Etanercept; Plaque psoriasis; Psoriasis; Clinical trial; Randomized controlled trial; Internal medicine; Dermatology; Pharmacology; Psoriatic arthritis; Tumor necrosis factor alpha; Secukinumab","score_opus":0.045482967405203044,"score_gpt":0.40517980120416425,"score_spread":0.3596968337989612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211167150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712677,0.0015884832,0.0039546574,0.0019709002,0.019576242,0.0013005919,0.00014627274,0.000014572409,0.00018055445],"genre_scores_gemma":[0.9899853,0.0054645166,0.0013396671,0.0012502125,0.0009331929,0.000043101794,0.00016002964,0.00006535151,0.00075864815],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9673917,0.020782435,0.009904513,0.0010786646,0.00019233604,0.0006502928],"domain_scores_gemma":[0.94941753,0.04418656,0.005091319,0.0005545316,0.00035471655,0.00039533374],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015850414,0.00073986646,0.013918008,0.0016811216,0.000112137815,0.00004152285,0.0005601415,0.0011985431,0.00017630312],"category_scores_gemma":[0.029365022,0.00059078576,0.0014301599,0.0009272443,0.0008028668,0.00014834973,0.0002565636,0.0022322105,0.00004223312],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6240871,0.0009055909,0.0039293594,0.000019648545,0.00441646,0.0002608327,0.0018163656,0.00010615455,0.00022281957,0.0000060910306,0.035440274,0.32878932],"study_design_scores_gemma":[0.9187284,0.009964659,0.025650488,0.0027977896,0.008542168,0.0015160159,0.0027102157,0.00094717153,0.00039177734,0.00035100678,0.02660923,0.0017910813],"about_ca_topic_score_codex":0.0019350005,"about_ca_topic_score_gemma":0.0023382455,"teacher_disagreement_score":0.32699823,"about_ca_system_score_codex":0.00011221241,"about_ca_system_score_gemma":0.00097509165,"threshold_uncertainty_score":0.99965435},"labels":[],"label_agreement":null},{"id":"W4225303623","doi":"10.1007/s40257-022-00685-0","title":"Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Glenmark Pharmaceuticals; LEO Pharma; Galderma; Incyte; Dermira; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Off-label use; Internal medicine","score_opus":0.036607971002882,"score_gpt":0.388442262458741,"score_spread":0.351834291455859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225303623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994107,0.000079058365,0.00022110305,0.0037801163,0.0001257917,0.0016075629,0.000019797313,0.000009601719,0.000049950675],"genre_scores_gemma":[0.9943585,0.00002480537,0.0021732543,0.003266504,0.000025968819,0.000077442266,0.000008267946,0.000025152647,0.000040109633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968239,0.00075625244,0.0015174736,0.00032558895,0.00025028692,0.0003264756],"domain_scores_gemma":[0.99729663,0.0010159465,0.0006577898,0.00030359824,0.0002926677,0.0004333531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051644177,0.00016793858,0.0016189632,0.00027588653,0.000111261994,0.000020513766,0.00043274785,0.000053783177,0.00005228236],"category_scores_gemma":[0.0008297126,0.00014272421,0.000059067308,0.00042595484,0.00023575386,0.00019275889,0.00028311592,0.00040362103,0.0000012265183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07169889,0.007953848,0.85112846,0.00013735403,0.00041902196,0.0021264749,0.0059991432,0.000453332,0.000005641165,0.0001243171,0.0034087978,0.05654473],"study_design_scores_gemma":[0.059026647,0.0250232,0.87920725,0.000138126,0.00026510103,0.0041356087,0.028971527,0.00065988343,0.000015085162,0.00009522235,0.0021992687,0.00026306],"about_ca_topic_score_codex":0.000080722704,"about_ca_topic_score_gemma":0.00016696136,"teacher_disagreement_score":0.056281667,"about_ca_system_score_codex":0.000036901594,"about_ca_system_score_gemma":0.00051894254,"threshold_uncertainty_score":0.5820125},"labels":[],"label_agreement":null},{"id":"W4226034331","doi":"10.1007/s40257-022-00690-3","title":"A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovaderm (Canada)","funders":"Incyte","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Dermatology; Pharmacotherapy; Internal medicine","score_opus":0.022736813773633416,"score_gpt":0.3382440697066223,"score_spread":0.3155072559329889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226034331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618745,0.00035359774,0.000030073688,0.0027649777,0.00023916538,0.0002656764,0.0000106143925,0.000007874544,0.00014059765],"genre_scores_gemma":[0.9964848,0.00027085055,0.0004466878,0.00270179,0.000056646088,0.000012327585,0.000004196625,0.000014458296,0.000008230262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966668,0.0008899351,0.0016845765,0.00019387828,0.00030729533,0.00025755283],"domain_scores_gemma":[0.99744487,0.00075729936,0.0011682124,0.00021688904,0.00014018305,0.0002725387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034803213,0.00014372604,0.001453298,0.0002486908,0.00004668014,0.000005280994,0.00016028182,0.00007035656,0.000057916855],"category_scores_gemma":[0.00084748043,0.0001151473,0.00020108485,0.0002619269,0.000948642,0.00010226791,0.00008678684,0.00070794235,0.0000017226823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04217797,0.0024096991,0.9324707,0.00011028379,0.00013871366,0.0036358372,0.00020641854,0.000003077154,7.4587626e-7,0.00006575355,0.0007931907,0.01798763],"study_design_scores_gemma":[0.074419096,0.006228675,0.8937478,0.00035240548,0.00018272894,0.020723442,0.0011180454,0.000041003834,0.000014839545,0.00022990673,0.0028210175,0.00012105695],"about_ca_topic_score_codex":0.000047938694,"about_ca_topic_score_gemma":0.000015393707,"teacher_disagreement_score":0.038722895,"about_ca_system_score_codex":0.000016610327,"about_ca_system_score_gemma":0.00035747347,"threshold_uncertainty_score":0.46955705},"labels":[],"label_agreement":null},{"id":"W4243004000","doi":"10.1007/s40257-019-00486-y","title":"Acknowledgement to Referees","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Foundation for the Arts","funders":"","keywords":"Medicine; Acknowledgement; Pharmacotherapy; Family medicine; Medical physics; Medical education; Internal medicine; Computer science","score_opus":0.03991488209805869,"score_gpt":0.4170627384689888,"score_spread":0.37714785637093007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243004000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92198724,0.00053975754,0.0002795932,0.025892913,0.0021173211,0.00018465573,5.9060585e-7,0.000016783348,0.04898116],"genre_scores_gemma":[0.9347507,0.00020845923,0.003104324,0.060842745,0.00036609863,0.0000025186177,9.628769e-7,0.000015984795,0.0007082101],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974121,0.0002515401,0.001588845,0.00020174102,0.00026739223,0.00027837366],"domain_scores_gemma":[0.997353,0.00068559917,0.0006805193,0.00033698822,0.00047865853,0.00046522537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056038453,0.00013855388,0.0017339797,0.00023479135,0.0000282811,0.0000022721113,0.00018859367,0.00008655539,0.00019856077],"category_scores_gemma":[0.0009843515,0.000101775346,0.00030506746,0.00023318453,0.00044721318,0.00003937098,0.00007704946,0.000540904,0.0013535575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018101245,0.00044369383,0.5325557,0.00007968187,0.0005615378,0.001188509,0.00027839845,0.0000016633593,0.000097896685,0.00046419477,0.39653274,0.06598587],"study_design_scores_gemma":[0.0028700684,0.0041930093,0.09943269,0.00010155407,0.00021553652,0.0038456463,0.0009722639,0.000010705125,0.000074548996,0.000052834097,0.88810295,0.00012817528],"about_ca_topic_score_codex":0.0000019638182,"about_ca_topic_score_gemma":0.0000019423594,"teacher_disagreement_score":0.49157023,"about_ca_system_score_codex":0.00003326556,"about_ca_system_score_gemma":0.00027983452,"threshold_uncertainty_score":0.999424},"labels":[],"label_agreement":null},{"id":"W4285992899","doi":"10.1007/s40257-022-00702-2","title":"Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research; BC Children's Hospital; University of Toronto","funders":"LEO Pharma","keywords":"Medicine; Atopic dermatitis; Post-hoc analysis; Pharmacotherapy; Dermatology; Post hoc; Pediatrics; Internal medicine","score_opus":0.013145860085310535,"score_gpt":0.3302098550957344,"score_spread":0.31706399501042387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285992899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845741,0.0004411585,0.00007157329,0.014141935,0.00009455837,0.0005634608,0.000017922499,0.000027202494,0.00006811974],"genre_scores_gemma":[0.99004376,0.000050236617,0.0007863295,0.008913451,0.00006355183,0.000051032886,0.000035863974,0.000027530414,0.00002825206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957045,0.0011584825,0.0016902175,0.00046963262,0.0004594771,0.0005177465],"domain_scores_gemma":[0.99698704,0.0007318565,0.00084123306,0.00035662294,0.0003212607,0.00076196174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002609571,0.00030077997,0.0021060088,0.00058566476,0.00016989319,0.000045618304,0.00028333213,0.00012646074,0.00023068923],"category_scores_gemma":[0.00070794206,0.0002377529,0.00033730286,0.0008590172,0.0008521223,0.00023335186,0.00012785362,0.00094004226,0.0000031115558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04430772,0.003164415,0.8792568,0.00015675474,0.0018571868,0.034840602,0.0056449436,0.00038016716,0.0000057361103,0.00017069411,0.0006681488,0.029546814],"study_design_scores_gemma":[0.017517205,0.012636716,0.91445935,0.0001406805,0.0012476144,0.037042398,0.013773967,0.0021157293,0.000013530029,0.000087773646,0.0006020013,0.00036304395],"about_ca_topic_score_codex":0.00010288593,"about_ca_topic_score_gemma":0.00011755532,"teacher_disagreement_score":0.03520253,"about_ca_system_score_codex":0.000089831985,"about_ca_system_score_gemma":0.00096616807,"threshold_uncertainty_score":0.9695282},"labels":[],"label_agreement":null},{"id":"W4292324125","doi":"10.1007/s40257-022-00722-y","title":"Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Secukinumab; Hazard ratio; Internal medicine; Ixekizumab; Retrospective cohort study; Discontinuation; Proportional hazards model; Psoriasis; Cohort; Confidence interval; Psoriatic arthritis; Immunology; Arthritis","score_opus":0.025827744074120234,"score_gpt":0.3257116528310061,"score_spread":0.29988390875688586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292324125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930485,0.0028711846,0.00008235168,0.00048552893,0.0024104316,0.00085748546,0.0002191746,0.000008913659,0.000016412429],"genre_scores_gemma":[0.997946,0.0014749767,0.00019486598,0.000054823176,0.00009262361,0.00009038046,0.00001759376,0.000020607551,0.00010810512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99550074,0.0017750604,0.0019701875,0.00031956658,0.00012693134,0.00030750473],"domain_scores_gemma":[0.99290293,0.004136733,0.0023304757,0.00031700468,0.00025711034,0.000055763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012570388,0.00025152645,0.0018158752,0.00019163864,0.00020623008,0.0000055870264,0.00034051016,0.00008981841,0.00005409728],"category_scores_gemma":[0.00044435041,0.0001660011,0.0004965927,0.0003010143,0.0011450911,0.00004807404,0.000099248275,0.00030903678,0.0000023568678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004305875,0.0044840113,0.94568974,0.00000880952,0.004581537,0.000053087893,0.00256386,0.00001394592,0.00019584077,0.000059114318,0.000573078,0.0374711],"study_design_scores_gemma":[0.02447042,0.019039232,0.9012396,0.00002448555,0.0035917899,0.0008933472,0.029399961,0.000051377363,0.001909196,0.00004744059,0.019026786,0.00030639037],"about_ca_topic_score_codex":0.00033181856,"about_ca_topic_score_gemma":0.00017575818,"teacher_disagreement_score":0.044450164,"about_ca_system_score_codex":0.00008537156,"about_ca_system_score_gemma":0.00018485708,"threshold_uncertainty_score":0.6769329},"labels":[],"label_agreement":null},{"id":"W4308834973","doi":"10.1007/s40257-022-00739-3","title":"Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"","keywords":"Medicine; Roflumilast; Psoriasis; Psoriasis Area and Severity Index; Eczema Area and Severity Index; Erythema; Dermatology; Dermatology Life Quality Index; Severity of illness; Body surface area; Dose-ranging study; Randomized controlled trial; Post-hoc analysis; Physical therapy; Internal medicine; Atopic dermatitis; Placebo; Double blind; Pathology; COPD","score_opus":0.011840739231970945,"score_gpt":0.30982363626329584,"score_spread":0.2979828970313249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308834973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996357,0.0011007407,0.0000070128917,0.00048781524,0.0012903932,0.0006260084,0.00006465868,0.000015435282,0.00005092459],"genre_scores_gemma":[0.9993088,0.000358798,0.00003277515,0.000113378504,0.000037010894,0.000057000118,0.000045226032,0.000030614785,0.00001640177],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9923365,0.0034845578,0.0030998604,0.00042717654,0.00020165645,0.00045024086],"domain_scores_gemma":[0.9915325,0.004216567,0.0036236148,0.0003783105,0.00014580988,0.00010319042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012266727,0.0003801913,0.0028787265,0.0004313293,0.00010309271,0.00000433171,0.00037407837,0.00027467698,0.0001745956],"category_scores_gemma":[0.00073262776,0.00027162497,0.00048699608,0.00049135805,0.0010128274,0.00008092773,0.0001269581,0.0009437828,0.0000068297304],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26516223,0.0044365823,0.5885671,0.000057297806,0.0033298503,0.0010105249,0.0006582483,0.000047765854,0.00071745116,0.000032028034,0.00013885026,0.13584207],"study_design_scores_gemma":[0.60258275,0.17075595,0.18480077,0.0005318514,0.0029686105,0.009296326,0.0014534938,0.000039456558,0.024802675,0.0000626068,0.0018381529,0.0008673282],"about_ca_topic_score_codex":0.00016212088,"about_ca_topic_score_gemma":0.00004111376,"teacher_disagreement_score":0.40376633,"about_ca_system_score_codex":0.00006665466,"about_ca_system_score_gemma":0.00034688067,"threshold_uncertainty_score":0.9999736},"labels":[],"label_agreement":null},{"id":"W4321003521","doi":"10.1007/s40257-023-00763-x","title":"Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009–2022)","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Lady Davis Institute for Medical Research; Compute Canada; Fondation de l'Hôpital général juif; Jewish General Hospital; Terry Fox Research Institute; Fonds de Recherche du Québec - Santé","keywords":"Meta-analysis; Medicine; Systematic review; Basal cell carcinoma; Oncology; Sonic hedgehog; Internal medicine; Bioinformatics; MEDLINE; Basal cell; Biology; Genetics","score_opus":0.08804275370804993,"score_gpt":0.4070937080088804,"score_spread":0.31905095430083047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321003521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043139355,0.99448436,0.000037752845,0.00019867228,0.0000854415,0.00077558553,0.00008755939,0.0000057748466,0.0000108886425],"genre_scores_gemma":[0.012087267,0.9870862,0.00019647571,0.00036845915,0.00006095017,0.000028372078,0.00008439827,0.000056953737,0.000030963718],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9886309,0.00422263,0.0058693523,0.00064531114,0.0002559975,0.00037579334],"domain_scores_gemma":[0.9925791,0.001129333,0.005034866,0.00066853216,0.00029020468,0.0002979669],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0030785715,0.0005525257,0.015554699,0.00049104344,0.00004462014,0.000013889167,0.00050876226,0.00039098068,0.000012359901],"category_scores_gemma":[0.0015681561,0.00038172756,0.002258979,0.0010726118,0.0008321648,0.000008769553,0.00029067925,0.0007278129,0.0000036883443],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030237072,0.00083994644,0.0011888812,0.6679021,0.31127214,0.00080479524,0.00017668825,0.000015968364,0.000023913244,0.000019469087,0.0016127136,0.015841022],"study_design_scores_gemma":[0.0013292511,0.0019614068,0.00023008863,0.014168299,0.9553502,0.0009968313,0.00023657348,0.000009249791,0.000029731813,0.000011642889,0.024779465,0.0008972584],"about_ca_topic_score_codex":0.000018721285,"about_ca_topic_score_gemma":0.000036658177,"teacher_disagreement_score":0.6537338,"about_ca_system_score_codex":0.000015992611,"about_ca_system_score_gemma":0.00043351398,"threshold_uncertainty_score":0.99986345},"labels":[],"label_agreement":null},{"id":"W4321435758","doi":"10.1007/s40257-022-00754-4","title":"Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Placebo; Eczema Area and Severity Index; Atopic dermatitis; Dermatology Life Quality Index; Adverse effect; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Pathology; Disease","score_opus":0.0714840113927091,"score_gpt":0.4185551478489848,"score_spread":0.3470711364562757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321435758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952808,0.00033946597,0.0008990478,0.0025705704,0.00013433016,0.000539569,0.00017557366,0.000012334162,0.00004830947],"genre_scores_gemma":[0.9948712,0.0017895818,0.0023299418,0.0007916015,0.000050628263,0.000005468509,0.00013681095,0.000018941268,0.000005806286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.985433,0.00647777,0.0069934158,0.00040374717,0.00040507692,0.00028702497],"domain_scores_gemma":[0.9638291,0.030860484,0.0038662597,0.0007459565,0.00031774587,0.00038043587],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0065633296,0.0002172928,0.008721272,0.00079717365,0.000019749623,0.000005490873,0.00047382596,0.00023082359,0.00007415049],"category_scores_gemma":[0.028587604,0.0001620279,0.00079271145,0.0012536631,0.0017725558,0.00010234023,0.00020095315,0.00053106813,0.0000045119054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3517643,0.00095489377,0.60333985,0.00014692533,0.012660274,0.005335064,0.0004045896,0.000248591,0.000008364558,0.00008012107,0.0012122393,0.023844808],"study_design_scores_gemma":[0.15271801,0.00054972485,0.8338999,0.00061662495,0.0059526083,0.00031776357,0.00045289812,0.005026595,0.000014016839,0.0002615736,0.00005952279,0.00013077524],"about_ca_topic_score_codex":0.00013619015,"about_ca_topic_score_gemma":0.00010360662,"teacher_disagreement_score":0.23056006,"about_ca_system_score_codex":0.000009687481,"about_ca_system_score_gemma":0.0004589157,"threshold_uncertainty_score":0.979595},"labels":[],"label_agreement":null},{"id":"W4367187120","doi":"10.1007/s40257-023-00778-4","title":"Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Monkeypox; Chills; Rash; Outbreak; Transmission (telecommunications); Smallpox; Intensive care medicine; Health care; Adverse effect; Public health; Disease; Dermatology; Virology; Vaccination; Vaccinia; Surgery; Pathology; Internal medicine","score_opus":0.153715069364175,"score_gpt":0.4852617229763247,"score_spread":0.3315466536121497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367187120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075868896,0.9963105,0.000112500464,0.00062448456,0.0008385642,0.0011196083,0.000198449,0.000020206553,0.000017007489],"genre_scores_gemma":[0.00034335325,0.99861693,0.00016678698,0.00011722775,0.00011992401,0.00025130188,0.00014033279,0.000051416348,0.00019271047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918903,0.0025610293,0.0044299355,0.00042770331,0.00010529807,0.0005857088],"domain_scores_gemma":[0.98723704,0.0073497123,0.0044989223,0.0004116846,0.0003333047,0.00016932817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064493116,0.0004858726,0.008398836,0.0003506134,0.000084152554,0.0000099025765,0.0005538251,0.00060223526,0.00011601431],"category_scores_gemma":[0.0023509378,0.0003186736,0.002335356,0.00030976482,0.0017863113,0.000057325593,0.00013443707,0.0006676658,0.00008017731],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001843262,0.00051520247,0.00058157754,0.009757684,0.002879309,0.00010667114,0.000015157119,9.734546e-9,6.609653e-7,0.00008749602,0.010129175,0.97574276],"study_design_scores_gemma":[0.0017102412,0.003083104,0.00013554966,0.015079576,0.0029024782,0.004093666,0.000017726214,1.9236907e-7,0.000018198245,0.00011403516,0.9726022,0.00024303501],"about_ca_topic_score_codex":0.000028054297,"about_ca_topic_score_gemma":0.00001940066,"teacher_disagreement_score":0.9754997,"about_ca_system_score_codex":0.000038968614,"about_ca_system_score_gemma":0.0009378186,"threshold_uncertainty_score":0.9999265},"labels":[],"label_agreement":null},{"id":"W4375852732","doi":"10.1007/s40257-023-00779-3","title":"Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Acute generalized exanthematous pustulosis; Dermatology; Differential diagnosis; Etiology; Disease; Intensive care medicine; Acne; Desquamation; Pathology","score_opus":0.14832034626515395,"score_gpt":0.5024705409521212,"score_spread":0.35415019468696723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375852732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028769292,0.98678327,0.00008327562,0.0028957308,0.0048589716,0.0014441117,0.00007575075,0.00013130547,0.00085064763],"genre_scores_gemma":[0.00051346817,0.995007,0.0018270711,0.0006930724,0.0013269739,0.000101738864,0.000048017802,0.00016005171,0.00032263802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98980933,0.0019364663,0.0062221363,0.0007710474,0.00060819305,0.00065281696],"domain_scores_gemma":[0.9885106,0.0045342334,0.0049146023,0.00078444416,0.00022249277,0.0010336397],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001127838,0.00072002393,0.010582228,0.00072210847,0.00010246836,0.00004401607,0.00053594704,0.00064896845,0.000023322416],"category_scores_gemma":[0.0011570415,0.00050757284,0.0032479386,0.00065267686,0.0013012475,0.00009014483,0.00038766614,0.0031277859,0.00015627952],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088098364,0.0007379846,0.0006362319,0.0032002022,0.010702359,0.010269921,0.000009441031,5.2340333e-8,4.432649e-8,0.0003021668,0.007285605,0.9667679],"study_design_scores_gemma":[0.0027919216,0.00040197922,0.0031839665,0.00957688,0.022581892,0.043148443,0.00009572676,0.000002381856,3.216325e-7,0.000061121595,0.9177459,0.00040945463],"about_ca_topic_score_codex":0.000010515314,"about_ca_topic_score_gemma":0.000005835143,"teacher_disagreement_score":0.9663584,"about_ca_system_score_codex":0.00008010582,"about_ca_system_score_gemma":0.00058228546,"threshold_uncertainty_score":0.99973756},"labels":[],"label_agreement":null},{"id":"W4376609056","doi":"10.1007/s40257-023-00780-w","title":"Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Clinical endpoint; Maintenance therapy; Adverse effect; Eczema Area and Severity Index; Double blind; Incidence (geometry); Randomized controlled trial; Placebo; Surgery; Internal medicine; Dermatology; Chemotherapy","score_opus":0.04220595719627587,"score_gpt":0.3948880800747534,"score_spread":0.35268212287847756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376609056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191666,0.00015828908,0.00010444679,0.005915029,0.0005337235,0.0010964362,0.000014571745,0.00006451348,0.00019634662],"genre_scores_gemma":[0.9926857,0.0005701975,0.0003486977,0.0059484355,0.00013318541,0.00008429971,0.000021891952,0.000049727336,0.00015791874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99290085,0.0018697429,0.0033376908,0.00061766565,0.000510063,0.00076398137],"domain_scores_gemma":[0.9950289,0.001732876,0.0013263258,0.00060265535,0.000399797,0.00090942136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007292484,0.0004302532,0.0029333634,0.0004481382,0.000107409105,0.000029130812,0.00037212126,0.00019084373,0.00005478424],"category_scores_gemma":[0.0014444779,0.00030462962,0.00047796604,0.000864861,0.0008624796,0.00017246448,0.00010713538,0.00082126295,0.00026783274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005829527,0.007917109,0.9414247,0.000031869055,0.0009207646,0.014988826,0.00064732326,0.000026178597,2.940268e-7,0.0000069084826,0.006257469,0.021948999],"study_design_scores_gemma":[0.021681495,0.018603675,0.95524913,0.00030478483,0.0004984064,0.0014929754,0.0010517844,0.0000592713,0.000010523001,0.00007111427,0.00070880045,0.00026804986],"about_ca_topic_score_codex":0.00008192017,"about_ca_topic_score_gemma":0.0002445314,"teacher_disagreement_score":0.02168095,"about_ca_system_score_codex":0.00010967416,"about_ca_system_score_gemma":0.0008213496,"threshold_uncertainty_score":0.9999406},"labels":[],"label_agreement":null},{"id":"W4376871458","doi":"10.1007/s40257-023-00792-6","title":"Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Pharmacotherapy; Clinical trial; Pediatrics; Internal medicine","score_opus":0.04778213975216787,"score_gpt":0.41340118672728016,"score_spread":0.36561904697511227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376871458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966089,0.00022799347,0.0005251878,0.0020985696,0.00015856074,0.00027047432,0.000046073084,0.000015407768,0.000048840808],"genre_scores_gemma":[0.99645185,0.0011558558,0.00091861683,0.0013663366,0.00004408766,0.000004193432,0.000035286932,0.000017954944,0.000005826489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99000114,0.0035755162,0.00542643,0.00034337386,0.0003374426,0.0003161145],"domain_scores_gemma":[0.99333715,0.0027278687,0.0024506508,0.00038038718,0.00054261176,0.00056135195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027308417,0.00022726832,0.005026262,0.0010169138,0.000030059962,0.000006367166,0.00025037257,0.00024494843,0.00003923342],"category_scores_gemma":[0.0048782704,0.0001588125,0.00060940714,0.001889173,0.0011632134,0.00013491363,0.00006357389,0.00066429534,0.000005313249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015159161,0.0007884725,0.94382,0.00015480405,0.0018185094,0.0010821696,0.00023023569,0.00014421764,0.0000020478192,0.000029539971,0.00055191194,0.036218904],"study_design_scores_gemma":[0.009127073,0.0014775216,0.98089683,0.0010231443,0.0018613742,0.0010944156,0.0008735632,0.0031184957,0.000036328856,0.00006685931,0.0002786282,0.00014575287],"about_ca_topic_score_codex":0.000054372696,"about_ca_topic_score_gemma":0.000120344834,"teacher_disagreement_score":0.03707682,"about_ca_system_score_codex":0.000015323407,"about_ca_system_score_gemma":0.00051004207,"threshold_uncertainty_score":0.6476186},"labels":[],"label_agreement":null},{"id":"W4376872206","doi":"10.1007/s40257-023-00784-6","title":"Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials","year":2023,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Medicine; Dupilumab; Atopic dermatitis; Randomized controlled trial; Dermatology; Pharmacotherapy; Clinical trial; Pooled analysis; Internal medicine; Meta-analysis","score_opus":0.05962794377999545,"score_gpt":0.40276020670482243,"score_spread":0.34313226292482696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376872206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97989285,0.00094878057,0.0018183265,0.0045443797,0.010281334,0.0016186372,0.00042307624,0.000028621354,0.0004439673],"genre_scores_gemma":[0.9921921,0.0030811804,0.0016862043,0.0013919623,0.00030136923,0.000016145897,0.00085901574,0.000059766568,0.0004122365],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9784338,0.009400754,0.010328968,0.00073879317,0.00069916603,0.000398503],"domain_scores_gemma":[0.95536673,0.034148436,0.0078827245,0.0011742318,0.00079133175,0.0006365545],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008029996,0.00042823653,0.015215134,0.0016073717,0.000027598344,0.000019427795,0.0007989087,0.0007031854,0.0000995786],"category_scores_gemma":[0.07485418,0.00033366398,0.0013605875,0.001731918,0.0016426152,0.00017355081,0.00033578294,0.0017578818,0.0000055700557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3683753,0.0013195025,0.1490483,0.00033707154,0.02361551,0.004863918,0.00037291515,0.00018504771,7.125535e-7,0.0000141608525,0.42559892,0.026268655],"study_design_scores_gemma":[0.1478339,0.0012911588,0.82283705,0.003534997,0.017545342,0.0006064265,0.00059318607,0.003403158,0.000001437103,0.00019032165,0.0018019218,0.00036112158],"about_ca_topic_score_codex":0.00055722735,"about_ca_topic_score_gemma":0.0007597484,"teacher_disagreement_score":0.6737887,"about_ca_system_score_codex":0.00003246663,"about_ca_system_score_gemma":0.0013770938,"threshold_uncertainty_score":0.99991155},"labels":[],"label_agreement":null},{"id":"W4385651095","doi":"10.1007/s40257-023-00811-6","title":"Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Itraconazole; Terbinafine; Medicine; Voriconazole; Fluconazole; Griseofulvin; Dermatology; Pharmacology; Antifungal","score_opus":0.09327526366804266,"score_gpt":0.43481238422380614,"score_spread":0.34153712055576346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385651095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27683267,0.7188627,0.000013399158,0.0006672438,0.0003762472,0.0020578264,0.00046135756,0.0000674828,0.00066104165],"genre_scores_gemma":[0.08528592,0.9131852,0.0009878991,0.00013549213,0.00014140991,0.00004543002,0.00003504239,0.000086894775,0.000096765994],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9933938,0.0010487385,0.003756276,0.0007621027,0.00052154914,0.0005175719],"domain_scores_gemma":[0.98944205,0.003923104,0.004999655,0.00059063005,0.00042490324,0.0006196392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031995884,0.0006799168,0.0075828335,0.0005658933,0.00008272534,0.000018403955,0.00022351903,0.00014444099,0.00000672892],"category_scores_gemma":[0.0010232024,0.00046770409,0.0015119206,0.0017011935,0.0013386181,0.000044806675,0.000060489714,0.0006044457,0.000013192311],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015540292,0.002754082,0.11161989,0.003131853,0.005426251,0.0034985289,0.00004918013,2.3228799e-7,2.0848934e-7,0.00002298358,0.00062233815,0.8713204],"study_design_scores_gemma":[0.025778847,0.042620562,0.4734778,0.026249593,0.04765202,0.003686947,0.0018700727,0.000016380229,0.000015281823,0.00014231433,0.37646776,0.0020224124],"about_ca_topic_score_codex":0.00011447372,"about_ca_topic_score_gemma":0.000060632992,"teacher_disagreement_score":0.86929804,"about_ca_system_score_codex":0.0003472526,"about_ca_system_score_gemma":0.00053647417,"threshold_uncertainty_score":0.9997775},"labels":[],"label_agreement":null},{"id":"W4386153609","doi":"10.1007/s40257-023-00810-7","title":"Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Post-hoc analysis; JADE (particle detector); Dermatology; Post hoc; Sleep (system call); Work productivity; Productivity; Internal medicine","score_opus":0.018667143190910195,"score_gpt":0.3217709866784355,"score_spread":0.30310384348752534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386153609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989568,0.000092126305,0.00012324296,0.009845,0.00008245548,0.00021808642,0.0000062707622,0.000013424919,0.00005139366],"genre_scores_gemma":[0.9984366,0.00002536736,0.00031863997,0.0011603063,0.000020632664,0.000007941732,0.000010259226,0.000012224583,0.000007977848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724364,0.0007935997,0.001265184,0.00022359136,0.00023265657,0.00024131098],"domain_scores_gemma":[0.9956146,0.0027653472,0.0008626211,0.00027805654,0.00028067452,0.00019871569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055434793,0.00014305949,0.0012376133,0.00054200285,0.000064914966,0.000010820947,0.00015998314,0.000093284994,0.000010668447],"category_scores_gemma":[0.0030115764,0.00009300568,0.00019997467,0.0017933779,0.0010201525,0.00013216746,0.00007377031,0.00050415564,0.000003879583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001735428,0.00018934939,0.9903797,0.000026855218,0.00077272946,0.0001515608,0.00066782656,0.00030706046,1.5633394e-7,0.00003205887,0.00036146966,0.005375785],"study_design_scores_gemma":[0.0013981052,0.00032361387,0.99580824,0.00018935544,0.0007407767,0.00014570369,0.0005888331,0.0005797559,0.0000032623332,0.00009954024,0.000031439464,0.000091381575],"about_ca_topic_score_codex":0.000021843522,"about_ca_topic_score_gemma":0.00007345705,"teacher_disagreement_score":0.0088686505,"about_ca_system_score_codex":0.00001485273,"about_ca_system_score_gemma":0.000111924826,"threshold_uncertainty_score":0.37926617},"labels":[],"label_agreement":null},{"id":"W4386529783","doi":"10.1007/s40257-023-00806-3","title":"Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"LEO Pharma; Ludwig-Maximilians-Universität München","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Post-hoc analysis; Atopic dermatitis; Regimen; Randomized controlled trial; Internal medicine; Clinical trial; Dermatology","score_opus":0.07569444120710184,"score_gpt":0.43786725018776146,"score_spread":0.3621728089806596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386529783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888934,0.00029176348,0.00033355586,0.009241517,0.0003940681,0.00041840255,0.00013596365,0.000055296925,0.00024011491],"genre_scores_gemma":[0.99268985,0.00038743074,0.0011531592,0.0051456825,0.0003364353,0.000008660278,0.00021046116,0.00003643245,0.00003189999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99409103,0.0015172436,0.0029946936,0.00049329724,0.00040825692,0.0004954725],"domain_scores_gemma":[0.99262226,0.0045482893,0.0012287113,0.0008091969,0.00017073788,0.0006208335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011097407,0.00028222255,0.0031754253,0.00040341783,0.00005387657,0.000023792152,0.0006164171,0.0001669462,0.00034946477],"category_scores_gemma":[0.0038537327,0.000207233,0.0003211431,0.0007044663,0.00052070414,0.00024771807,0.0001523038,0.0007913019,0.00022015726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067054994,0.0029924067,0.6698185,0.00011941831,0.0028085522,0.031755306,0.0011264656,0.00020909571,0.000019287687,0.00017430917,0.13272925,0.09119238],"study_design_scores_gemma":[0.15820925,0.001771397,0.81340706,0.0013700179,0.0013651662,0.0060963556,0.0012837793,0.0040315525,0.00009146189,0.00078054087,0.0110347085,0.0005586892],"about_ca_topic_score_codex":0.00009764718,"about_ca_topic_score_gemma":0.000083438084,"teacher_disagreement_score":0.14358854,"about_ca_system_score_codex":0.000022652972,"about_ca_system_score_gemma":0.00062230177,"threshold_uncertainty_score":0.8450717},"labels":[],"label_agreement":null},{"id":"W4390815344","doi":"10.1007/s40257-023-00837-w","title":"Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Dupilumab; Janus kinase; Clinical trial; Intensive care medicine; Dermatology; Immunology; Internal medicine","score_opus":0.01717014091111071,"score_gpt":0.33215766984991213,"score_spread":0.31498752893880144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390815344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749536,0.017345173,0.0011741847,0.005636203,0.0005532963,0.00022060945,0.000017629616,0.000055500543,0.00004383411],"genre_scores_gemma":[0.99321693,0.001599769,0.0029608305,0.0018535864,0.00031358824,0.000012007468,0.000013968036,0.000022012195,0.000007291371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997856,0.00033249237,0.0011833046,0.00024952763,0.00012485286,0.00025377783],"domain_scores_gemma":[0.9959335,0.002967973,0.0005301126,0.00013138616,0.00021634783,0.00022069467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026102192,0.00018098581,0.0011662381,0.00014140594,0.00006775713,0.000024126326,0.000103037986,0.00015898158,0.000015718362],"category_scores_gemma":[0.0007157822,0.00011511529,0.0002271474,0.00019266468,0.0007360086,0.00012474204,0.0000227003,0.0004621901,0.0000057001166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011433761,0.00014960648,0.91886175,0.00044142193,0.0015126697,0.001988833,0.0012340695,0.0000018079674,0.00006771479,0.0002204369,0.0058331303,0.068545215],"study_design_scores_gemma":[0.014382229,0.007414112,0.77095085,0.0075484538,0.002888964,0.12953842,0.018987427,0.0024378374,0.0013229377,0.0035129893,0.04004106,0.0009747001],"about_ca_topic_score_codex":0.000013458193,"about_ca_topic_score_gemma":0.0000061689725,"teacher_disagreement_score":0.14791085,"about_ca_system_score_codex":0.000013227081,"about_ca_system_score_gemma":0.00027730284,"threshold_uncertainty_score":0.4694265},"labels":[],"label_agreement":null},{"id":"W4391130620","doi":"10.1007/s40257-024-00846-3","title":"Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"National Center for Advancing Translational Sciences; Pfizer","keywords":"Medicine; Placebo; Internal medicine; Alopecia areata; Adverse effect; Cohort; Gastroenterology; Incidence (geometry); Surgery; Dermatology; Pathology","score_opus":0.11009822980209649,"score_gpt":0.46786878886518185,"score_spread":0.35777055906308536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391130620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987424,0.0022122804,0.0021374861,0.0057669063,0.0010561522,0.0009433709,0.0003001267,0.000025899362,0.00013376828],"genre_scores_gemma":[0.99167824,0.0030814498,0.003148025,0.0011187431,0.0007187882,0.000034143206,0.00017854483,0.000027754822,0.000014301233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937571,0.0012423806,0.0039456547,0.0003655187,0.00036990203,0.00031941305],"domain_scores_gemma":[0.98673546,0.010969251,0.0008938716,0.0005935316,0.00047219812,0.00033566417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016464371,0.00026209446,0.002734267,0.00021290003,0.000065403394,0.000024344228,0.0004129969,0.00021739071,0.00009689036],"category_scores_gemma":[0.0023647614,0.00012502668,0.0022188304,0.001033702,0.0019046022,0.0000750151,0.000032037515,0.00057307555,0.0000035582564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05184553,0.0038216012,0.04342944,0.000014089999,0.007798554,0.00016930421,0.00038664386,0.000010981767,0.0000111948475,0.00014979986,0.0025506865,0.8898122],"study_design_scores_gemma":[0.046699237,0.04107394,0.10914896,0.00016042638,0.015327347,0.00011653608,0.0053288373,0.00770215,0.00006623595,0.00024359886,0.77389044,0.00024227292],"about_ca_topic_score_codex":0.00046109266,"about_ca_topic_score_gemma":0.00042774438,"teacher_disagreement_score":0.8895699,"about_ca_system_score_codex":0.000030333598,"about_ca_system_score_gemma":0.00090213696,"threshold_uncertainty_score":0.70175856},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4392926834","doi":"10.1007/s40257-024-00854-3","title":"Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; Memorial University of Newfoundland; Centre de Recherche Dermatologique du Québec Métropolitain; McGill University Health Centre; McGill University; University of Toronto","funders":"","keywords":"Psoriasis; Medicine; Incidence (geometry); Demography; Context (archaeology); Socioeconomic status; Environmental health; Gerontology; Population; Geography; Dermatology","score_opus":0.03423073616569131,"score_gpt":0.3359677600582995,"score_spread":0.30173702389260815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392926834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078345,0.00229028,0.00026824736,0.003598179,0.002706211,0.00016972734,0.00013301289,0.000017462675,0.00003342697],"genre_scores_gemma":[0.9989357,0.00005004229,0.00009095037,0.0004206404,0.00014555134,0.000008827958,0.00006214183,0.000020210695,0.0002659618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573725,0.0018943974,0.001611987,0.0003015257,0.0001808546,0.00027396012],"domain_scores_gemma":[0.9939848,0.004685447,0.0008161964,0.00025207712,0.0001676716,0.00009379249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063663203,0.0002182946,0.0010000531,0.00015717845,0.00013641601,0.000015433581,0.0004350895,0.000121533085,0.0005246266],"category_scores_gemma":[0.0009449497,0.00014317974,0.0003227511,0.00037085556,0.00035157506,0.00007095367,0.000109114466,0.00054674933,0.000043868466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010381031,0.00023850612,0.93073773,0.0000058599267,0.0016084904,0.0002829942,0.00043099816,0.00012914804,0.0005291853,0.000020164776,0.0035008562,0.061477978],"study_design_scores_gemma":[0.0017836405,0.0008662003,0.98480284,0.00006455991,0.0006922344,0.00019561822,0.00091134437,0.00006251427,0.0008918185,0.000029842662,0.009541556,0.00015784687],"about_ca_topic_score_codex":0.23286033,"about_ca_topic_score_gemma":0.639477,"teacher_disagreement_score":0.4066167,"about_ca_system_score_codex":0.00009323531,"about_ca_system_score_gemma":0.0012440482,"threshold_uncertainty_score":0.7722481},"labels":[],"label_agreement":null},{"id":"W4393164331","doi":"10.1007/s40257-024-00853-4","title":"Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"National Center for Advancing Translational Sciences; AbbVie","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Quality of life (healthcare); Clinical trial; Pharmacotherapy; Pediatrics; Internal medicine; Dermatology","score_opus":0.05139782894144093,"score_gpt":0.4066843368383661,"score_spread":0.3552865078969252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393164331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122053,0.0036110154,0.00045648208,0.0032898833,0.00021208644,0.0010842392,0.00008241975,0.00001717318,0.00002616623],"genre_scores_gemma":[0.9964852,0.0013533627,0.00038203102,0.0016202517,0.000090191366,0.000018775989,0.000013727743,0.000027617754,0.000008875708],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9875105,0.005726278,0.00530707,0.00063541945,0.00043310874,0.00038762353],"domain_scores_gemma":[0.9889439,0.007847285,0.0017576682,0.00026832713,0.00036133928,0.0008214776],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0063536707,0.00036794948,0.005257184,0.0003404421,0.000048072994,0.00004919978,0.00012815701,0.00026076636,0.0000058224373],"category_scores_gemma":[0.011447716,0.00024318838,0.00021227347,0.00030198577,0.0019711433,0.00024875643,0.000082754195,0.0010021126,6.5665023e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41960734,0.0004646222,0.54476035,0.00034846665,0.00080248923,0.0009027358,0.0010065342,0.0000015574483,0.000005271186,0.00004300632,0.00009712486,0.03196049],"study_design_scores_gemma":[0.4955357,0.00184555,0.49420944,0.004113816,0.0006426112,0.000922139,0.0013602348,0.00079569034,0.000013812146,0.00026278893,0.00003101305,0.0002672139],"about_ca_topic_score_codex":0.00038407615,"about_ca_topic_score_gemma":0.00020634137,"teacher_disagreement_score":0.075928345,"about_ca_system_score_codex":0.000017067969,"about_ca_system_score_gemma":0.0006600578,"threshold_uncertainty_score":0.9968793},"labels":[],"label_agreement":null},{"id":"W4396573295","doi":"10.1007/s40257-024-00855-2","title":"Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Incyte","keywords":"Medicine; Ruxolitinib; Atopic dermatitis; Dermatology; Randomized controlled trial; Pharmacotherapy; Term (time); Dupilumab; Internal medicine; Disease; Disease control; Myelofibrosis; Environmental health","score_opus":0.021750270050277888,"score_gpt":0.38418697223797615,"score_spread":0.36243670218769825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396573295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746291,0.01688616,0.0013858528,0.0058801286,0.0004378552,0.0005525777,0.00012518192,0.000042715415,0.000060439987],"genre_scores_gemma":[0.99332607,0.0044159307,0.00016914266,0.0017485738,0.00025573722,0.0000064776214,0.000032455093,0.000030496585,0.00001514219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940384,0.0016222501,0.0032166105,0.00039957368,0.00036838997,0.00035478707],"domain_scores_gemma":[0.9899197,0.007059639,0.001515644,0.0003600839,0.000389395,0.0007555241],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0007745652,0.000326477,0.0038233285,0.00023562298,0.00006524453,0.000023566052,0.00020067893,0.00010798511,0.00002205487],"category_scores_gemma":[0.0046166643,0.00021397076,0.000658668,0.00020333125,0.0046644956,0.00016968521,0.000064721986,0.00064696075,0.000008451385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27053818,0.0012893834,0.689737,0.00042046153,0.0047116205,0.01348043,0.00031401525,0.0000075209527,0.0000026069606,0.00010407088,0.00053458,0.018860083],"study_design_scores_gemma":[0.32307503,0.000675409,0.66358685,0.003847297,0.005137371,0.0023719992,0.00017725448,0.00047351216,0.000023545954,0.00028429882,0.00015542447,0.00019202924],"about_ca_topic_score_codex":0.000021340802,"about_ca_topic_score_gemma":0.000010404896,"teacher_disagreement_score":0.052536827,"about_ca_system_score_codex":0.000018549077,"about_ca_system_score_gemma":0.0004424379,"threshold_uncertainty_score":0.99804425},"labels":[],"label_agreement":null},{"id":"W4396948193","doi":"10.1007/s40257-024-00867-y","title":"Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Alberta; Stollery Children's Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Pediatrics; Population; MEDLINE; Pathology","score_opus":0.04453943385293979,"score_gpt":0.4296405962073905,"score_spread":0.3851011623544507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396948193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032685116,0.9650986,0.0000074006816,0.00047180778,0.00026202874,0.0013356244,0.0000058853293,0.00001407819,0.00011944518],"genre_scores_gemma":[0.029284777,0.9701965,0.00014819438,0.00018712811,0.0000742619,0.000024612737,0.0000089539135,0.00004778439,0.000027784854],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99511176,0.00058272807,0.003342117,0.00041077693,0.00030677931,0.0002458113],"domain_scores_gemma":[0.9955506,0.00074100844,0.0029993877,0.00036024733,0.00010443377,0.00024437954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007584358,0.00039177795,0.006523198,0.0006223279,0.000021550328,0.0000118615,0.00014916297,0.00015538184,0.0000014541401],"category_scores_gemma":[0.00020664999,0.00024737735,0.0005118987,0.0004840613,0.0005745789,0.00010016672,0.00010337542,0.0012371058,0.0000068622207],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016595164,0.00013022512,0.056219008,0.106862985,0.0020111792,0.0012077704,0.000016356315,4.3053088e-8,7.6235644e-8,0.000029076742,0.0000149630605,0.83349174],"study_design_scores_gemma":[0.0011480335,0.00021938221,0.077955395,0.8049208,0.013525231,0.099766225,0.00006228028,5.3085404e-7,1.07121e-7,0.000004330671,0.0021507116,0.0002469698],"about_ca_topic_score_codex":0.000010686869,"about_ca_topic_score_gemma":0.000006159893,"teacher_disagreement_score":0.83324474,"about_ca_system_score_codex":0.000075779746,"about_ca_system_score_gemma":0.00039110464,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W4398775198","doi":"10.1007/s40257-024-00864-1","title":"Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2024,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"National Center for Advancing Translational Sciences","keywords":"Alopecia areata; Medicine; TEC; Dermatology; Clinical trial; Pharmacotherapy; Family medicine; Internal medicine","score_opus":0.10880036531010523,"score_gpt":0.4783574250397168,"score_spread":0.36955705972961156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398775198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55005807,0.014261237,0.015320739,0.12390933,0.28034124,0.010493059,0.004196571,0.00015977024,0.0012600023],"genre_scores_gemma":[0.88010293,0.05345453,0.012160127,0.0085084345,0.031446442,0.00029649987,0.008792085,0.0003144973,0.0049244286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906816,0.0018025467,0.0058332444,0.000562715,0.00078487064,0.0003350521],"domain_scores_gemma":[0.9841763,0.010653653,0.002656868,0.0007903207,0.0012639695,0.00045891144],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002951874,0.00041644627,0.004490677,0.00039300177,0.00009486682,0.00003172002,0.0005372957,0.0010287896,0.00007933505],"category_scores_gemma":[0.0036585925,0.00019571338,0.0029790008,0.0014759783,0.0038494603,0.00004193648,0.00006814899,0.0024767683,0.000003379894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034426715,0.0028668894,0.0008408827,0.000026420117,0.008995799,0.00007264067,0.0002527972,0.000008652066,0.000003544317,0.000040554478,0.21254301,0.7399221],"study_design_scores_gemma":[0.012561109,0.028117836,0.022192517,0.00049070735,0.015268591,0.000068154775,0.0009447208,0.006918273,0.000007879735,0.00012964649,0.91312146,0.00017908507],"about_ca_topic_score_codex":0.0008963407,"about_ca_topic_score_gemma":0.001276197,"teacher_disagreement_score":0.739743,"about_ca_system_score_codex":0.00009268403,"about_ca_system_score_gemma":0.002133238,"threshold_uncertainty_score":0.9998246},"labels":[],"label_agreement":null},{"id":"W4401346421","doi":"10.1007/s40257-024-00881-0","title":"Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Chronic urticaria; Disease; Pharmacotherapy; Association (psychology); Internal medicine; Dermatology","score_opus":0.013461216021379003,"score_gpt":0.313283677923859,"score_spread":0.29982246190248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401346421","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35564965,0.012444679,0.0001968728,0.6290186,0.0016945079,0.00072410435,0.00012429294,0.000030174004,0.000117131945],"genre_scores_gemma":[0.95387155,0.0015785162,0.00007057164,0.041458957,0.0027629714,0.00001083966,0.000010853991,0.000053877495,0.0001818787],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99500966,0.0014134948,0.0022513922,0.00035817537,0.00061964185,0.00034762072],"domain_scores_gemma":[0.99490035,0.0025429504,0.001312364,0.00046653853,0.00044016988,0.00033764294],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00081940315,0.00027468574,0.0029630314,0.00030950058,0.000045593668,0.000018760313,0.00013422675,0.00057741883,0.00006763624],"category_scores_gemma":[0.0014844532,0.00020589432,0.0014861632,0.00023520873,0.0005480406,0.000039128372,0.00004770001,0.0038341454,0.00001966551],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004147599,0.00036064684,0.009448391,0.00011385612,0.11661593,0.77231157,0.00010679401,0.000022800508,0.000001599029,0.000011496461,0.09317744,0.0074147233],"study_design_scores_gemma":[0.0072804377,0.0061665773,0.010353544,0.00044959484,0.32856593,0.45495927,0.00028753778,0.0004732652,0.000001030453,0.0002629855,0.19083953,0.00036031244],"about_ca_topic_score_codex":0.000034892517,"about_ca_topic_score_gemma":0.0000048603633,"teacher_disagreement_score":0.5982219,"about_ca_system_score_codex":0.00013961198,"about_ca_system_score_gemma":0.00096875406,"threshold_uncertainty_score":0.99846405},"labels":[],"label_agreement":null},{"id":"W4402549751","doi":"10.1007/s40257-024-00889-6","title":"Update on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; Medical Research Council; National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; National Health and Medical Research Council; National Institutes of Health","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Pharmacotherapy; Erythroderma; Intensive care medicine; Psychiatry","score_opus":0.07949413642189881,"score_gpt":0.4421618073581992,"score_spread":0.36266767093630037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402549751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050825337,0.98652196,0.000015494752,0.005819741,0.0010137428,0.00056203274,0.000025522537,0.000037328842,0.00092161994],"genre_scores_gemma":[0.008839761,0.9885373,0.00071659236,0.0014590616,0.0002239159,0.00004191846,0.000010247413,0.00008242547,0.00008877814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949458,0.0008026049,0.0029032107,0.00057596975,0.0003512121,0.00042117466],"domain_scores_gemma":[0.99497765,0.001986337,0.0018642055,0.00043788957,0.00008222286,0.00065166247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000756166,0.00052107277,0.0058627836,0.00083432096,0.000060507624,0.00003717309,0.00020367095,0.00032383736,0.000013212646],"category_scores_gemma":[0.00043597617,0.00036502702,0.00110617,0.0005011639,0.000717628,0.00009277369,0.00018846078,0.001990387,0.00017567757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023804536,0.00023548248,0.0001696989,0.0045367396,0.0030536654,0.015810998,0.000009816315,2.0667272e-7,1.9848866e-8,0.00020966309,0.0012700753,0.9746798],"study_design_scores_gemma":[0.00064701313,0.0005094317,0.0014070619,0.012740596,0.012405539,0.09592835,0.00008807979,0.000004441181,1.5073121e-7,0.000052895695,0.8759644,0.00025204592],"about_ca_topic_score_codex":0.000005702125,"about_ca_topic_score_gemma":0.000001895797,"teacher_disagreement_score":0.97442776,"about_ca_system_score_codex":0.00008109464,"about_ca_system_score_gemma":0.00026416068,"threshold_uncertainty_score":0.9998802},"labels":[],"label_agreement":null},{"id":"W4403223396","doi":"10.1007/s40257-024-00885-w","title":"Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Merkel cell carcinoma; Oncology; Dermatology; Internal medicine; Carcinoma; Cancer; Immunotherapy","score_opus":0.13686947256272802,"score_gpt":0.45425315595615123,"score_spread":0.3173836833934232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403223396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627511,0.017470827,0.00094251096,0.015618842,0.0011024347,0.0016881484,0.00031913212,0.000016764023,0.00009027052],"genre_scores_gemma":[0.99491173,0.00295208,0.00082624255,0.0008557976,0.00023961152,0.000052404725,0.000024955194,0.000038023165,0.000099160425],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955562,0.0005420229,0.0028159746,0.00039298183,0.0003429864,0.00034987624],"domain_scores_gemma":[0.9873653,0.010065455,0.001407403,0.00055850507,0.00028892563,0.0003144293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059613516,0.00030518512,0.0018318116,0.00008851896,0.00014735131,0.000041191914,0.00054596266,0.00007309237,0.000040202664],"category_scores_gemma":[0.0011327825,0.00012861863,0.00047063443,0.00035198414,0.0007728377,0.00009293668,0.00009891091,0.0004457596,0.0000076090737],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16660428,0.04451689,0.00079057756,0.00007612717,0.0037935541,0.0031295514,0.001792519,0.000092691276,0.00008309835,0.000026821222,0.0051530674,0.7739408],"study_design_scores_gemma":[0.43769997,0.3663955,0.007829653,0.0012034113,0.026925212,0.003338991,0.010633677,0.014618048,0.0013795043,0.0005499804,0.12865816,0.00076787797],"about_ca_topic_score_codex":0.00028597214,"about_ca_topic_score_gemma":0.00009179332,"teacher_disagreement_score":0.773173,"about_ca_system_score_codex":0.00006424826,"about_ca_system_score_gemma":0.0009417385,"threshold_uncertainty_score":0.52449155},"labels":[],"label_agreement":null},{"id":"W4404399925","doi":"10.1007/s40257-024-00901-z","title":"Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Incyte","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Quality of life (healthcare); Pharmacotherapy; Dermatology; Pediatrics; Internal medicine","score_opus":0.04186626408346513,"score_gpt":0.4118241197351304,"score_spread":0.3699578556516653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404399925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98748034,0.0079700025,0.00016309017,0.0037962496,0.00022824293,0.0003039819,0.00002218897,0.00002176509,0.000014147082],"genre_scores_gemma":[0.99269265,0.0018124996,0.00056678604,0.0048412792,0.000050323248,0.000008280182,0.0000049589867,0.000020515983,0.0000026818213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99590766,0.00059325073,0.0026670685,0.0003434024,0.00021738312,0.00027123958],"domain_scores_gemma":[0.9966616,0.0013665475,0.0010315203,0.00023122961,0.0002585804,0.00045049147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031844358,0.000247688,0.0024467076,0.00023143878,0.000035941473,0.000014960217,0.000094092014,0.00009890892,0.000008894973],"category_scores_gemma":[0.0010522126,0.00017056294,0.00018187685,0.00020024004,0.0010264625,0.00013125094,0.000053270163,0.00043604433,0.0000012178868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007340044,0.00068258547,0.9563638,0.00030062837,0.0013700029,0.0008685233,0.0012617676,0.0000016600134,0.000012968808,0.000026290767,0.00012703112,0.031644717],"study_design_scores_gemma":[0.026178112,0.0016242482,0.9659669,0.0021292209,0.00034548127,0.00090426137,0.0017756652,0.00041023598,0.000102854436,0.00024693098,0.000114667695,0.0002014366],"about_ca_topic_score_codex":0.00020198688,"about_ca_topic_score_gemma":0.000075389944,"teacher_disagreement_score":0.031443283,"about_ca_system_score_codex":0.00001469706,"about_ca_system_score_gemma":0.00027241884,"threshold_uncertainty_score":0.6955355},"labels":[],"label_agreement":null},{"id":"W4404798340","doi":"10.1007/s40257-024-00906-8","title":"Real-World Experience of Spesolimab for Generalized Pustular Psoriasis Flares in Adult Patients: A Multicenter Retrospective Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Retrospective cohort study; Multicenter study; Psoriasis; Dermatology; Pharmacotherapy; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.03851048109186108,"score_gpt":0.40787636072416705,"score_spread":0.369365879632306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404798340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88492286,0.000046781282,0.000042065643,0.10999908,0.00296354,0.0013324426,0.000087169676,0.000024576082,0.0005814547],"genre_scores_gemma":[0.93498206,0.00045854267,0.0027187348,0.05945658,0.00193559,0.00009256611,0.000044999375,0.00011254674,0.00019835673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993281,0.00081838947,0.004018469,0.000627821,0.0007120872,0.00054225593],"domain_scores_gemma":[0.9933362,0.0014344007,0.002992814,0.00057694904,0.0014463665,0.00021329202],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004884253,0.00044212674,0.003823832,0.0010282529,0.00003494541,0.000016977086,0.0003946207,0.00040100593,0.000018291039],"category_scores_gemma":[0.0032967192,0.0003530044,0.0011047113,0.0007059289,0.0007346471,0.00013417049,0.000110294386,0.003197149,0.000013703447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021862637,0.0055991984,0.8400097,0.00057667604,0.0039891773,0.008682287,0.004425925,0.000005465909,0.000037150006,0.000065187836,0.116523206,0.017899746],"study_design_scores_gemma":[0.04067942,0.0065047373,0.6629462,0.0025320568,0.0065182555,0.0014578328,0.012491752,0.00030750403,0.00019080486,0.00027141618,0.26492652,0.0011734646],"about_ca_topic_score_codex":0.00047943898,"about_ca_topic_score_gemma":0.00018046571,"teacher_disagreement_score":0.17706348,"about_ca_system_score_codex":0.00030013346,"about_ca_system_score_gemma":0.00045734397,"threshold_uncertainty_score":0.9998922},"labels":[],"label_agreement":null},{"id":"W4406087364","doi":"10.1007/s40257-024-00909-5","title":"A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Incyte","keywords":"Medicine; Ruxolitinib; Adverse effect; Atopic dermatitis; Tolerability; Janus kinase inhibitor; Eczema Area and Severity Index; Internal medicine; Clinical endpoint; Quality of life (healthcare); Pharmacokinetics; Body surface area; Clinical trial; Tofacitinib; Dermatology; Bone marrow","score_opus":0.01936643116546527,"score_gpt":0.3473711334280457,"score_spread":0.32800470226258044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406087364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329334,0.00011312736,0.00030654127,0.0052493685,0.00021437401,0.00042650604,0.000012164609,0.00001438398,0.00037016327],"genre_scores_gemma":[0.9910231,0.00013941337,0.0021151146,0.0065633063,0.00006478401,0.00001092905,0.0000071171994,0.000015616088,0.00006060335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965345,0.0007143317,0.0019421345,0.00023930472,0.00023787415,0.00033184633],"domain_scores_gemma":[0.99712473,0.0012295516,0.0007892913,0.00033961795,0.00020624812,0.00031054727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035037767,0.00018708587,0.0018889322,0.00043121574,0.0000295065,0.000012639086,0.00024325987,0.00016081681,0.000042422434],"category_scores_gemma":[0.0014348573,0.00015122192,0.00030871364,0.000500934,0.0006836926,0.0001243715,0.00006125125,0.00055847206,0.00000859482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02459452,0.0013340256,0.9570202,0.0000364458,0.00042833542,0.0013340814,0.00011259185,0.00003004803,0.0000015280208,0.00020178905,0.005364492,0.009541907],"study_design_scores_gemma":[0.0436401,0.0015978159,0.9468485,0.00032695552,0.00027016152,0.0053194202,0.0001465718,0.00001833495,0.00005544859,0.00052934117,0.0011168714,0.00013044103],"about_ca_topic_score_codex":0.00008876336,"about_ca_topic_score_gemma":0.000049560495,"teacher_disagreement_score":0.01904558,"about_ca_system_score_codex":0.000021101778,"about_ca_system_score_gemma":0.00067583856,"threshold_uncertainty_score":0.61666507},"labels":[],"label_agreement":null},{"id":"W4407095389","doi":"10.1007/s40257-025-00922-2","title":"Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study","year":2025,"lang":"en","type":"letter","venue":"American Journal of Clinical Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; Dermatrials Research; Probity Medical Research; SKiN Health; University of Calgary; Nova Chemicals (Canada); University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Plaque psoriasis; Retrospective cohort study; Multicenter study; Pharmacotherapy; Interleukin; Dermatology; Internal medicine; Cytokine; Randomized controlled trial","score_opus":0.014459903883459971,"score_gpt":0.3520595910678784,"score_spread":0.3375996871844184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407095389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92627233,0.000030719602,0.00007418553,0.070241675,0.00094660063,0.0022750816,0.00007404751,0.000020183214,0.00006515995],"genre_scores_gemma":[0.93028945,0.00004693191,0.0023957628,0.06622943,0.00062948803,0.00016502973,0.000036709473,0.00007728091,0.00012992232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927275,0.000835422,0.0043431153,0.00071990816,0.0007864421,0.0005876106],"domain_scores_gemma":[0.99103796,0.0021377942,0.0038208843,0.00076953083,0.0019884564,0.00024538828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037613302,0.0005438334,0.004296107,0.001113241,0.00004398812,0.000017139828,0.00063902914,0.00036636184,0.00002727118],"category_scores_gemma":[0.004420642,0.00040994905,0.0006730926,0.00081165624,0.00079413905,0.00010709953,0.00019424917,0.002222498,0.0000044239464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014493765,0.0027942269,0.8884425,0.0002261085,0.0009412968,0.0016091143,0.002367907,0.000002000321,0.000001365668,0.0000024780652,0.08329964,0.0058196075],"study_design_scores_gemma":[0.022655768,0.021249011,0.93427247,0.003761784,0.0011014144,0.00015041344,0.0033781992,0.000008549966,0.00007275412,0.000014665479,0.012844211,0.0004907873],"about_ca_topic_score_codex":0.00033111687,"about_ca_topic_score_gemma":0.00021984434,"teacher_disagreement_score":0.070455424,"about_ca_system_score_codex":0.00031008627,"about_ca_system_score_gemma":0.0009892213,"threshold_uncertainty_score":0.99983525},"labels":[],"label_agreement":null},{"id":"W4408445833","doi":"10.1007/s40257-025-00931-1","title":"Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"LEO Pharma","keywords":"Medicine; Atopic dermatitis; Dupilumab; Pharmacotherapy; Dermatology; Pediatrics; Disease; Head and neck; Disease control; Internal medicine; Surgery","score_opus":0.011971134804463901,"score_gpt":0.33388276177344606,"score_spread":0.3219116269689822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408445833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950067,0.00038734233,0.00006502241,0.0041149966,0.00008501104,0.00028115645,0.00002930734,0.0000072802145,0.000023180728],"genre_scores_gemma":[0.9974439,0.00013767449,0.000079640035,0.0022868628,0.000015868654,0.0000070548394,0.0000045747174,0.0000097710445,0.000014638912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812305,0.00038406707,0.0008805818,0.00022333366,0.00015890576,0.00023008644],"domain_scores_gemma":[0.99797547,0.0006105713,0.00042341792,0.00018994635,0.00013682153,0.00066379516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010249854,0.00016139669,0.0012264893,0.00025044818,0.000025536467,0.000007968039,0.00009437322,0.00006714773,0.000010002417],"category_scores_gemma":[0.00058673363,0.00012828408,0.00013129023,0.00022232658,0.0008380963,0.00010028272,0.000035769564,0.00026750547,0.0000012273885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011911715,0.0006557936,0.96212775,0.00014186034,0.00021157549,0.0016237878,0.000053955064,9.730063e-7,0.000001366894,0.000018297258,0.00033110174,0.022921843],"study_design_scores_gemma":[0.012387651,0.00090150384,0.9853356,0.0004406441,0.00044453325,0.00020695016,0.000023501221,0.00003472006,0.0000091546,0.00003533092,0.000079676814,0.00010074587],"about_ca_topic_score_codex":0.000015475429,"about_ca_topic_score_gemma":0.000017008622,"teacher_disagreement_score":0.023207858,"about_ca_system_score_codex":0.000015273628,"about_ca_system_score_gemma":0.0003107985,"threshold_uncertainty_score":0.52312726},"labels":[],"label_agreement":null},{"id":"W4409448141","doi":"10.1007/s40257-025-00944-w","title":"Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Pharmacotherapy; Dermatology; MEDLINE; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.02826216597991016,"score_gpt":0.35803172884862633,"score_spread":0.32976956286871617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409448141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98493844,0.00028930354,0.00020228807,0.011561361,0.001900176,0.00018750541,0.000058917016,0.000008690052,0.0008533173],"genre_scores_gemma":[0.99837756,0.00014846682,0.00038737978,0.0007155516,0.00012072314,0.000009200668,0.000016371581,0.000007975019,0.00021677183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968991,0.0010674346,0.0014948763,0.00024482037,0.00008784243,0.00020592457],"domain_scores_gemma":[0.99463147,0.0036754808,0.0010114807,0.0003520585,0.000284356,0.000045183846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006580398,0.0001604736,0.0009772669,0.00013271694,0.000070015754,0.000009028644,0.0006645782,0.000101809965,0.0000518934],"category_scores_gemma":[0.0010006978,0.00009316437,0.0002178864,0.0003358224,0.0004165699,0.000047753016,0.00010588012,0.0003207121,0.000051739935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018453928,0.0012188801,0.7512834,0.0000029044136,0.007273185,0.0001295866,0.0051691425,0.000074632975,0.00040370677,0.00030922197,0.015361209,0.2003202],"study_design_scores_gemma":[0.012988328,0.003159896,0.89627296,0.000104736,0.0010190951,0.00022687811,0.02656264,0.000003613972,0.00089681667,0.00012329494,0.058453295,0.0001884619],"about_ca_topic_score_codex":0.00045784368,"about_ca_topic_score_gemma":0.00020635728,"teacher_disagreement_score":0.20013173,"about_ca_system_score_codex":0.000015147435,"about_ca_system_score_gemma":0.00026415545,"threshold_uncertainty_score":0.37991327},"labels":[],"label_agreement":null},{"id":"W4411964459","doi":"10.1007/s40257-025-00959-3","title":"Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Psoriasis; Disease; Pharmacotherapy; Systematic review; Duration (music); MEDLINE; Clinical trial; Internal medicine; Dermatology","score_opus":0.10144247819161838,"score_gpt":0.45203061981818654,"score_spread":0.35058814162656815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411964459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003716684,0.9927359,0.000065723536,0.00048546604,0.0026821594,0.0034388308,0.00016148624,0.000019110372,0.000039635375],"genre_scores_gemma":[0.0005115111,0.9973562,0.00008986187,0.0010707597,0.00009408536,0.00034251664,0.00034759493,0.00003246148,0.00015502602],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.96895576,0.01835489,0.011591775,0.00051854434,0.00013057221,0.00044843717],"domain_scores_gemma":[0.978762,0.010695564,0.009251308,0.00068384747,0.00038589962,0.00022143914],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0046663308,0.0006297768,0.018176565,0.0009216352,0.00006894332,0.000016366203,0.0007649245,0.00048782444,0.000114932045],"category_scores_gemma":[0.028420774,0.0004188727,0.002808147,0.0011766352,0.0002327992,0.0000943751,0.00011202959,0.0008302448,0.00023596025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013945886,0.0011492039,0.00013326082,0.17151006,0.002564744,0.00016270288,0.000024382358,6.6319e-8,5.2045493e-8,0.000022851498,0.0039344025,0.81910366],"study_design_scores_gemma":[0.011057898,0.001457405,0.000114351606,0.6097221,0.032418385,0.0002921016,0.000030918924,1.7583888e-7,7.3731616e-7,0.000017428809,0.3443527,0.00053578726],"about_ca_topic_score_codex":0.000008020944,"about_ca_topic_score_gemma":0.0000042645506,"teacher_disagreement_score":0.8185679,"about_ca_system_score_codex":0.00011519728,"about_ca_system_score_gemma":0.0013515303,"threshold_uncertainty_score":0.9998263},"labels":[],"label_agreement":null},{"id":"W4412727529","doi":"10.1007/s40257-025-00964-6","title":"Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; University of Toronto","funders":"AbbVie","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Discontinuation; Adverse effect; Internal medicine; Dermatology Life Quality Index; Randomized controlled trial; Severity of illness; Dermatology","score_opus":0.07167977802277621,"score_gpt":0.40167062400092113,"score_spread":0.32999084597814493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412727529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99121964,0.0010362419,0.0010819952,0.003736325,0.0017069855,0.000672035,0.00012092101,0.000015918204,0.0004099254],"genre_scores_gemma":[0.99654555,0.0009457966,0.0009194133,0.00092495506,0.00010810798,0.000013453077,0.0000447264,0.000019928724,0.0004780487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994607,0.0015926429,0.0027283803,0.00054912356,0.00008608732,0.00043678135],"domain_scores_gemma":[0.9944307,0.0033437242,0.0012480951,0.00049387466,0.00029548162,0.00018810689],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009554332,0.00034108604,0.002340765,0.00036570197,0.0001734477,0.0000283543,0.000661622,0.00035640819,0.00004363986],"category_scores_gemma":[0.0015420992,0.00026722552,0.00025596115,0.0004354996,0.0005245924,0.00012629456,0.0003030591,0.0004883174,0.000048760743],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5703167,0.003106238,0.001756772,0.000017855498,0.0008047708,0.0002587838,0.00021042473,0.000024603325,0.0009126122,0.00016731229,0.0035246906,0.41889927],"study_design_scores_gemma":[0.87173617,0.030809745,0.06404888,0.0008330743,0.0023196386,0.0032348717,0.0003992503,0.000022082153,0.01266008,0.0001928912,0.012914403,0.00082891405],"about_ca_topic_score_codex":0.000054454442,"about_ca_topic_score_gemma":0.000027528664,"teacher_disagreement_score":0.41807035,"about_ca_system_score_codex":0.000040487856,"about_ca_system_score_gemma":0.00050348986,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W4413569229","doi":"10.1007/s40257-025-00979-z","title":"Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Quality of life (healthcare); Psychosocial; Botulinum toxin; Apremilast; Dermatology; Psoriasis; Bioinformatics; Psoriatic arthritis; Psychiatry; Pathology; Surgery","score_opus":0.07866549000410561,"score_gpt":0.5097149119420339,"score_spread":0.4310494219379283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413569229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093606184,0.99364364,0.00016866029,0.0026970066,0.0007367106,0.0003716565,0.000011239834,0.000037313668,0.0013977266],"genre_scores_gemma":[0.016636446,0.98076785,0.00047404013,0.0013667186,0.00060098234,0.000011645008,0.000011502476,0.000045041852,0.00008577878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99079716,0.0028924553,0.0049198936,0.0006008749,0.00027993214,0.00050970755],"domain_scores_gemma":[0.9860574,0.009113529,0.003352878,0.0005429565,0.00038507616,0.00054813706],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011818418,0.00056639523,0.009083271,0.00048164892,0.00010071881,0.000042388598,0.00047577135,0.0006826819,0.0001135565],"category_scores_gemma":[0.0028294171,0.00039410105,0.0024127115,0.0004486813,0.003422723,0.00014973774,0.00017076463,0.0025573962,0.000025204103],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029692333,0.0004951164,0.0050781164,0.0043540187,0.0031613694,0.001642602,0.00009389452,1.1745027e-7,9.3641e-9,0.000808584,0.005058924,0.97901034],"study_design_scores_gemma":[0.001611502,0.0008830864,0.0033716862,0.0068315426,0.007081599,0.016095651,0.0024377173,0.000007366851,5.7257612e-8,0.00062268664,0.96071166,0.00034543235],"about_ca_topic_score_codex":0.000004573415,"about_ca_topic_score_gemma":0.0000028302197,"teacher_disagreement_score":0.9786649,"about_ca_system_score_codex":0.00004188804,"about_ca_system_score_gemma":0.004733845,"threshold_uncertainty_score":0.9998511},"labels":[],"label_agreement":null},{"id":"W4413938704","doi":"10.1007/s40257-025-00975-3","title":"Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; Probity Medical Research; SKiN Health; University of Calgary","funders":"AbbVie","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Pharmacotherapy; Dermatology; Clinical trial; Internal medicine","score_opus":0.027768150268074828,"score_gpt":0.4017457693328107,"score_spread":0.37397761906473587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413938704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641634,0.00028711074,0.0014660166,0.008886019,0.00054867234,0.0011907982,0.000028288656,0.000014647923,0.0011620932],"genre_scores_gemma":[0.9911082,0.00053034036,0.0027548491,0.005437543,0.000088229484,0.000013318671,0.000022088574,0.000016151242,0.000029272525],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99010414,0.0031725415,0.0056460686,0.0003960224,0.00032474336,0.00035647518],"domain_scores_gemma":[0.9855663,0.011207867,0.0019922664,0.00039729258,0.00047117105,0.00036505694],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0019645733,0.0002751206,0.0044821156,0.00028020423,0.000057843743,0.000011868246,0.00024186043,0.00027071088,0.000026269885],"category_scores_gemma":[0.012701957,0.0001924986,0.0004830589,0.00043751622,0.0021635739,0.00014914277,0.00008882943,0.00089573115,0.0000057498364],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8079889,0.0029837284,0.161974,0.000056516383,0.00074500864,0.00035611622,0.00013398108,0.000010128322,1.03328006e-7,0.00023404317,0.0027422893,0.02277521],"study_design_scores_gemma":[0.75966996,0.0029322775,0.2329643,0.0005263958,0.0005886747,0.00031573977,0.00010326969,0.00008525136,0.000010020755,0.00041260367,0.0022444918,0.00014700071],"about_ca_topic_score_codex":0.000014552696,"about_ca_topic_score_gemma":0.000005793331,"teacher_disagreement_score":0.07099032,"about_ca_system_score_codex":0.00001921163,"about_ca_system_score_gemma":0.0007040698,"threshold_uncertainty_score":0.99561447},"labels":[],"label_agreement":null},{"id":"W4414167313","doi":"10.1007/s40257-025-00976-2","title":"Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2025,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Alopecia areata; Clinical trial; Pharmacotherapy; Safety profile; MEDLINE","score_opus":0.0974651543288489,"score_gpt":0.47585318935152604,"score_spread":0.37838803502267715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414167313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52377003,0.010440018,0.036787517,0.14460778,0.26293927,0.014225158,0.0048716986,0.00015243374,0.0022060948],"genre_scores_gemma":[0.8437177,0.070276335,0.021112302,0.01569863,0.027630653,0.00040148088,0.012866393,0.0002632676,0.0080332635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903424,0.0021600612,0.0059237424,0.00052720436,0.0007169842,0.00032964605],"domain_scores_gemma":[0.980313,0.0136172185,0.0032258125,0.0008507329,0.0015869312,0.0004062872],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0028324896,0.0004020284,0.0047498858,0.0004042928,0.0001166561,0.000022984572,0.00059339515,0.0010505934,0.000067902154],"category_scores_gemma":[0.005328989,0.00019569135,0.0027725142,0.0015160806,0.0036921701,0.000040591804,0.00006776018,0.0021049357,0.0000011214797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043937337,0.0034776833,0.0017092736,0.000020972499,0.007973044,0.000035820358,0.00016546657,0.000010445304,0.0000025608372,0.000038482245,0.17863436,0.7639946],"study_design_scores_gemma":[0.018039873,0.024534855,0.044691455,0.0004638325,0.012998047,0.00003239652,0.00084372563,0.0050886194,0.000009142808,0.00008549125,0.8930433,0.00016930589],"about_ca_topic_score_codex":0.0010839277,"about_ca_topic_score_gemma":0.0013753064,"teacher_disagreement_score":0.76382524,"about_ca_system_score_codex":0.00009119479,"about_ca_system_score_gemma":0.0026410883,"threshold_uncertainty_score":0.9990192},"labels":[],"label_agreement":null},{"id":"W4414358590","doi":"10.1007/s40257-025-00962-8","title":"Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Atopic dermatitis; Pharmacotherapy; MEDLINE; Young adult; Clinical trial; Systemic therapy","score_opus":0.02782264573178088,"score_gpt":0.36507156720074485,"score_spread":0.33724892146896396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414358590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333036,0.0002852846,0.000025237945,0.00481412,0.00056223106,0.00043935984,0.00003631023,0.000008858648,0.0004982113],"genre_scores_gemma":[0.9956341,0.00070738635,0.00022646265,0.0030872494,0.000051850824,0.00002708417,0.000017639559,0.000013559205,0.00023468686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963171,0.0007150706,0.002152017,0.00027271465,0.00023488214,0.00030823032],"domain_scores_gemma":[0.99617696,0.002270612,0.0007497755,0.00043375284,0.0001183869,0.00025050066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018510458,0.00021623644,0.0018567197,0.0004368904,0.000029718238,0.000009812513,0.00029871764,0.000121332996,0.000019581259],"category_scores_gemma":[0.0010216628,0.00015226103,0.00031313853,0.0005836769,0.00021943427,0.000059238064,0.000069937356,0.00033089495,0.000017737693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080811704,0.00068521564,0.98007625,0.00004022624,0.00025237197,0.0013044459,0.0004829683,0.000030394847,3.333241e-7,0.0000316328,0.0038005596,0.012487488],"study_design_scores_gemma":[0.0060268166,0.00035844286,0.9916708,0.00025464225,0.00035608912,0.00012078366,0.000384235,0.000012565289,0.0000073669444,0.00016799849,0.0005371261,0.00010314625],"about_ca_topic_score_codex":0.00078733166,"about_ca_topic_score_gemma":0.0009782268,"teacher_disagreement_score":0.012384342,"about_ca_system_score_codex":0.00014307795,"about_ca_system_score_gemma":0.00047179378,"threshold_uncertainty_score":0.6209024},"labels":[],"label_agreement":null},{"id":"W4414459865","doi":"10.1007/s40257-025-00952-w","title":"The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Atopic dermatitis; Clinical trial; Pharmacotherapy; Safety profile; Rescue therapy","score_opus":0.02295494221768726,"score_gpt":0.36751946206121494,"score_spread":0.3445645198435277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414459865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97607255,0.0058334386,0.0005883765,0.016597811,0.0002523411,0.0005238247,0.00007104614,0.0000035882242,0.000057016263],"genre_scores_gemma":[0.9871932,0.010669965,0.00041674415,0.0016423778,0.000038608836,0.000007956709,0.000011024857,0.000006977861,0.000013127061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974898,0.00034174733,0.0016548396,0.00018396438,0.00012538242,0.00020426905],"domain_scores_gemma":[0.99551266,0.0029327471,0.000710399,0.00054314046,0.00018618265,0.000114841045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003380113,0.00013318396,0.0011270681,0.00010400918,0.000079362326,0.0000057226966,0.00037771364,0.000083033425,0.000004049535],"category_scores_gemma":[0.0011858499,0.00007276045,0.0001770708,0.0001999894,0.0009104385,0.00005478331,0.00008547032,0.000194622,6.841621e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004167594,0.00051599287,0.7947614,0.00007110571,0.00045764467,0.00003529079,0.00013739856,0.00000934063,5.921855e-7,0.00018123776,0.0029373753,0.19672504],"study_design_scores_gemma":[0.0067203385,0.0006365537,0.9826332,0.0004321085,0.00033655396,0.0009437969,0.00036478354,0.0006751803,0.000047003647,0.00022318163,0.0069269165,0.000060423918],"about_ca_topic_score_codex":0.000062874366,"about_ca_topic_score_gemma":0.00010671725,"teacher_disagreement_score":0.19666462,"about_ca_system_score_codex":0.000013748318,"about_ca_system_score_gemma":0.00032974896,"threshold_uncertainty_score":0.33545485},"labels":[],"label_agreement":null},{"id":"W4414537613","doi":"10.1007/s40257-025-00974-4","title":"Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"LEO Pharma","keywords":"Hand eczema; Quality of life (healthcare); Clinical trial; Safety profile; Pharmacotherapy; Chronic disease","score_opus":0.1267621694134489,"score_gpt":0.4697093432548251,"score_spread":0.3429471738413762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414537613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14845613,0.8432645,0.00012419427,0.0016341739,0.0001944295,0.0054264027,0.000697259,0.000007889035,0.00019499284],"genre_scores_gemma":[0.090259925,0.90830684,0.00078188913,0.00015841481,0.000213401,0.000058272235,0.00014902104,0.000038500417,0.00003371855],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98343277,0.004959572,0.009783859,0.0006498544,0.0006396396,0.00053432886],"domain_scores_gemma":[0.9411442,0.05078475,0.0058117867,0.0005599683,0.0010916378,0.00060760975],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0059974124,0.0005650333,0.016356371,0.0010173396,0.00007942386,0.000040763032,0.0003693155,0.00042883327,0.000026254325],"category_scores_gemma":[0.015577715,0.00035919994,0.00090776413,0.00069976575,0.001482922,0.00012113818,0.00020784553,0.0016219621,0.000001073777],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54533845,0.00089457433,0.000068219815,0.0036041662,0.0018306262,0.00066318095,0.00027116542,0.0000094665,8.5951166e-7,0.000011164535,0.00033226184,0.44697586],"study_design_scores_gemma":[0.8534532,0.0065316116,0.00016616374,0.09269599,0.0032549393,0.0012192567,0.00052541686,0.0001896676,0.0000128701095,0.000017896065,0.041585155,0.00034782614],"about_ca_topic_score_codex":0.0004734536,"about_ca_topic_score_gemma":0.0004754792,"teacher_disagreement_score":0.44662803,"about_ca_system_score_codex":0.000068297,"about_ca_system_score_gemma":0.0026959095,"threshold_uncertainty_score":0.999886},"labels":[],"label_agreement":null},{"id":"W4415285914","doi":"10.1007/s40257-025-00988-y","title":"Understanding Enthesitis in Psoriatic Disease: Insights and Implications","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Enthesitis; Psoriatic arthritis; Psoriasis; Referral; Psychological intervention; Multidisciplinary approach; Rheumatology","score_opus":0.1503657843594049,"score_gpt":0.4546404194953279,"score_spread":0.304274635135923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415285914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046010452,0.9965371,0.000089399335,0.0018694425,0.00029659644,0.00029853836,0.000013550123,0.0000060800785,0.00042921692],"genre_scores_gemma":[0.013835463,0.9854797,0.00021106559,0.00030412173,0.00010127213,0.000018547407,0.000010544602,0.00001579464,0.000023459615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970879,0.00044214007,0.0019039115,0.0002396616,0.00012216663,0.00020425083],"domain_scores_gemma":[0.99548125,0.0028071958,0.0011463003,0.00021783724,0.00006474351,0.0002826719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016216653,0.00022644157,0.0037738883,0.00038585457,0.000052890235,0.000009667011,0.0001072349,0.00012114067,0.000010605658],"category_scores_gemma":[0.0009275325,0.00016231985,0.0005518058,0.00039443473,0.00045801603,0.000035320554,0.00006431966,0.00052708085,0.000004679595],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007568567,0.00022098185,0.010042304,0.0018805085,0.00063760206,0.0013738008,0.000024035893,2.5975103e-8,1.9526638e-9,0.001673414,0.0003534618,0.98371816],"study_design_scores_gemma":[0.002752125,0.0006725568,0.017875152,0.026587283,0.0045469794,0.00428499,0.0001889562,0.0000017631959,1.2785419e-8,0.0016257274,0.94124055,0.00022393174],"about_ca_topic_score_codex":0.0000055420724,"about_ca_topic_score_gemma":0.00001233877,"teacher_disagreement_score":0.9834942,"about_ca_system_score_codex":0.000116350995,"about_ca_system_score_gemma":0.0007097083,"threshold_uncertainty_score":0.6619211},"labels":[],"label_agreement":null},{"id":"W4415376342","doi":"10.1007/s40257-025-00985-1","title":"Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"LEO Pharma","keywords":"Post-hoc analysis; Post hoc; Clinical trial; Phase (matter); Pharmacotherapy; MEDLINE","score_opus":0.022060589844944738,"score_gpt":0.4044911377009969,"score_spread":0.3824305478560521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415376342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993691,0.00090504385,0.0010013456,0.0036941615,0.00012267932,0.00036963928,0.00007483242,0.000007858947,0.00013339624],"genre_scores_gemma":[0.9966651,0.0005969493,0.00066112005,0.0019982778,0.000031208725,0.0000059511067,0.000022612396,0.000010645123,0.00000812764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939218,0.0012229714,0.003986877,0.00028473986,0.0002573479,0.00032622882],"domain_scores_gemma":[0.9932613,0.003719324,0.0019444051,0.00030475005,0.00046864216,0.0003016191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010965504,0.00022622797,0.004787942,0.0006736375,0.00005042257,0.000008068272,0.00021933537,0.00019024196,0.000046304784],"category_scores_gemma":[0.0024708826,0.0001673683,0.00055525085,0.0011923973,0.0011942828,0.00011150243,0.000057829264,0.0004651735,9.976883e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20599748,0.0032363231,0.64455324,0.00035200786,0.007754484,0.0017374934,0.0027819662,0.00019375284,0.000034883647,0.0003023047,0.00056675373,0.13248931],"study_design_scores_gemma":[0.065118834,0.0025457954,0.9237035,0.0008237545,0.0035810214,0.0012641733,0.0016900417,0.00044318713,0.00022405604,0.000079759724,0.00034253753,0.0001833413],"about_ca_topic_score_codex":0.000049774048,"about_ca_topic_score_gemma":0.00017344276,"teacher_disagreement_score":0.27915025,"about_ca_system_score_codex":0.000019749396,"about_ca_system_score_gemma":0.0005072904,"threshold_uncertainty_score":0.6825081},"labels":[],"label_agreement":null},{"id":"W4415503732","doi":"10.1007/s40257-025-00983-3","title":"The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"Sanofi","keywords":"Psychosocial; Acne; Quality of life (healthcare); Pharmacotherapy; MEDLINE; Systematic review","score_opus":0.02698976605609848,"score_gpt":0.4267974220270276,"score_spread":0.3998076559709291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415503732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8512063,0.037933744,0.00009636911,0.108601965,0.0003714728,0.00070090493,0.0000019245613,0.000006742085,0.0010806067],"genre_scores_gemma":[0.9595231,0.03530039,0.00011785594,0.004936385,0.00004929616,0.0000043496552,9.373407e-7,0.0000064598867,0.00006126636],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99439543,0.0017085292,0.003382942,0.00012276556,0.00022089429,0.00016941018],"domain_scores_gemma":[0.9922757,0.0039442265,0.0031885158,0.00024531942,0.00017843598,0.00016781449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023449508,0.00012155626,0.0030158414,0.000069023816,0.000086045555,0.0000036331448,0.00012564195,0.00008387606,0.0000062615177],"category_scores_gemma":[0.0034627675,0.000062708736,0.00038316436,0.00023821888,0.0006173565,0.000021061294,0.000028814218,0.00037212393,0.0000022774313],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018390452,0.0050031627,0.16908199,0.52425015,0.02788783,0.000665673,0.005563545,0.000013075573,0.00010357793,0.033291638,0.07004547,0.14570342],"study_design_scores_gemma":[0.055877056,0.04085452,0.16507736,0.6772069,0.013242989,0.0047524935,0.014473847,0.00039530155,0.00015575292,0.011801223,0.015084244,0.0010783665],"about_ca_topic_score_codex":0.00011501592,"about_ca_topic_score_gemma":0.0000029734542,"teacher_disagreement_score":0.15295668,"about_ca_system_score_codex":0.000016014332,"about_ca_system_score_gemma":0.00031193145,"threshold_uncertainty_score":0.41455063},"labels":[],"label_agreement":null},{"id":"W4415761490","doi":"10.1007/s40257-025-00989-x","title":"Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials","year":2025,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Pharmacotherapy; Hand eczema; Delta; Phase (matter)","score_opus":0.06400379933982515,"score_gpt":0.42056833524607884,"score_spread":0.3565645359062537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415761490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97172374,0.007145703,0.00053632684,0.0081088245,0.004800168,0.0053166687,0.0007707674,0.000014681185,0.0015831406],"genre_scores_gemma":[0.96653754,0.02890779,0.00096603367,0.00071674195,0.00090014376,0.00005962148,0.0003461022,0.00005547821,0.0015105312],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98783135,0.0031168403,0.007079339,0.00067805283,0.00075485866,0.00053956016],"domain_scores_gemma":[0.96444553,0.028439548,0.0041889665,0.000513851,0.0017244872,0.0006876106],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004853495,0.00049158273,0.008415615,0.0011113171,0.00010028841,0.000049336606,0.00030616976,0.00045987804,0.000030599625],"category_scores_gemma":[0.023314694,0.0003511531,0.0004901838,0.0006715212,0.001076559,0.00012877466,0.00018823775,0.0022813932,0.0000010816848],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8506708,0.0012477643,0.0004745,0.00036242217,0.0016024,0.0006446552,0.00093456334,0.00011762772,0.00002421691,0.0000052414593,0.08221581,0.06169999],"study_design_scores_gemma":[0.9353142,0.013769915,0.004068779,0.021947159,0.0012856165,0.0008463464,0.0017181695,0.0029503147,0.0001754901,0.000022205984,0.017497515,0.00040433794],"about_ca_topic_score_codex":0.0018210727,"about_ca_topic_score_gemma":0.0030086935,"teacher_disagreement_score":0.08464334,"about_ca_system_score_codex":0.00009401874,"about_ca_system_score_gemma":0.0023746786,"threshold_uncertainty_score":0.999894},"labels":[],"label_agreement":null},{"id":"W48128272","doi":"10.2165/00128071-200607040-00006","title":"The Role of Antimalarials in the Exacerbation of Psoriasis","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Psoriasis; Exacerbation; Pharmacotherapy; Dermatology; Intensive care medicine; Immunology; Internal medicine","score_opus":0.04442707188023524,"score_gpt":0.37156793728451737,"score_spread":0.3271408654042821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48128272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00979927,0.98812807,0.000011607898,0.00021942823,0.0010418,0.00027317807,0.000036302445,0.0000031378613,0.0004872316],"genre_scores_gemma":[0.053929854,0.94573545,0.0000896295,0.00003151687,0.00012682896,0.000012293166,0.000030236606,0.000017383793,0.000026820997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98923105,0.006058827,0.004137261,0.00019123532,0.00009742046,0.00028417754],"domain_scores_gemma":[0.98223627,0.010666292,0.006479391,0.00042623805,0.00017143728,0.0000203504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002515484,0.00027822226,0.0039353515,0.0002142698,0.00006893559,0.000006508067,0.0008849315,0.0004713547,0.000023913524],"category_scores_gemma":[0.000925957,0.00013604295,0.0013067409,0.00039805804,0.0012732961,0.00004289527,0.000056110443,0.0006738153,0.000020835594],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016349541,0.00027741122,0.0026882386,0.0001550814,0.0009093349,0.000021292522,0.00006166756,4.912493e-7,0.0000074519335,0.0007352249,0.00052885525,0.99445146],"study_design_scores_gemma":[0.0009672733,0.0006171769,0.0021352526,0.0007257889,0.001896489,0.0012201364,0.0003428731,2.1226153e-7,0.00007866329,0.00026528706,0.9916228,0.0001280175],"about_ca_topic_score_codex":0.00008950165,"about_ca_topic_score_gemma":0.000024893272,"teacher_disagreement_score":0.99432343,"about_ca_system_score_codex":0.000015311809,"about_ca_system_score_gemma":0.00048909674,"threshold_uncertainty_score":0.5547671},"labels":[],"label_agreement":null},{"id":"W83713607","doi":"10.2165/11587890-000000000-00000","title":"The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis","year":2011,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Western University","funders":"Allergan; Genentech; LEO Pharma; Medac; Mitsubishi Tanabe Pharma Corporation; Cilag; Astellas Pharma; Novo Nordisk; Incyte; University of Connecticut; Abbott Laboratories; Zalicus; Biogen; Celgene; Amgen; Pfizer; Galderma; Eli Lilly and Company; GlaxoSmithKline; Eisai","keywords":"Adalimumab; Medicine; Adverse effect; Psoriasis; Placebo; Population; Clinical trial; Internal medicine; Dosing; Incidence (geometry); Dermatology; Pathology; Disease","score_opus":0.07252126911291348,"score_gpt":0.3763919246789039,"score_spread":0.30387065556599047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W83713607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014674985,0.9819727,0.000038245027,0.00023736198,0.0021411069,0.00057894556,0.00008823605,0.000010657847,0.00025778526],"genre_scores_gemma":[0.013737376,0.98548573,0.00014673443,0.00008372801,0.00011353831,0.000043988737,0.000036955702,0.000046401547,0.00030556988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99071527,0.0037898044,0.004416958,0.00042198127,0.00007148864,0.00058450195],"domain_scores_gemma":[0.9908939,0.0044602435,0.0036741442,0.0006515959,0.0001889813,0.00013113924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009068361,0.0005862849,0.0061750384,0.00034931322,0.00011895713,0.000010318662,0.0008674484,0.0006195624,0.00010939341],"category_scores_gemma":[0.00037925987,0.0003300969,0.0017913596,0.00041989106,0.0008151295,0.00005765078,0.00012718102,0.0007079658,0.00019000642],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020239097,0.0005075529,0.0033851818,0.00018322625,0.0031502307,0.00023870947,0.00015186812,9.518718e-7,3.9922324e-7,0.00013753207,0.00018725597,0.9900332],"study_design_scores_gemma":[0.0041859304,0.003072632,0.0034500365,0.0021664912,0.0032783705,0.0058135143,0.000112607544,1.4048885e-7,0.000027415668,0.00004821555,0.9774058,0.00043887034],"about_ca_topic_score_codex":0.00009337554,"about_ca_topic_score_gemma":0.00020367722,"teacher_disagreement_score":0.98959434,"about_ca_system_score_codex":0.00012175771,"about_ca_system_score_gemma":0.0011125811,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W839775831","doi":"10.1007/s40257-015-0141-9","title":"23rd World Congress of Dermatology: Vancouver, Canada, June 8–13, 2015","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Pharmacotherapy; Family medicine; Internal medicine","score_opus":0.03432645344616939,"score_gpt":0.3251040620749621,"score_spread":0.2907776086287927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W839775831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96406543,0.0050772117,0.00010056675,0.007425639,0.021730788,0.00014847054,0.00006014591,0.0000236063,0.0013681183],"genre_scores_gemma":[0.99601424,0.00022887973,0.00048713898,0.00085077464,0.0001146344,0.0000042085517,0.0000176799,0.000024181027,0.0022582365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511176,0.0015204626,0.0024156831,0.0002775581,0.00014354374,0.0005310061],"domain_scores_gemma":[0.99464446,0.0015829736,0.002483943,0.00039223573,0.00064354687,0.00025284232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005315555,0.0002974251,0.002237646,0.00026884367,0.00006410708,0.0000049076625,0.0006002064,0.00025198126,0.0001534988],"category_scores_gemma":[0.0008512698,0.00023702733,0.00037569457,0.0003920346,0.0014666343,0.00011371658,0.00010411458,0.0006117523,0.000064023014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015651163,0.00041279962,0.22259037,0.000015167662,0.001391063,0.0012574715,0.00009607875,0.000009899776,0.0001549417,0.00022069144,0.74814105,0.024145365],"study_design_scores_gemma":[0.011775189,0.0010142614,0.022977049,0.000090504385,0.00086679077,0.011800716,0.0014333305,0.000008008006,0.010739469,0.0003494652,0.93842953,0.00051566056],"about_ca_topic_score_codex":0.015937801,"about_ca_topic_score_gemma":0.25056624,"teacher_disagreement_score":0.23462845,"about_ca_system_score_codex":0.00006109633,"about_ca_system_score_gemma":0.0024172426,"threshold_uncertainty_score":0.9906151},"labels":[],"label_agreement":null},{"id":"W98489906","doi":"10.2165/00128071-200304100-00004","title":"Photodynamic Therapy and Topical Aminolevulinic Acid","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Photodynamic therapy; Medicine; Actinic keratosis; Phototoxicity; Dermatology; Mycosis fungoides; Actinic keratoses; Acne; Prodrug; Protoporphyrin IX; Psoriasis; Skin cancer; Cancer; Cancer research; Pathology; Basal cell; Pharmacology; Internal medicine; Lymphoma; Chemistry","score_opus":0.11317456751194192,"score_gpt":0.47996568885444374,"score_spread":0.3667911213425018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W98489906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026413755,0.9714078,0.00002725808,0.0006447514,0.0005360686,0.00052033615,0.000009938955,0.000016900827,0.00042320302],"genre_scores_gemma":[0.003234271,0.9941449,0.00089077995,0.0012170919,0.00028023246,0.00001964012,0.0000064949404,0.000068786176,0.0001377884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931079,0.0018993446,0.0035105126,0.00046768473,0.00045246238,0.00056208344],"domain_scores_gemma":[0.993163,0.0029003841,0.0025454932,0.0005157002,0.00026792826,0.00060752215],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001093421,0.00052979303,0.008356748,0.00039163363,0.00006538553,0.000019770801,0.0004141178,0.0004411504,0.00008444799],"category_scores_gemma":[0.0009989459,0.00034237406,0.0016474578,0.0003935599,0.002122876,0.000058038026,0.00011032051,0.0026849431,0.000028527527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032666532,0.00034053114,0.00024129999,0.0012214561,0.0013165362,0.0011825499,0.000025704354,6.9045942e-9,0.000003723026,0.000024902021,0.00043641197,0.9948802],"study_design_scores_gemma":[0.002401695,0.003765864,0.00047057203,0.0020320646,0.00082313264,0.02214472,0.00006528283,0.0000030560857,0.0000047863405,0.00006393436,0.96794033,0.00028455484],"about_ca_topic_score_codex":0.0000045382517,"about_ca_topic_score_gemma":0.0000017245158,"teacher_disagreement_score":0.99459565,"about_ca_system_score_codex":0.00007134692,"about_ca_system_score_gemma":0.0012754524,"threshold_uncertainty_score":0.99990284},"labels":[],"label_agreement":null}]}